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Statistical methods for multi-omic data integration
Alessandra Cabassi
The thesis is focused on the development of new ways to integrate multiple ’omic
datasets in the context of precision medicine. This type of analyses have the po-
tential to help researchers deepen their understanding of biological mechanisms
underlying disease. However, integrative studies pose several challenges, due to
the typically widely differing characteristics of the ’omic layers in terms of num-
ber of predictors, type of data, and level of noise.
In this work, we first tackle the problem of performing variable selection and
building supervised models, while integrating multiple ’omic datasets of differ-
ent type. It has been recently shown that applying classical logistic regression
with elastic-net penalty to these datasets can lead to poor results. Therefore, we
suggest a two-step approach to multi-omic logistic regression in which variable
selection is performed on each layer separately and a predictive model is subse-
quently built on the ensemble of the selected variables.
In the unsupervised setting, we first examine cluster of clusters analysis (COCA),
an integrative clustering approach that combines information from multiple data
sources. COCA has been widely applied in the context of tumour subtyping, but
its properties have never been systematically explored before, and its robustness
to the inclusion of noisy datasets is unclear. Then, we propose a new statistical
method for the unsupervised integration of multi-omic data, called kernel learn-
ing integrative clustering (KLIC). This approach is based on the idea to frame the
challenge of combining clustering structures as a multiple kernel learning prob-
lem, in which different datasets each provide a weighted contribution to the final
clustering.
Finally, we build upon the notion of the posterior similarity matrix (PSM) in order
to suggest new approaches for summarising the output of MCMC algorithms
for Bayesian mixture models. A key contribution of our work is the observation
that PSMs can be used to define probabilistically-motivated kernel matrices that
capture the clustering structure present in the data. This observation enables us to
employ a range of kernel methods to obtain summary clusterings, and, if we have
multiple PSMs, use standard methods for combining kernels in order to perform
integrative clustering. We also show that one can embed PSMs within predictive
kernel models in order to perform outcome-guided clustering.
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High-throughput technologies have made it possible to collect an enormous amount
of ’omic data in a variety of contexts, ranging from medical (e.g. oncology; Aure
et al., 2017) to commercial applications (Zhu et al., 2012). To give an example,
data for over 10,000 cancer patients have been collected for The Cancer Genome
Atlas (TCGA) project alone (The Cancer Genome Atlas Research Network et al.,
2013) with the goal of uncovering similarities and dissimilarities between differ-
ent tumour types and exploit them to develop more specific and effective cancer
treatments.
Common to multi-omic studies is the desire to deepen biological insight, to im-
prove our ability to characterise biological processes, and/or to enable better pre-
dictions (e.g. regarding disease outcome) to be made. In precision medicine, for
example, the goal is to exploit ’omic data in order to increase the accuracy and
efficiency of medical decisions and treatments (Hasin, Seldin, and Lusis, 2017).
Multi-omic studies have been extensively used, for example, to discover novel
disease subtypes in cancer (see e.g. Shen et al., 2012 for glioblastoma; The Can-
cer Genome Atlas Research Network, 2012 for breast cancer; The Cancer Genome
Atlas Research Network, 2017 for liver cancer), inflammatory myopathies (Green-
berg et al., 2002), and auto-immune diseases (Lee et al., 2011).
The challenge is then to develop statistical methods that can cope with the huge
amount and variety of data and, at the same time, are able to take into account
the fact that each data layer has different properties and characteristics. In this
thesis, novel methodologies are proposed to address some of the open questions
in this field. In particular, we focus on supervised and unsupervised integration
of multi-omic datasets.
Chapter outline
The motivation for developing statistical methodologies for multi-omic data inte-
gration is elucidated in Section 1.1. The ’omic data types considered in this thesis
are introduced in Section 1.2. Then, the statistical setting and mathematical nota-
tion used throughout this thesis are introduced in Section 1.3. The goals of super-
vised and unsupervised integration of multi-omic data are presented in Section
1.4, followed by a description of some of the issues associated with the statistical
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analysis of multi-omic data, in Section 1.5. Finally, we give an overview of the
structure of the thesis in Section 1.7.
1.1 MOTIVATION
A molecular term followed by the suffix ’omics indicates a comprehensive or full
assessment of a set of molecules (Hasin, Seldin, and Lusis, 2017). Before intro-
ducing the types of ’omic data layers used in this thesis, we explain why it is
important that these datasets are collected and analysed together.
The most mature of the ’omic fields is genomics. As opposed to genetics, which
focuses on single genes or variants, the word genomics indicates the study of
an organism’s complete set of DNA, the genome (WHO definitions of genetics and
genomics). In the early 2000s, thanks to the availability of large amounts of whole-
sequencing data, genome-wide association studies (GWAS) were designed to iden-
tify genotype-phenotype associations (Klein et al., 2005). These studies have
made it possible to improve understanding of many complex traits, including
both common and rare diseases (Calvo et al., 2006). For instance, they have led
to the discovery of heritable mutations linked to breast cancer, such as muta-
tions in the BRCA1 and BRCA2 genes (Venkitaraman, 2014). Nevertheless, it has
become clear in recent years that the genetic variants identified by GWAS only
account for a fraction of the heritability of specific traits and that gene regula-
tion also plays an important role in explaining phenotype (Visscher et al., 2012).
Moreover, the same genetic variants can lead to different outcomes depending on
external factors (Tam et al., 2019). Finally, while the analysis of the genome can
only reveal correlations, by integrating multiple ’omic data layers, one might ex-
pect to uncover potential causes of a certain disease, deepen their understanding
of the mechanisms underlying its development, and/or identify putative treat-
ment targets (Hasin, Seldin, and Lusis, 2017). Therefore, one of the reasons why
multi-omic analyses have become so widespread, is that they overcome some of
the limitations of GWAS.
The central dogma of molecular biology, as formulated by Francis Crick in the
1950s, states that the flow of genetic information is unidirectional: DNA is copied
to RNA via a process called transcription, and proteins are synthesised from the
information contained in the RNA (more precisely messenger RNA, as explained
below) through a process known as translation (Crick, 1958). Since the central
dogma was first introduced, the understanding of how genetic information is
transferred within biological systems has greatly improved and more complex
interactions between their components have been discovered (Shapiro, 2009).
Multi-omic studies take a holistic (or systems) approach and incorporate differ-
ent ’omic data layers into coherent models, acknowledging that complex inter-
connections exist between them (Huang, Chaudhary, and Garmire, 2017). This
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allows researchers to overcome the limitations of single ’omic analyses and has
many advantages. First, each ’omic layer provides different types of information.
This can be beneficial in prediction and subtyping analyses such as those pre-
sented in this thesis, given that each layer provides complementary information
that can be used to produce the final output (Bersanelli et al., 2016). Moreover,
when the relative importance of each layer for the problem at hand is unknown,
this can be inferred using multi-omic statistical methods. Additionally, if the data
collected for one of the statistical units in the study is noisy, information can be
borrowed from other layers. Another advantage is that jointly analysing differ-
ent ’omic layers can provide deeper insights into the mechanisms underlying the
biological phenomenon of interest compared to single-omic analyses, potentially
uncovering interactions between the ’omic layers (Rogers et al., 2008). In Figure
1.1 is depicted a simplified representation of the main ’omic types considered in
this thesis and some of the ways in which they are related.
Holistic approaches combining multiple ’omic data layers have proved useful in
several fields. They have been widely applied, for instance, to cancer studies
(Karczewski and Snyder, 2018), with various goals, including: locating genetic
mutations that are drivers for cancer development The Cancer Genome Atlas Re-
search Network (2017), identifying molecular signatures of specific tumour types
(Kristensen et al., 2012), discovering cancer subtypes (The Cancer Genome Atlas
Research Network, 2011; Sato et al., 2013). Recent progress in this field, from the
point of view of the statistical methodology, has been reviewed and summarised,
among others, by Kristensen et al. (2014) and Nicora et al. (2020).
1.2 MULTI-OMIC DATA
In this section we give a brief description of the types of datasets that are consid-
ered in this thesis.
Genomics
As we have mentioned, genomics is concerned with the study of an organism’s
full DNA, and the advent of high-throughput DNA sequencing technologies gen-
erated a proliferation of whole-genome studies over the past two decades (Good-
win, McPherson, and McCombie, 2016). The genome-wide associations studies
mentioned above focus on finding specific genetic variants associated with the
trait of interest. However, other features of the genome can explain phenotype
variability. For instance, in many living organisms, some sections of the genome
are repeated. In humans, two-thirds of the genome are composed of repeats (Kon-
ing et al., 2011). Therefore, copy number variation is also routinely recorded and
examined in genomics. Data of this type have been used to gain insight into hu-















FIGURE 1.1: Simplified representation of the interactions be-
tween some of the ’omic data layers considered in this the-
sis. DNA is transcribed to make different types of RNA. For
simplicity, only mRNA is represented here. Proteins are syn-
thesised from the information contained in the mRNA. The
metabolites present in a cell are determined by the proteins
as well as environmental factors. Proteins interact not only
between them, but also with the DNA. For example, tran-
scription factors (TFs) are proteins that initiate and regulate




and schizophrenia (St Clair, 2009).
Transcriptomics
The transcriptome is the set of all RNA transcripts produced under specific circum-
stances or in a specific cell (Watson et al., 2014, Chapter 7). The field of transcrip-
tomics therefore examines genome-wide RNA levels. The technique that is used
most frequently to study the transcriptome is RNA sequencing (RNA-seq; Allison
et al., 2006; Ozsolak and Milos, 2011). This sequencing technique is used to reveal
the presence and quantity of RNA in a biological sample. Different types of RNA
exist. In most applications, interest is focused on messenger RNA (mRNA), which
is the one containing the necessary information for protein synthesis. In one of the
real data applications considered in this thesis, however, we also have microRNA
expression data available. microRNAs, commonly referred to as miRNAs, are
small non-coding RNA molecules that have been identified more recently than
mRNA (Bartel, 2004). They regulate gene expression by influencing the stability
of mRNA or its ability of being translated (Watson et al., 2014, Chapter 8).
Proteomics
The transcription rate of a gene only gives an approximate estimate of the ex-
pression of the protein encoded by it. This is because the corresponding mRNA
can decay quickly or not be translated much and therefore looking only at gene
expression can be misleading. This is why it is important to also identify and
quantify the cellular levels of each protein encoded by the genome, the so-called
proteome, in the cell or tissue of interest. This is what is commonly referred to
as proteomics (Joyce and Palsson, 2006). Protein-protein interactions and post-
translational modifications are also of interest, as they influence the proteins’ ac-
tivity (Watson et al., 2014, Chapter 7).
Metabolomics
The term metabolite indicates any intermediate or end product of metabolism
(Venes, 2017). Metabolomics is then the systematic study of metabolites within a
specific cell or tissue (Tweeddale, Notley-McRobb, and Ferenci, 1998). As pointed
out by Hollywood, Brison, and Goodacre (2006), metabolomics is complementary
to transcriptomics and proteomics, because multiple factors (i.e. post-transcriptional
and post-translational events) influence metabolic fluxes. Thus, the metabolome
is considered to be closer to the phenotype (see Figure 1.1).
Lipidomics
A type of metabolite that is of particular interest for one of the motivating ex-
amples of this thesis are lipids. For this reason, we also introduce lipidomics: the
system-level analysis of lipids and their interactions with proteins and with other
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metabolites (Wenk, 2005). A number of human and animal diseases have been
associated with abnormal lipid levels, including cancer (Reynolds, Maurer, and
Kolesnick, 2004), diabetes (Shi and Burn, 2004), and neurodegenerative diseases
(Cutler et al., 2004).
Epigenomics
Epigenomics is the study of the complete set of epigenetic modifications on the
genetic material of a cell, known as the epigenome (Fazzari and Greally, 2004).
Changes to the epigenome are heritable and can result in modifications of chro-
matin structure and to the function of the genome (Yong, Hsu, and Chen, 2016).
In this thesis we analyse both histone modifications and transcription factor data.
In eukaryotic cells, histones are the proteins around which the DNA is packed
(Campos and Reinberg, 2009). Histone modifications include a few chemical
modifications, each having a different effect on gene regulation (Kuo and Al-
lis, 1998). Here we only consider DNA methylation, which occurs when methyl
groups are added to a DNA molecule (Moore, Le, and Fan, 2013). If a gene pro-
moter is methylated, transcription of the corresponding gene is usually repressed
(Joyce and Palsson, 2006).
Transcription factors (TFs) are proteins that control the transcription rate of certain
genes by binding to specific DNA binding sites (Latchman, 1997). The data that
we analyse in this thesis have been collected using either chromatin immuno-
precipitation DNA sequencing (ChIP-seq) or ChIP-chip techniques (i.e. where
chromatin immunoprecipitation experiments are performed on DNA microar-
rays, also known as chips) to identify the binding sites of each transcription factor
of interest.
Other ’omics
Other ’omic data types that are not considered here include, among others: mi-
crobiomics, the study of all microorganisms of a given community (see e.g. Egert
et al., 2006), glycomics, the comprehensive study of glycan structures of a given
cell type or organism (Wandall et al., 2017).
1.2.1 Individual-level versus gene-level multi-omic analyses
We have already mentioned a few multi-omic studies where the goal is to uncover
the structure of a population of individuals. For example, in precision medicine
applications such as those cited above, multiple types of ’omic data are combined
to characterise the molecular signature of the disease of interest, investigate dis-
ease pathogenesis pathways and develop personalised therapies.
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However, it is important to note that multi-omic datasets can also be collected for
a specific set of genes; datasets of this kind can be used to identify sets of genes
that have similar functions. A typical example is transcriptional module discovery
(Wu et al., 2002): genes belonging to the same transcriptional modules are reg-
ulated by the same transcription factors and share the same biological function.
Combining gene expression and transcription factor binding data can help iden-
tify transcriptional modules and improve the understanding of cellular processes
(Savage et al., 2010).
Throughout this thesis, we consider and develop methodologies that can be ap-
plied to both types of data. In fact, two out of three real data applications consid-
ered in this work belong to the first category (i.e. individual-level multi-omics),
while the remaining one is part of the second category (i.e. gene-level multi-
omics).
1.3 MATHEMATICAL NOTATION
In this section, we set out the mathematical framework and notation of the method-
ological and applied problems tackled in this thesis.
In every application considered in this thesis, we have a collection of N statistical
units (e.g. individuals or genes) for which M different types of ’omic measure-
ments have been taken. We indicate each ’omic data layer by Xm and by Pm the
number of features in that layer, that is Xm ∈ RN×Pm for m = 1, . . . , M. Moreover,
throughout this thesis we indicate by X the matrix containing all data layers, de-
fined as
X = [X1, . . . , XM] ∈ RN×P,
where P = P1 + · · · + PM is the total number of features available for each in-
dividual, taking all data layers together. In supervised settings we also have a
response yn for each observation n = 1, . . . , N (Figure 1.2).
1.4 STATISTICAL METHODS FOR MULTI-OMIC INTEGRATION
There are many ways in which multi-omic analysis approaches could be classi-
fied. Subramanian et al. (2020), for instance, grouped them by the type of biolog-
ical question they address. Here, we divide them into supervised and unsuper-
vised analyses. Both types of analyses are briefly introduced here; however, to




X1 ∈ RN×P1 . . . XM ∈ RN×PM y ∈ RN
X ∈ RN×P
FIGURE 1.2: Schematic representation of multi-omic data.
X1, X2, . . . , XM are ’omic layers relative to the same obser-
vations, y is a response/outcome variable. The data matrix
comprising all data layers is indicated by X. Each colour in-
dicates a different ’omic layer.
Supervised integration
In supervised settings, the ’omic data layers are commonly used to learn a pre-
dictive model for the response variable of interest. In precision medicine appli-
cations, for instance, this can be a binary variable indicating the disease status of
each individual, a continuous score that is known to be associated to the severity
of disease, or survival/relapse time (see e.g. Seoane et al., 2014; Zhao et al., 2015).
Additionally, the supervised integration of multiple ’omic data layers can also
be exploited for biomarker discovery via variable selection methods (Rohart et
al., 2017). This can give insights into the molecular mechanisms underlying the
pathogenesis and ætiology of a certain disease.
To give an example, one of the perspectives of development for the supervised
integration of multi-omic data identified very recently by Karczewski and Sny-
der (2018) was the construction of predictive models of disease risk, to be used to
perform early detection of disease on healthy individuals. Karczewski and Sny-
der envisioned, for example, the creation of models of cardiovascular disease that
could stratify individuals into high- and low-risk categories, combining genomic
and metabolomic data. The supervised integration problem considered in this
thesis is closely related to this.
In this thesis we focus on binary classification models. In particular, we consider
penalised likelihood approaches, which are scalable, widely used, and have the
advantage of having efficient implementations available. A more detailed expla-
nation of how these methods work is presented in Chapter 2.
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Unsupervised integration
The unsupervised integration methods considered in this thesis are integrative
clustering algorithms. The goal of multi-omic integrative clustering is to identify
individuals or genes that appear similar across most of the available data layers.
For example, Hoadley et al. (2014) used cancer samples from 12 different tumour
tissues to identify cancer subtypes having similar molecular profiles. The novel
cancer subtypes found by Hoadley et al. were shown to provide prognostic infor-
mation, which could be used to develop targeted therapy for each subtype. The
unsupervised methods developed in this thesis target applications of this kind.
An extensive literature review of unsupervised methods for the integration of
multiple ’omic data layers is presented in Chapter 3.
It is important to note, however, that unsupervised integration methods of multi-
omic data also include factor analysis (Argelaguet et al., 2018) and variance de-
composition methods (Lock et al., 2013). The goal of this type of methods is to
identify a set of latent factors which capture the different sources of variability
across ’omic data layers. We do not focus on these methods here, since our objec-
tives are substantially different, as is explained in Chapter 3.
1.5 STATISTICAL CHALLENGES OF MULTI-OMIC INTEGRATION
Detailed reviews of current statistical methods for integrative ’omics include those
of Richardson, Tseng, and Sun (2016), Bersanelli et al. (2016), Huang, Chaudhary,
and Garmire (2017), Li, Wu, and Ngom (2018), and Subramanian et al. (2020). We
summarise here the most well-known issues associated with the joint statistical
analysis of multiple ’omic datasets that have emerged over the years.
Different types of data
’Omic data layers can be of different types. For instance, measurements expres-
sion level can either be continuous or count data. The transcription factor data
analysed in the following chapters, instead, are binarised so that ones indicate
interactions between a DNA-binding site and a transcriptional regulator, zeros
represent absence of interaction. When developing integrative methods for multi-
omic data, it is crucial to take this into account.
Different layer sizes
The number of features available can differ greatly across data layers. For hu-
mans, for example, genomic data layers can have a huge number of features,
since their DNA contains approximately 3 billion base pairs and more than 20,000
genes (Watson et al., 2014, Chapter 2). Human metabolomic and lipidomic data,
on the contrary, are usually of much lower dimension (Wishart, Tzur, and Knox,
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2007). When all data layers are considered together, untangling the contribu-
tions of each layer is often difficult. Moreover, there is a risk of inadvertently let-
ting larger datasets have greater impact on the analysis than smaller ones, even
though they are not necessarily the most informative ones.
Varying levels of noise
High-throughput techniques are known to be plagued by high levels of technical
noise (see e.g. Marshall, 2004; Ioannidis, 2005) and batch effects (Leek et al., 2010).
Similar to the previous point, this one too must be tackled by carefully monitoring
how much each data layer contributes to the final output, so that noisy datasets
are prevented from having excessive influence on the analysis.
High computational cost
Due to the ever increasing size of high-throughput datasets, multi-omic data
usually comprise very large numbers of features P and, in some instances, also
present a large number of observations N. This can make it impossible or ex-
tremely computationally demanding to apply existing methods to these types of
data. As we discuss at length in the next chapters, possible solutions to this prob-
lem include reducing the number of features with variable selection methods
or other pre-screening techniques, and/or making use of two-step approaches
where the dimensionality of each layer is reduced in the first step independently
from the other layers. However, care must be exercised when using these strate-
gies, as these may result in unclear or unwanted up- or down-weighting of the
impact of each dataset on the final prediction/clustering.
Large P small N
Another issue related to the large size of high-throughput datasets is the so-called
large P small N problem. For instance, supervised methods are known to require
extra care when the number of variables P exceeds the number of statistical units
N. This is because classical statistical methods designed for large N small P sit-
uations may fail or overfit the data (James et al., 2013). More details about this
issue are given in Chapter 2, where penalised likelihood methods are introduced.
Moreover, in situations where one may want to perform an hypothesis test for
each ’omic variable, multiple testing correction makes the overall procedure ex-
tremely conservative (McIntyre et al., 2000), as we shall see in Chapter 2. Combin-
ing multiple large P, small N datasets of different types raises new questions, as
the large P small N problem is exacerbated by the presence of multiple datasets.
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1.6 TWO-STEP INTEGRATIVE METHODS
Integrative methods can also be divided into joint and two-step models. In the
former, all ’omic layers are analysed together. In two-step approaches, instead,
dimension reduction is first performed on each ’omic layer separately. All ’omic
layers are then integrated in a subsequent step to generate the final output. These
methods have sometimes also been referred to as sequential analysis (Kristensen
et al., 2014) or late integration methods (Rappoport and Shamir, 2018).
While joint models can in principle detect and exploit dependencies between fea-
tures in different layers, they suffer from the issues described in the previous
section and, for that reason, are often not applicable to large multi-omic datasets
in practice. Therefore in this thesis we focus our attention on two-step integrative
methods, which overcome these issues in a principled way. As we shall see, the
first step enables us to solve the problems of high computational cost and large
P small N, by decreasing the dimension of each layer separately. Moreover, in
the first step, different types of data can be analysed with different techniques.
Therefore, depending on the data type of each layer, the most appropriate me-
thod can be selected. Similarly, the problem of unbalanced feature numbers in
the ’omic layers can be alleviated by either making sure that a reasonable num-
ber of features is selected in each layer or summarising the information of each
’omic layer into more easily comparable statistical objects. Finally, we show in
later chapters how the use of appropriate weighting strategies can help tackle the
issue of varying levels of noise.
1.7 THESIS OVERVIEW
Chapter 2: Two-step penalised logistic regression for multi-omic data
In Chapter 2 we build two classification models that predict a binary class label
on the basis of multiple ’omic layers. We use a wide range of simulation stud-
ies to show that these methods identify higher numbers of relevant features and
achieve comparable misclassification rates to competitor methods.
Furthermore, we analyse a novel dataset comprising eight layers of ’omic data,
as well as a wide range of clinical covariates associated to cardiometabolic dis-
ease, for lipodystrophy patients, obese individuals, and blood donors. We de-
scribe a multi-omic analysis aimed at identifying molecular signatures of car-
diometabolic syndrome and building a predictive model for the risk of devel-
oping cardiometabolic syndrome.
The work presented in Chapter 2 was carried out as part of a larger study, that
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was done in collaboration with the Department of Hæmatology of the Univer-
sity of Cambridge. Part of the data analysis included in the chapter has been in-
corporated into a manuscript entitled “Transcriptional, epigenetic and metabolic
signatures in cardiometabolic syndrome defined by extreme phenotypes” that is
available on bioRχiv (Seyres et al., 2020). The methodological content of the chap-
ter has been published as an arχiv preprint with title “Two-step penalised logistic
regression for multi-omic data with an application to cardiometabolic syndrome”
(Cabassi et al., 2020), which is currently under review at the Statistical Applications
in Genetics and Molecular Biology journal1.
Chapter 3: Multiple kernel learning for integrative clustering of ’omic datasets
In Chapter 3 we present a review of the existing clustering methods for multi-
omic data and systematically explore one of them, called cluster-of-clusters analysis
(COCA). This provides the motivation to propose an alternative strategy named
kernel learning integrative clustering (KLIC). This method is based on the idea that
kernels can be built for each ’omic data layer using consensus clustering (Monti
et al., 2003) and combined in a principled way via multiple kernel learning. We
assess both methods via extensive simulation studies and compare them to com-
petitor methods. Finally, we apply them to two real clustering problems: pan-
cancer clustering and transcriptional module discovery.
The content of Chapter 3 has been published as a manuscript entitled “Multiple
kernel learning for integrative consensus clustering of ‘omic datasets” (Cabassi
and Kirk, 2020b). Together with the article, two R packages, called coca and klic
have been published on the Comprehensive R archive network (CRAN; Cabassi
and Kirk, 2020a; Cabassi, Gönen, and Kirk, 2020).
Chapter 4: Summarising and combining posterior similarity matrices
In Chapter 4 we propose a new way of summarising the posterior similarity ma-
trices (PSMs) derived from the Markov chain Monte Carlo output of Bayesian
model-based clustering, making use of kernel methods. At the same time, we
also prove that PSMs are valid kernels, which can be used as input to KLIC. Us-
ing Bayesian model-based clustering algorithms instead of heuristic approaches
of Chapter 3 has several advantages: not only it represents a more principled way
of seeking a partition of the data, but it also provides elegant solutions to some
of the difficulties encountered in Chapter 3, such as the choice of the number of
clusters and the selection of the variables relevant for clustering. Moreover, we
extend the kernel learning integrative clustering methodology to the outcome-
guided setting, where a response variable is used to guide the kernel weight-




methods perform in practice, through a set of simulation studies, and apply these
methods to the same real data applications presented in Chapter 3.
The work presented in Chapter 4 has been made available on arχiv as a preprint
titled “Kernel learning approaches for summarising and combining posterior sim-
ilarity matrices” (Cabassi, Richardson, and Kirk, 2020).
Chapter 5: Integrative analysis of cardiometabolic disease data
The cardiometabolic syndrome dataset introduced in Chapter 2 is used in Chap-
ter 5 to show how all the methodological developments of this thesis are linked
together. In particular, after using the classification models of Chapter 2 to iden-
tify the variables that discriminate between healthy individuals and those af-
fected by cardiometabolic syndrome, we are able to apply the unsupervised and
outcome-guided methods of Chapter 3 and 4 to this dataset.
Chapter 6: Discussion
Finally, in Chapter 6 are summarised the overall findings of the thesis and are




TWO-STEP PENALISED LOGISTIC REGRESSION FOR
MULTI-OMIC DATA
In this chapter we focus on the problem of making predictions for a binary vari-
able using multiple high-dimensional ’omic layers. In our motivating example,
we are interested in finding molecular signatures of cardiometabolic syndrome in
eight ’omic layers. We propose a two-step approach in which a variable selection
step is first performed on each ’omic layer separately, using penalised logistic re-
gression approaches. In the second step, all the selected variables are included in
a ridge-penalised logistic regression model, which is fitted to the data. We com-
pare this approach to (i) fitting a logistic regression model with elastic-net penalty
on the data matrix formed by concatenating all layers (matrix X in Figure 1.2), (ii)
a newly developed integrative method that fits a regression model on all data
types together, but assigning different penalty factors to each of them (Zhao and
Zucknick, 2020), (iii) selecting features via a univariate approach and then using
all the selected variables to fit a ridge-penalised logistic regression model.
We consider a wide range of simulation studies. In each simulation setting there
are two data types with varying characteristics (e.g. number of features, percent-
age of relevant features, etc.), as well as a smaller data type that only contains
features that are known to be associated with the outcome of interest, and there-
fore are not penalised. In ’omic data applications, this corresponds to having
two ’omic datasets and a small set of clinical parameters. The simulation studies
show that, depending on the goal of the analysis (e.g. estimation of patient risk of
developing a disease, multi-omic signature identification, etc.), different integra-
tive methods should be preferred. If the objective is to make accurate predictions
and, at the same time, identify the highest possible number of variables that are
relevant for the problem at hand, then our approach is the most suitable.
We apply the developed methods to a novel multi-omic dataset, collected with
the aim of understanding and identifying a molecular characterisation of car-
diometabolic syndrome, that could improve our understanding of this condition
and, as a consequence, help develop new treatment strategies. We analyse eight
different types of ’omic data from 184 blood donors, as well as 11 obese and 10
lipodystrophy individuals. We use these data to identify putative signatures of
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cardiometabolic syndrome and build a predictive model to determine the proba-
bility of belonging to the obese or lipodystrophy group. We investigate the impact
of the choice of the elastic-net parameter on the estimated probabilities and the
variables selected, by comparing to a rank aggregation approach.
Chapter outline
The chapter is structured as follows. Section 2.1 contains an introduction to pe-
nalised regression, with particular focus on the models that have been developed
specifically for multi-omic data. The novel methods are introduced in Section 2.2
and simulation studies are performed in Section 2.3 to compare the new and ex-
isting methods. The dataset available for this study is presented in Section 2.4.
The multivariate data analysis is reported in Section 2.5. The comparison to the
univariate analysis of the data is presented in Section 2.6. In Section 2.7, the find-
ings of the multivariate analysis are validated using two external cohorts. Finally,
in Section 2.8 we summarise the main findings of this work and the challenges en-
countered when performing this analysis.
2.1 PENALISED REGRESSION FOR MULTI-OMIC DATA
First, we briefly recall the basics of penalised logistic regression in Section 2.1.1.
Then, a review of the predictive models of this type that have been used to inte-
grate multiple ’omic datasets is given in Section 2.1.2. Finally, Section 2.1.3 con-
tains the details of the algorithm that is extensively used in the remainder of this
chapter to tune the penalty parameters.
2.1.1 Penalised logistic regression
In traditional logistic regression settings, one has a data matrix X ∈ RN×P com-
prising N observations xn, n = 1, . . . , N, for which a set of p variables has been
measured, and a set of binary responses y = [y1, . . . , yN ] ∈ {0, 1}N , one for each
observation in X. Logistic regression is a statistical method that can be used to
build a model that predicts the probability that the response ynew corresponding
to a new observation xnew is equal to one (Cramer, 2002; Hastie, Tibshirani, and
Friedman, 2009). This is done via the logistic function




where β0 and β = [β1, . . . , βp] are the so-called regression coefficients. In particular,
β0 is the intercept of the model and each βp is the coefficient corresponding to the
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pth variable (i.e. column) in X. The regression coefficients can be estimated by




l(X, y; β0, β),
where l(X, y; β0, β) indicates the log-likelihood of the data given β0 and β. By






= β0 + βx.
The expression on the left hand side is called the log-odds (Hastie, Tibshirani, and
Friedman, 2009, Chapter 4).
In the presence of large numbers of predictors, the estimates of the regression co-
efficients β0 and β given by solving the optimisation problem above are highly
variable (Hastie, Tibshirani, and Friedman, 2009, Chapter 3). To avoid this prob-
lem, shrinkage methods are often used. The most popular shrinkage approaches
are ridge regression and least absolute shrinkage and selection operator (LASSO).
Ridge regression maximises the maximum likelihood subject to a quadratic penalty
on the coefficients. This corresponds to solving the optimisation problem
min
β0∈R, β∈RP
− l(X, y; β0, β) + λ‖β‖2, (2.2)
where ‖ · ‖2 is the l2 norm, defined as ‖β‖2 = ∑Pp=1 β2j and λ is a tuning parameter
that determines the strength of the penalty (Hoerl and Kennard, 1970). The pa-
rameter λ is usually determined by cross-validation (CV), so as to minimise some
measure of the average prediction error (Kohavi, 1995). More details about CV
and the choice of λ are given at the end of this section.
LASSO regression instead has an l1-penalty:
min
β0∈R, β∈RP
− l(X, y; β0, β) + λ‖β‖1,
where ‖ · ‖1 is the l1 norm, defined as ‖β‖1 = ∑Pp=1 |β j|. Contrary to ridge regres-
sion, LASSO sets some of the regression coefficients to zero, which is equivalent to
doing variable selection. This gives rise to more interpretable predictive models,
since the predictions are based on fewer variables (Tibshirani, 1996). However, if
there is a set of highly correlated variables associated with the response, LASSO
tends to select only one of them (Zou and Hastie, 2005). This might not always
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be the desired outcome. For instance, in the application presented here, we want
to be able to select all the variables that are predictive of patient status.
In what follows, we make extensive use of a penalised logistic regression method
that uses a mixture of the l1 and l2 penalties, called the elastic-net (EN):
min
β0∈R, β∈RP
− l(X, y; β0, β) + λ [(1− α)‖β‖2 + α‖β‖1] (2.3)
Here α ∈ [0, 1] is the weight assigned to the LASSO penalty, and 1 − α is the
weight assigned to the ridge penalty (Zou and Hastie, 2005). Therefore, the num-
ber of selected variables decreases as α increases (Hastie, Tibshirani, and Fried-
man, 2009, Chapter 3).
Choice of the tuning parameters
In EN, the parameters that need to be tuned are λ, which represents the strength
of the penalty, and α, which defines how much importance is given to the l1
penalty relative to the l2 penalty (see Equation 2.3).
As mentioned previously, a popular method to choose the parameter λ is cross-
validation (Kohavi, 1995). Briefly, k-fold CV is a resampling method that helps
estimating the out-of-sample error of a predictive model. In the case of logistic
regression, the out-of-sample error is usually measured as the average number of
misclassified observations in the test set. Indicating by ŷi the predicted value for
observation i and by Ntest the number of observations in the test set, the misclas-
sification rate (MR) is
MR =
∑Ntestn=1 1(yi 6= ŷi)
Ntest
.
In CV, first the data are split into k folds, using one of the folds in turn as the
test set and the others as the training set. The out-of-sample error for a certain
value of the parameter of interest is then estimated as the average validation error
over the k repetitions. This procedure is repeated for a set of plausible values of
the parameter of interest; the value that minimises the average error is selected.
Alternatively, one can choose the model that has the smallest number of non-
zero coefficients among those that have out-of-sample error within one-standard
deviation of the minimum (Hastie, Tibshirani, and Friedman, 2009, Chapter 7).
This is known as the one standard deviation rule. The choice of the number k is
usually made taking into account the bias-variance trade-off (James et al., 2013,
Chapter 5). The parameter α can be tuned using CV or chosen so as to give the
desired number of selected variables (Zou and Hastie, 2005).
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2.1.2 Penalised likelihood models for multi-omic data
In the context of the integration of multiple ’omic datasets, prediction can be done
for a variety of purposes. For instance, diagnostic models can be trained to detect
whether a person has a certain disease or not, while prognostic models can be
used to predict the mortality risk for people suffering from a given condition.
The integration of multiple ’omic datasets in the context of prediction, however,
cannot be done via the classical methods for penalised logistic regression such as
those presented in the previous section, but requires the development of novel
statistical methods. Indeed, previous research has shown that applying classical
logistic regression with EN penalty to these datasets can lead to poor results (Liu
et al., 2018). The main ideas behind the methods available in the literature are
illustrated below.
Predictive models for multi-omic data have also been proposed in the Bayesian
literature (Wang et al., 2013; Velten and Huber, 2018). However, these models
require a specific set of multi-omic layers, which does not correspond the one we
have available in our motivating example. Therefore, we do not consider them
here.
A two-step approach
One of the first examples of predictive models for multi-omic datasets is that of
Zhao et al. (2015), in the context of cancer prognosis. First, they apply LASSO
regression to a multi-omic dataset in order to do variable selection in each layer
separately, choosing the tuning parameter λ so as to select at least ten variables
in each layer. They then use the selected variables in a l2-penalised Cox regres-
sion model. Boulesteix et al. (2017) criticised this method because it does not
take into account the correlations between variables belonging to different layers.
However, we show later in this chapter (Section 2.3) that, in the context of binary
class prediction, two-step approaches can achieve similar performances to more
sophisticated ones, while allowing to select a reasonable number of features in
each layer.
Integrative LASSO with penalty factors (IPF-LASSO)
Boulesteix et al. (2017) instead developed a bespoke penalised regression me-
thod for multi-omic data. It is similar to a LASSO regression, but it assigns a
different penalty to each layer. This approach is called integrative LASSO with
penalty factors (IPF-LASSO). Denoting by M the number of layers and by Xm each
layer’s data matrix, where m = 1, . . . , M, Boulesteix et al., like us, are interested
in those situations where each layer has the same N observations and a differ-
ent set of Pm features, i.e. X ∈ RN×Pm , and the rows in each matrix Xm corre-
spond to the same statistical units. Let β(m)j be the regression coefficient for the
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jth feature of the mth layer. IPF-LASSO tries to find the optimal set of coefficients
β = [β
(1)
1 , . . . , β
(1)
P1 , . . . , β
(M)
1 , . . . , β
(M)
PM ] such that
min
β0∈R, β∈RP1+···+PM





Boulesteix et al. suggest choosing the penalty parameters by a double CV ap-






where i = 1, . . . , n and j = 1, . . . , Pm (note that the features in the first layer remain
unchanged). Thanks to this, the same penalty λ1 can be applied to all the scaled
variables, and the parameter λ1 is estimated via CV in the standard way. The
candidate set of penalties λ2, . . . , λM that gives the best prediction performance
is then selected together with the corresponding value of λ1 found via CV. How
to choose the candidate penalty factors λ2, . . . , λM remains an open question; the
authors pick a grid of predefined values 2k, k = −a,−(a− 1), . . . , 0, . . . , a− 1, a,
where a is an integer that varies between 3 and 6 depending on the application.
The limitation of this approach is that the computational burden increases very
quickly with the number of layers, making it impossible to explore a large set of
possibilities for the penalty terms. Boulesteix et al. apply this method to a wide
range of simulation settings, as well as real datasets on acute myeloid leukæmia
(The Cancer Genome Atlas Research Network, 2013) and breast cancer (Hatzis et
al., 2011) where the outcomes are overall survival time and relapse-free survival
time respectively.
Multi-tuning parameter elastic-net (MTP-EN)
Similarly to what Boulesteix et al. did for LASSO, Liu et al. (2018) show that, if
the number of informative features is not the same in each dataset, fitting EN
regression models with different penalties for each dataset yields better predic-
tions. They do so by defining a multi-tuning parameter elastic-net regression
(MTP-EN). For simplicity, let
N(β) = (1− α)‖β‖2 + α‖β‖1.




− l(X, y; β0, β) + λ1N(β1) + · · ·+ λMN(βM),
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and the weights wp are w = [1, . . . , 1, λ2/λ1, . . . , λ2/λ1, . . . , λM/λ1, . . . , λM/λ1].
This model too is shown to work well for diagnostic and prognostic purposes in
cancer studies.
Both IPF-LASSO and MTP-EN can be easily fitted using the glmnet package
(Friedman, Hastie, and Tibshirani, 2010; R Core Team, 2020), specifying the rel-
ative weight of each feature in the penalty.factor argument of the cv.glmnet
function. However, there remains the problem of choosing the penalties of all
’omic layers except the first one.
Integrative elastic-net with penalty factors (IPF-EN)
IPF-LASSO has recently been extended by Zhao and Zucknick (2020) to combine
it with the tree-guided group LASSO of Kim and Xing (2012) for which the grid
search-type approach proposed by Boulesteix et al. (2017) is not a viable option,
given its high computational cost. Therefore, they use the efficient parameter selec-
tion via global optimisation (EPSGO) algorithm of Fröhlich and Zell (2005) instead
(details of the algorithm are given in Section 2.1.3). In the same manuscript, Zhao
and Zucknick (2020) also give a more flexible formulation of the structured pe-
nalised regression model of Liu et al. (2018) that allows different values of the
parameter α for each layer:
min
β0∈R, β∈RP1+···+PM
− l(X, y; β0, β) + λ1N1(β1) + · · ·+ λMNM(βM)
where Nm(βM) = (1− αm)‖βm‖2 + αm‖βm‖1. Zhao and Zucknick (2020) call the
model of Liu et al. (2018) sIPF-EN (where the “s” stands for “simple”), and this
new, more general one, IPF-EN. This is the naming convention that is used in the
remainder of this thesis.
2.1.3 Efficient parameter selection via global optimisation (EPSGO)
We present here in more detail the EPSGO algorithm mentioned above, since it is
widely used in the simulation studies reported in the next section. Before doing
so, we give a short introduction to Gaussian processes (GPs), which are not only
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central to the EPSGO algorithm, but also useful to introduce some of the concepts
that are key to the kernel methods presented in Chapter 3.
Gaussian processes
Following the definition of Rasmussen and Williams (2006),
Definition 2.1 A Gaussian process is a collection of random variables, any finite num-
ber of which have a joint Gaussian distribution.
A GP is fully specified by its mean function µ : X → R and covariance function
κ : X ×X → R. Here we assume that X ⊆ RD.
Given a finite sample of points x = [x1, . . . , xN ], the GP provides a probabilistic
model for the function q(x). For this reason, Gaussian processes are often used as
priors on functions. We indicate this by
q ∼ GP(µ, κ).
For simplicity, the mean function is often considered to take value zero on the
entire domain, without loss of generality. The choice of the covariance function
is instead crucial. From Definition 2.1, it is easy to see that, in order to be a valid
covariance function, κ must be
- symmetric, i.e. such that κ(x, x′) = κ(x′, x) for all x, x′ ∈ X and
- positive semi-definite (PSD), i.e. such that for any finite set of points x1, . . . , xn
the matrix Σ with ijth entry Σij = κ(xi, xj) is PSD.
If κ is a valid covariance function, the matrix Σ is called covariance matrix.
There exist many covariance functions that satisfy these requirements (see Ras-
mussen and Williams, 2006). Here we consider the Gaussian covariance function,
defined as







where l is an hyperparameter defining the characteristic length scale. Various meth-
ods exist to pick the values of the hyperparameters of the covariance function.
For instance, one can use CV, or maximise the marginal likelihood of the data
(Rasmussen and Williams, 2006, Chapter 5). In Figure 2.1 are represented the
predictive distributions obtained conditioning on the same data, for different pa-
rameters of the characteristic length scale.
Tipically one does not observe exactly q(x), but has instead available noisy obser-
vations of q(x), which we denote as
y = q(x) + ε,
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FIGURE 2.1: Predictive mean (in red) ± 2 standard devia-
tion credible intervals (shaded area) of a Gaussian process
fitted to a dataset (in black). On the left, the value of charac-
teristic length scale is too low, on the right, too high, and in
the middle it is selected via a heuristic implemented in the R
package kernlab.
where ε is independent and identically distributed (i.i.d.) noise with variance σ2ε .
Equivalently, we can write
y|x ∼ N
(
0, κ(x, x) + σ2ε IN
)
where IN is the N × N identity matrix.
Using standard properties of Gaussian distributions, one can show that, given
a set of N data points DN = {d1, . . . , dN}, where dn = (xn, yn), the predictive
distribution conditioned of DN is also Gaussian:
q(xnew)|xnew,DN ∼ N (µN(xnew), ΣN(xnew, xnew)) .
for any finite set of points xnew = [xnew1 , . . . , x
new
N ] where the conditional mean
vector µN and covariance matrix KN are available in closed form (Rasmussen
and Williams, 2006, Chapter 2). From Definition 2.1, it follows that the posterior
distribution q is a Gaussian process:
q|DN ∼ GP(µN , kN).
Online Gaussian processes
The predictive distribution can also be updated in an iterative fashion using Bayes’
rule. Having observed N data points, once a new data point dN+1 is available, the





Here the integral in the denominator is intractable, so the predictive distribution
after observing N points is denoted by p̂N to indicate that only an approximation
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is available. Both the expected model value µ̂N(x) and the estimated variance
of the model σ̂2N(x) can be evaluated by recursive formulæ that can be easily
updated as soon as a new data point is available (Csató and Opper, 2002).
The EPSGO algorithm
The EPSGO algorithm was initially developed by Fröhlich and Zell (2005) to effi-
ciently tune the parameters of support vector machines (SVMs) and subsequently
used by Sill et al. (2014) to select the parameters α and λ of EN (Equation 2.3). The
implementation of Sill et al. is used in the R package IPFStructPenalty of Zhao
and Zucknick (2020) to tune the parameters of sIPF-EN and IPF-EN.
The idea is to reframe the task of tuning the model parameters as an optimisa-
tion problem. Denote by A the parameter space of the model of interest and by
q : A ⊆ RD → R a measure of the quality of the model. In the case of logis-
tic regression models, this can be the out-of-sample MR. The goal is to find the
parameters a∗ such that
a∗ = arg min
a∈A
q(a).
To do so, the EPSGO algorithm models the prior on the error surface q on the
parameter space A as a Gaussian process.
In the first step of the algorithm, some points are sampled from the parameter
space that are used to fit an online GP. In order to obtain a good coverage of the
parameter space A, the Latin hypercube sampling strategy of McKay, Beckman,
and Conover (1979) is used. The recommended number of points to be sampled
at this stage is 10D (McKay, Beckman, and Conover, 1979).
Once the online GP has been fit on a set of N points, the improvement function is
defined as
I(x) = max {qmin −Y, 0} .
where qmin indicates the smallest value of the function q observed up to the cur-
rent iteration, N, and Y ∼ N (µ̂N , σ̂N). A new point aN+1 in the parameter space
A is then chosen so as to maximise the expected improvement criterion of Jones,
Schonlau, and Welch (1998):
anew = arg max
a∈A
E[I(x)].
and the online GP is updated after evaluating the error surface at aN+1. This
procedure is repeated until convergence is reached (see Algorithm 2.1).
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Algorithm 2.1: Efficient parameter selection via global optimisation (EPSGO).
Input : Function q : A → R
l, u parameter bounds
Initialise: D = dim(A).
1 Create 10D sample points a1, . . . , aN in [l, u] using Latin hypercube sampling
2 Compute q(ai), i = 1, . . . , N
3 qmin = mini q(ai)
4 a∗ = arg mini q(ai)
5 Train online GP
6 neval = 10D
7 repeat
8 anew = arg maxa E[I(a)]
9 Compute mean and standard deviation of E[I(a)]
10 qnew = q(anew)
11 if qnew < qmin then
12 qmin = qnew
13 a∗ = anew
14 end
15 Update online GP
16 neval = neval + 1
17 until convergence;
Output : qmin, a∗, neval
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2.2 TWO-STEP APPROACHES
We are interested in predictive models that allow us to simultaneously make pre-
dictions and determine which variables are relevant for the problem at hand,
while being flexible on the number of selected variables. For this reason, we focus
on EN-type methods only. In particular, we propose two ways of doing penalised
logistic regression on multi-omic data: (i) separate EN on each layer with fixed α;
and (ii) separate EN on each layer where α is selected via EPSGO.
While the EN methods used here are not new, their application to multi-omic
data in the way that we propose here is novel. Most importantly, the system-
atic assessment of the performance of these methods and the comparison to their
competitors, which are presented in Section 2.3, has never been performed before.
Step 1: variable selection
- Separate EN on each layer with fixed α. First, a variable selection step is per-
formed on each ’omic layer separately using EN with a fixed value of α.
The regression models are fitted using the glmnet R package and the val-
ues of λ in each model are selected via CV. The value that minimises the
out-of-sample error is selected. The value of α should be chosen depending
on the particular application; here we explore how the performances of the
method change for different values of α. For our simulation studies and real
data analysis we find α = 0.1 to be a reasonable value.
- Separate EN on each layer, α selected via EPSGO. The difference between this
method and the previous one is that the EPSGO algorithm is used in the
first step to pick an optimal value for α in each ’omic layer. This can be con-
venient when the user does not have a particular preference for the value
of α. However, we show in Section 2.5.1 that this approach is not always
preferable to the previous one.
Step 2: fitting the predictive model
This step is common to both approaches: the variables selected in the first step
are used to build a predictive model using ridge-penalised logistic regression.
Again, the glmnet R package is used and the value of λ that minimises the CV
misclassification rate is picked.
2.3 SIMULATION STUDY
We perform a simulation study in order to compare the two approaches pre-
sented in the previous section to their main competitors: naïve EN and sIPF-EN,
detailed below. To this end, we modify the implementations of naïve EN and
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sIPF-EN of the R package IPFStructPenalty, which currently only handles lin-
ear regression, in order to do logistic regression. The two other methods are im-
plemented from scratch, heavily relying on the glmnet and IPFStructPenalty R
packages. We also consider a univariate approach. The code used to produce
all the results presented below is available at https://github.com/acabassi/
logistic-regression-for-multi-omic-data.
- Naïve EN. This is the original EN algorithm (Equation 2.3) applied to the
matrix X obtained by concatenating all the ’omic datasets (Figure 1.2). We
make use of the EPSGO algorithm to automatically select the best value of
α, while λ is chosen via CV.
- sIPF-EN. As mentioned in Section 2.1.2, this is a variation of EN that assigns
different penalty factors λ to each layer, but selects the same value of α for
each of them (Zhao and Zucknick, 2020).
- Univariate approach. For each ’omic variable, a logistic regression model is
built where the only predictors are the variable of interest, and, where ap-
propriate, any covariates that are known to be related to the outcome and
therefore are always included in the model. If the null hypothesis that the
regression coefficient of the variable of interest should be zero is rejected,
then that variable is selected. A ridge-penalised regression model is then
built using all the selected variables as well as the covariates that are al-
ways included in the model.
Simulation settings
Our simulation settings are similar to those of Boulesteix et al. (2017). We generate
three layers of data for each experiment, with N = 100 observations each. The
first layer represents a set of clinical covariates that are known to be related to the
outcome of interest, and for this reason are not penalised. The other two layers
represent two ’omic datasets with varying numbers of covariates and proportions
of covariates that are correlated with the outcome. We denote the number of
non-penalised covariates by PN , the number of variables in the first and second
penalised layers by P1 and P2 respectively. Each has a small number of relevant
variables, denoted by Pr1 and P
r
2 respectively.
In each dataset, the responses are drawn independently from a Bernoulli distri-
bution with parameter τ = 0.5. The variables are then drawn from the following
multivariate Gaussian distributions:
[X1, . . . , XPN+P1+P2 ] |Y = 0 ∼MN (0PN+P1+P2 , Σ),
[X1, . . . , XPN+P1+P2 ] |Y = 1 ∼MN (µPN+P1+P2 , Σ),
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where
µ = [β1, . . . , β1, 0, . . . , 0, β2, . . . , β2, 0, . . . , 0]
with Pr1 elements of µ equal to β1 and P
r
2 elements equal to β2. The covariance
matrix Σ is either the identity matrix
Σ0 = IPN+P1+P2
or a block diagonal matrix similar to the one considered in the simulation studies
of Boulesteix et al. (2017) and Zhao and Zucknick (2020) that we indicate with Σ1.
The penalised layers have blocks of correlated variables both within and across
layers. All the non-penalised covariates are correlated, but uncorrelated to the










. . . . . .
B21 A2

where b = 10, N, A1 and A2 are matrices of size PN × PN , P1/b × P1/b, and
P2/b× P2/b respectively with ones on the diagonal and all other elements equal
to ρ and B12 and B21 are matrices of size P1/b× P2/b and P2/b× P1/b respectively
with all elements equal to ρ.
We consider the same sets of values for P1, P2, Pr1 , P
r
2 , β1, β2 as Boulesteix et al.,
reported in Table 2.1. Moreover, we set PN = 2 and βN = β1. The value of ρ is
equal to 0.4 in all simulation settings, as in Boulesteix et al.
PN P1 P2 Pr1 P
r
2 βN β1 β2
Setting A 2 1000 1000 10 10 0.5 0.5 0.5
Setting B 2 100 1000 3 30 0.5 0.5 0.5
Setting C 2 100 1000 10 10 0.5 0.5 0.5
Setting D 2 100 1000 20 0 0.3 0.3 -
Setting E 2 20 1000 3 10 1 1 0.3
Setting F 2 20 1000 15 3 0.5 0.5 0.5
TABLE 2.1: Values of PN , P1, P2, Pr1 , P
r
2 , βN , β1, β2 used for the
simulation study.
In Appendix A we consider three additional sets of simulation settings. In the first
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one, only the two ’omic layers are included in the regression. In the other two,
we consider again the same simulation scenarios presented here, but with PN =
10 and 100. We also compare these methods to a different univariate selection
method followed by a ridge regression on the selected variables.
Simulation results
Figures 2.2 and 2.3 show the outcome of the simulation studies. For each setting
and each regression algorithm, we report the following quantities: the MR on the
test set, the MR on the training set, the number of selected variables minus the
number of non-penalised covariates, the proportion of selected variables that are
among the relevant ones, excluding the non-penalised covariates (precision), the
proportion of relevant variables that are selected by the algorithm, excluding the
non-penalised covariates (recall).
Figure 2.2 shows that, when the covariates are uncorrelated, all methods have
comparable out-of-sample MRs, except in settings E and F where the MR is slightly
higher for the naïve approach and slightly lower for sIPF-EN. The within-sample
MR is lower for the separate with EPSGO and separate with fixed α methods, sug-
gesting that those two might be prone to overfitting. Concerning the precision,
there is no clear pattern throughout settings. On the contrary, the two instances
of separate regression on each layer consistently show higher values of the re-
call. Unsurprisingly, the same two algorithms also select the highest number of
variables in all settings. This behaviour is opposite to that of the univariate me-
thod, which selects a very low number of variables and therefore has values of
the recall always close to zero.
In Figure 2.3, we see that if the covariates are correlated, sIPF-EN has the lowest
MR, thanks to the fact that, contrarily to the other methods, it takes into account
the correlation between data layers. The only other method that does this is naïve
EN, however, assigning the same penalty to all layers puts this method at a disad-
vantage in the settings where the two layers are highly unbalanced (i.e. settings
D, E and F). In those settings, the MR of the two-step approaches is comparable
if not better than that of naïve-EN. Again, the within-sample MR suggests that
the two algorithms that perform variable selection on each layer separately may
be overfitting. As above, the same two methods select the highest number of
variables. This is reflected in lower precision and higher recall, on average. As
expected, the univariate approach has the worst performance overall.
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FIGURE 2.2: Simulation study comparing different variants
of penalised logistic regression for multi-omic data. The co-
variance matrix used here is the diagonal matrix Σ0. MR is
the out-of-sample misclassification rate, MR CV the within-
sample misclassification rate. The non-penalised covariates










































































































































































































































































































































































































































































































































FIGURE 2.3: Simulation study comparing different variants
of penalised logistic regression for multi-omic data. The co-
variance matrix used here is the block matrix Σ1. MR is
the out-of-sample misclassification rate, MR CV the within-
sample misclassification rate. The non-penalised covariates
are not included when computing precision and recall.
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2.4 CARDIOMETABOLIC SYNDROME DATA
Cardiometabolic syndrome (CMS) is a combination of metabolic dysfunctions
such as abdominal obesity, high levels of fasting glucose, elevated blood pressure,
low-level inflammation, high level of low-density lipoprotein cholesterol (LDL-
C) also known as “bad” cholesterol, and low level of high-density lipoprotein
cholesterol (HDL-C) also known as “good” cholesterol (Kirk and Klein, 2009).
While the exact causes of CMS are not known, this syndrome has been shown
to be associated with higher risk of type 2 diabetes and cardiovascular disease
(CVD; see e.g. Grundy et al., 2005). The term CVD encompasses a wide range
of conditions, that can be divided into four main categories: coronary heart dis-
ease, strokes and transient ischæmic attacks, peripheral arterial disease and aortic
disease. According to the World Health Organization, CVD is the leading cause
of death and the most common non-communicable disease (WHO key facts about
cardiovascular diseases).
Here we seek to identify a set of molecular features that characterise CMS by in-
tegrating multiple ’omic layers. This can give insights into the molecular mecha-
nisms driving the development of this syndrome and identify relevant biological
markers. Moreover, these could be used to stratify the undiagnosed population
for their probability of being affected by CMS.
The available data came from three different cohorts:
- Blood donors. These are data collected as part of the BLUEPRINT Epigenome1
work package 10 (WP10) and are related to 184 volunteers recruited amongst
the UK’s National Health Service Blood and Transplant donors.
- Patients affected by lipodystrophy syndrome. Data were collected for ten pa-
tients cared for by the National Severe Insulin Resistance Service at Ad-
denbrooke’s Hospital in Cambridge. People affected by lipodystrophy syn-
drome have abnormal lipids distribution and are at high risk of developing
CVD. In particular, the individuals considered in this study have familial
partial lipodystrophy, which is characterised by loss of subcutaneous fat.
- Obese individuals. We have data for ten morbidly obese individuals, i.e. with
body mass index (BMI) greater than 40, who were referred for bariatric
surgery by the Obesity Clinic of Addenbrooke’s Hospital in Cambridge.
Anthropometric, biochemical and ’omic data are available for each individual.
Moreover, data collected both before and six months after bariatric surgery were
available for obese individuals. Some of the work that was carried out within the
framework of the larger study of Seyres et al. (2020) was focused on making use of
the data available for the obese individuals before and after surgery to investigate
1http://www.blueprint-epigenome.eu/
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FIGURE 2.4: A monocyte (left) and a neutrophil (right).
Images by Blausen.com staff (2014).
its effects. However, this is beyond the scope of this thesis. Therefore, only the
pre-surgery data are considered here.
2.4.1 ’Omic data
ChIP-seq, RNA-seq data, and DNA methylation data were collected from two
types of white blood cells which form an essential part of the innate immune
system in humans: monocytes and neutrophils.
Monocytes are white blood cells that can differentiate into macrophages and mye-
loid lineage dendritic cells. We mentioned above that CVD can be divided into
four categories. Three of those, namely coronary heart disease, strokes, and pe-
ripheral arterial disease involve atherosclerosis. This makes studying monocytes
particularly interesting, since it has been shown that monocytes and monocyte-
derived macrophages play an important role in atherosclerosis (van Tuijl et al.,
2019).
Neutrophils are white blood cells that act as first responders in case of acute in-
flammations. It has recently been suggested that neutrophils also play a role in
the low-grade inflammation that characterises CMS and that prolonged exposure
to this type of inflammation modifies their phenotype (Caielli, Banchereau, and
Pascual, 2012; Wright et al., 2010).
In addition to that, metabolites and lipids were measured from plasma. Here,
these measurements are of particular interest, since it has been shown that obesity
causes a significant perturbation of the plasma metabolome (Cirulli et al., 2019;
Moore et al., 2014). Similar conclusions have been made for patients suffering
from lipodystrophy (Fiorenza, Chou, and Mantzoros, 2011; Huang-Doran et al.,
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2010).
In what follows we give a brief description of how each dataset was collected and
preprocessed by our collaborators. Further details can be found in the manuscript
of Seyres et al. (2020).
ChIP-seq data
Chromatin immunoprecipitation was performed using the IP-Star Compact Au-
tomated System of Diagenode2 and sequencing was done using Illumina HiSeq
25003 or Illumina HiSeq 40004. 67,763 and 49,188 peaks were obtained for mono-
cytes and neutrophils, respectively. A batch effect due to the fact that the sequenc-
ing of the donors was performed in a different sequencing centre from the obese
and lipodystrophy individuals was corrected using the Combat function of the R
package sva (Leek et al., 2019). Details of the batch effect correction method can
be found in Johnson, Li, and Rabinovic (2007). After that, low variance peaks
and peaks located on sex chromosomes were removed, leaving 25,600 regions in
monocytes and 26,300 in neutrophils.
RNA-seq data
For obese and lipodystrophy patients, sequencing was done on Illumina HiSeq
2500 or Illumina HiSeq 4000, whereas RNA-seq data for the WP10 donors were re-
trieved from the European Genome-phenome Archive of the European Bioinfor-
matics Institute5. After preprocessing, 11,370 gene sets were available for mono-
cytes and 24,224 for neutrophils. In the RNA-seq datasets, transcript with more
than 25% identical counts were removed. In the monocyte dataset, this resulted
in removing 937 out of 11,370 transcripts and in the neutrophil dataset 3,627 out
of 24,224. Batch effect correction was performed in the same way as for ChIP-seq
data.
DNA methylation data
DNA methylation levels were measured using the microarray-based Infinium
Human Methylation 450 BeadChip6 assays by Illumina, which is a platform for
low-cost high-throughput methylation profiling. Methylation is (almost exclu-
sively) found in CpG sites, regions of DNA where a cytosine nucleotide is fol-
lowed by a guanine nucleotide in the 5’ to 3’ direction (indicated as 5’ – C – p –
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26,214 CpG sites for 193 of the available blood samples in monocytes and 21,442
CpG sites for 187 samples in neutrophils.
Metabolite data
Metabolites profiling was performed by Metabolon Inc.7 using their standard pro-
tocol. Overall, 988 species were quantified. Each of them was rescaled in order to
have a median equal to one. Missing values were imputed using the impute.knn
function of the R package impute (Hastie et al., 2019). Again, batch effect correc-
tion was performed in the same way as for ChIP-seq data.
Lipid data
Lipidomics profiling was performed via mass spectrometry using an Advion
TriVersa Nanomate8 interfaced to the Thermo Exactive Orbitrap9. The dataset
contains measurements of 123 lipids.
2.4.2 Anthropometric and biochemical parameters
The anthropometric parameters available for the study are weight, age, and sex.
Moreover, plasma biochemistry assays were performed for the leptin, adiponec-
tin, insulin, free fatty acid (FFA), glucose (GLC) and each individual’s serum
lipid profile, which includes: triglycerides (TG), total cholesterol (TC), HDL-C
and LDL-C. In addition, leptin to adiponectin ratio (LAR), homeostasis model as-
sessment of insulin resistance (HOMA-IR) and adipose tissue insuline resistance
(ADIPO-IR) were computed for each individual in the study. Detailed explana-
tions of the meaning of these quantities and why these are currently routinely
used to assess risk of CMS are given in Appendix A.
Definition of the control group
Based on their clinical parameters, the clinicians involved in this study selected
14 donors as controls. The parameters used to identify the controls are as follows:
- BMI < 25;
- GLC < 5.4 mmol/L;
- TG < 1.7 mmol/L;
- LDL-C < 2.59 mmol/L,
- HDL-C > 1 mmol/L for men and > 1.3 mmol/L for women;
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These are considered to be healthy people and together are referred to as controls
in the remainder of this thesis.
2.4.3 Missing data
One of the challenges of multi-omic studies is that each data layer often has miss-
ing values. There are several reasons why ’omic measurements may not be avail-
able, some of which are related to the specific ’omic type at hand. Therefore,
each individual will have a different set of observations available. Figure 2.5
shows which individuals had at least one missing value in each ’omic layer. Even
though in Seyres et al. (2020) inference is made on all the individuals available, in
this chapter we only consider the people who had complete measurements in all
layers: 96 out of 205. A different type of analysis is presented in Chapter 5, where
all the individuals who have measurements available are included.
In addition to that, not all the anthropometric and biochemical measurements
were available for all the people in the study. Table 2.2 shows the number of
missing values for each parameter. Considering only the set of people who have
no missing ’omic values, the missing values were imputed using the R package
mice (van Buuren and Groothuis-Oudshoorn, 2011) with default settings. This is
a popular package that does multivariate imputation by chained equations (hence
the name “mice”).
Blood donors Lipodystrophy patients Obese individuals
# of individuals 184 10 11
Age 0 1 0
Weight 35 0 0
LAR 6 0 0
Glucose 1 0 0
Total cholesterol 2 2 0
TG 1 0 0
HDL-C 1 0 0
LDL-C 7 4 0
ALT 4 0 0
AST 74 0 0
hsCRP 62 0 0
FFA 15 0 0
Insulin 15 0 0
HOMA-IR 16 0 0
ADIPO-IR 36 0 0
TABLE 2.2: Number of missing values for each anthropo-
metric and biochemical parameter before imputation.
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FIGURE 2.5: Missing values in each ’omic layer. Each row
corresponds to an individual, each column to a layer. Miss-
ing values are indicated in black. The rightmost column
shows the three cohorts, where the donors are divided into
control donors and others.
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2.5 MULTIVARIATE SIGNATURE IDENTIFICATION
This section is dedicated to the multivariate analysis of the CMS data. In Section
2.5.1 we select the variables that help distinguish obese individuals from healthy
people, using the penalised logistic regression methods presented in Section 2.2.
In Section 2.5.2 we use the selected variables to estimate the probability of each
blood donor having CMS.
2.5.1 Signature identification
We are interested in identifying combinations of variables that help discriminate
between healthy people and CMS patients which, in the remainder of this thesis
we refer to as the molecular signature of CMS. For this reason, we choose the two
algorithms that have the highest recall in our simulation settings, which are those
that perform variable selection by training a separate EN model on each layer.
Moreover, contrarily to the other methods, these have the advantage of selecting
a set of features in each dataset that together are predictive of patient status. This
allows us to identify a molecular signature of CMS in each layer.
In this section, first we explain how the available samples are divided into train-
ing and test sets. Then, we present the results obtained with a fixed value of α,
explaining the rationale behind the choice of the value 0.1. Finally, we comment
on the results obtained choosing the value of α as suggested by Zhao and Zuck-
nick (2020) and explain why fixing the value of α turns out to be more convenient
for our application.
Training and test sets
We consider the following comparisons:
1. obese individuals versus controls;
2. lipodystrophy patients versus controls.
Each of these defines a different split of our training set into healthy people (con-
trols, labelled by “0” in our logistic regression) and patients affected by lipodys-
trophy or obesity (cases, label “1”) and helps extracting the most relevant features
for each comparison. In this chapter we only present the results obtained for
comparison 1, results for comparison 2 are reported in Appendix A.
Separate EN on each layer with fixed α
We use separate EN on each layer with fixed α to identify putative multivariate
signatures that discriminate between the considered groups. Before doing so, we
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centre and scale each dataset so that all variables have mean 0 and variance 1
across the individuals in which they were measured.
The training set for comparison 1 is formed by the donors who have been selected
as controls and the obese individuals. We use 10-fold CV as suggested by Zou and
Hastie (2005). To do so, we use the cv.glmnet function of the R package glmnet.
An explanation of why 10 is a good default value for the number of folds to be
used in CV can be found in James et al. (2013, Section 5.1.4). Since different CV
splits result in different subsets of selected variables, we repeat the CV procedure
1000 times for each layer, and then consider the largest set of selected variables
that is selected across the 1000 repeated runs. In Appendix A we compare to a
strategy in which we instead choose the set of variables that is selected most often
across all the runs. We repeat the analysis with α = 1, 0.5 and 0.1. The two highest
values of α lead to selecting very few, if any, variables in most layers (Figure 2.6).
For this reason, we decide to pick α = 0.1. Note that, in this setting, despite
giving relative weight of only 10% to the LASSO penalty, a tiny percentage of the
available variables is selected.
Figure 2.6 shows, for each ’omic layer, the average value of each selected vari-
able for each category of people: donors who have been selected as controls, the
remaining donors, obese individuals and lipodystrophy patients. As we might
expect, the average values taken by each variable have opposite sign in the two
sets of people used in the training set. Perhaps more interestingly, we note that,
while the other donors have average values that are close to zero, lipodystrophy
patients take extreme values on most of the selected variables. On top of those
values, red bars indicate which variables are selected for each value of α. The
variables that are not selected for any value of α are not shown.
Comparison with separate EN with α selected by EPSGO
We now apply the same strategy as above, except that we let the EPSGO algo-
rithm choose α so as to minimise the MR. The first step of the EPSGO algorithm
fails on the lipid data. For this reason, the results presented here only comprise
the remaining seven ’omic layers.
Table 2.3 shows the number of selected variables in each layer by each method,
as well as the selected value of α and the number of selected variables that are
in common between the two algorithms. The optimal values of α selected via
error surface optimisation are all higher than 0.1, except for the metabolite data.
Consequently, fewer variables are selected compared to fixing α = 0.1. While in
some cases this may be a desirable feature, here it makes it difficult to identify
molecular signatures, especially for the ChIP-seq data of monocytes, where only
one variable is selected.
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FIGURE 2.6: Variables selected with separate EN and fixed α,
for different values of the parameter α. The red bars indicate
which variables are selected with α = 1, 0.5 and 0.1 respec-
tively. Below are shown the mean values of those variables
for the donors and controls and for the lipodystrophy and
obese individuals. Only the variables selected for at least
one of those values are reported here.
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#var. α = 0.1 #var. EPSGO α EPSGO ∩
ChIP-seq / Monocytes 428 1 0.59 1
ChIP-seq / Neutrophils 611 40 0.75 29
RNA-seq / Monocytes 425 111 0.96 21
RNA-seq / Neutrophils 592 219 0.13 82
Methylation / Monocytes 106 31 0.75 0
Methylation / Neutrophils 25 54 0.59 5
Metabolites 60 195 0.02 55
Lipids 62 - - -
TABLE 2.3: Comparison of separate EN methods. From left
to right, are reported: the number of selected variables when
α = 1, the number of selected variables when α is selected
using EPSGO, the value of α picked by EPSGO, and the num-
ber of variables that are selected both with fixed α and with
α selected via EPSGO.
Therefore, the automatic selection of α via the EPSGO algorithm presents two
main disadvantages in applications like ours. The first and most important one is
that the algorithm may not always work, as is the case for the lipid data. Secondly,
selecting the EN parameter so as to minimise the average out-of-sample error can
be quite convenient in some cases, it may not be the best choice in applications
where the goal is to select a reasonable number of predictive features in each
dataset.
2.5.2 Probability of being affected by cardiometabolic syndrome
After performing variable selection on each layer separately, we train a ridge-
penalised logistic regression model on the matrix formed by all the variables se-
lected in each layer to compute the probability of each individual to belong to the
case group. The training and test sets are the same as in Section 2.5.1. Again, we
present here only the results obtained for comparison 1 (obese individuals versus
controls); the results for comparison 2 (lipodystrophy patients versus controls)
can be found in Appendix A.
Figure 2.7 shows, for each person, the probability of belonging to the extreme
phenotype group (which in this case comprises the obese individuals). The prob-
abilities estimated on each layer separately are also reported. These are derived
by fitting a logistic regression with l2 penalty on the selected variables only. The
ChIP-seq and RNA-seq data give similar predictions, while the lipidomics dataset
produces slightly different ones. For the methylation and metabolomics datasets,
the probabilities of being a case do not differ greatly among individuals.
It is interesting to note that the lipodystrophy patients have higher probabilities of
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belonging to the same class as the obese individuals than the blood donors. This
suggests that, on the molecular level, lipodystrophy patients are more similar to
obese individuals than the average person. This is not surprising, as those two
conditions are characterised by similar biochemical and clinical profiles. On the
other hand, some blood donors have very similar predicted values to the obese
and lipodystrophy individuals. This may indicate that blood donors can show
similar characteristics to those in the extreme phenotype groups, which could
provide insights into the pathogenesis of CMS.
These peculiarities of the results can be better observed by assigning a ranking
to each person from 1 to 96 based on their probability of belonging to the class
with label “1”, where the person with rank 1 has the highest probability. We do
this based on the probabilities estimated on each layer separately, and then take
the average as the aggregated rank for each person. Note that this combined
ranking does not correspond to the ranking implied by the probabilities of class
membership obtained using the full ridge-penalised model (Figures 2.7b, 2.7d,
and 2.7f). Again, some of the lipodystrophy patients score similarly to the obese
individuals. Moreover, we find some donors among the lipodystrophy patients.
Many other ways of combing the rankings could have been considered. The lit-
erature on rank aggregation is vast; the first efforts on this topic date back to
the XVIII century (de Borda, 1781). This is still a thriving field in modern times,
with a wide range of rank aggregation methods being developed for different
types of applications, including genomic and multi-omic studies (Blangiardo and
Richardson, 2007; Lin and Ding, 2009). An overview is provided by Lin (2010).
Due to the fact that, as we have seen, data available for these studies often have
missing values, the focus has recently shifted to methods that can handle par-
tial rankings (Aerts et al., 2006; Kolde et al., 2012). A comparative study of such
methods has been performed by Li, Wang, and Xiao (2019). However, we find
that, in this simple case, taking the average ranks is a sensible choice.
2.6 UNIVARIATE DIFFERENTIAL ANALYSIS
We now compare the multivariate signature identification method described above
to a simpler approach that uses univariate tests. For each of the ’omic layers, we
use the Mann-Whitney test (Mann and Whitney, 1947) to test for differences in
distribution for each ’omic variable.
The Mann-Whitney test is a non-parametric test for the difference in the means of
two samples. It is used when the underlying distributions are not Gaussian. Let
x1, . . . , xN1 and y1, . . . , yN2 be two independent samples from populations X1 and
X2 with means µ1 and µ2 respectively. X1 and X2 are assumed to be continuous
distributions that differ only (and at most) in their locations. The hypotheses that
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(F) Combined rankings, α = 1.
FIGURE 2.7: Probabilities of belonging to the class of obese
individuals and ranking of each person according to those
probabilities. Both quantities are shown on each dataset sep-
arately and considering all the data types jointly. The model
is trained on the obese individuals and control donors. Each
column corresponds to one of the individuals who have no
missing data, each row corresponds to one of the layers. The
columns are sorted by probability of being a case in (A), (C),
and (E) and final ranking in (B), (D), and (F). All rankings
are divided by the total number of observations.
43
Chapter 2. Two-step penalised logistic regression for multi-omic data
we want to test are
H0 : µ1 = µ2 versus H1 : µ1 6= µ2.
To test this, it is sufficient to arrange all the observations in ascending order, as-
sign ranks 1 to N1 + N2 to them, and, if two or more observations have the same
value, use the mean of the ranks that would have been assigned to them if they
were not equal. Now, defining W1 as the sum of the ranks of the observations
in the first sample and W2 the ranks of the observations in the second sample,
one would expect that, after adjusting for the cardinality of each set, W1 and W2
have similar values if the null hypothesis is true. Therefore, the null hypothesis
is rejected if W1 and W2 are significantly different. In the case of small samples,
the reference distribution is tabulated.
In order to control the false discovery rate (FDR), that is the proportion of type I
errors in a set of tests, at the 5% level, we adjust the p-values according to the
Benjamini-Hochberg procedure. This means that, if p(1), . . . , p(K) is our set of p-





and reject the null hypothesis for all hypotheses having p-values smaller or equal
to p(k). This ensures that the expected number of type I errors is less than or equal
to α.
While the multivariate approach selects variables that are jointly useful for pre-
diction and is therefore more permissive, this is not possible with univariate
methods. Moreover, this univariate approach is more conservative as it provides
control over the FDR.
We repeat the analysis for both comparisons considered above: obese individuals
versus controls (comparison 1) and lipodystrophy patients versus controls (com-
parison 2). The Mann-Whitney test is performed using the wilcox.test function
of the R package stats (R Core Team, 2020); the adjusted p-values are obtained
using the qvalue function of the Bioconductor10 package qvalue (Storey et al.,
2019).
Due to the fact that this test is very conservative and that it cannot take into ac-
count synergies between sets of variables that divide the observations into two
groups, the number of selected variables is very low with respect to the multi-
variate setting. For example, only 14 tests are significant in the lipidomics layer,
when comparing the obese individuals to the control donors, and no variables
show significant differences in any of the other layers. In Figure 2.8 are shown
the number of variables that have been selected in the lipidomics layer with the
10https://www.bioconductor.org/
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multivariate approach (both choosing the largest set of selected variables and the
one that is selected most frequently) which are compared to those selected by uni-
variate testing. The corresponding information for the other seven layers can be


















(B) Lipodystrophy patients versus control donors.
FIGURE 2.8: Venn diagram showing the intersections be-
tween the variables selected in the lipids layer with the mul-
tivariate approach with the maximal and modal set of vari-
ables and those selected via univariate testing.
45
Chapter 2. Two-step penalised logistic regression for multi-omic data
2.7 VALIDATION VIA EXTERNAL COHORTS
The last step of the analysis is aimed at validating our findings. Due to the scarcity
of multi-omic datasets available for CMS studies, it is not currently possible to try
to replicate the entirety of our results with external data. However, we make use
of two external cohorts, both containing lipidomics data only, to partially validate
the identified CMS signature. In what follows we give a brief description of both
cohorts, and the results of the validation analysis.
The Fenland study
The first dataset that we use to validate our findings was collected as part of the
Fenland study (Lindsay et al., 2019). We consider a subset of 1,507 participants
out of the 12,345 Fenland study participants. These are volunteers without di-
abetes born between 1950 and 1975, recruited over the Cambridgeshire region
between 2005 and 2015. For each person, as well as the lipidomics data, a large
number of anthropometric and biochemical parameters are available. We refer
the reader to the original manuscript of Lindsay et al. for details on each of those.
Among the lipids measured for this study, we choose the eight top lipids that
are selected both by our multivariate and univariate analyses. Furthermore, we
choose five lipids at random which are not selected by any of our methods to
be our control group. We look at the associations between the clinical parameters
and the measurements of those lipids that we observe in our data (Figure 2.9). For
each pair of lipid and anthropometric or biochemical parameter, this is computed
as the regression parameter βlipid of the linear model
parameteri = β0 + βage × agei + βfemale × 1(femalei) + βlipid × lipidi + εi
where i indicates the ith person and 1 is the indicator function. The significance
of the association is tested as
H0 : βlipid = 0 versus H1 : βlipid 6= 0




where SE is the standard error (for further details on the t-tests for regression co-
efficients see James et al., 2013, Chapter 2). Since one such test is performed for
each pair of lipids and clinical parameters, multiple testing correction is required.
We control the family-wise error rate (FWER), that is the probability of making one
or more type I errors in a set of tests, using Bonferroni’s correction (Bonferroni,
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1936). This amounts to dividing all p-values by the total number of tests. De-
spite the fact that this correction is extremely conservative, many of the test are
significant at level 0.01. The same is not true for the lipids chosen at random.
The procedure is repeated for the same two sets of lipids in the Fenland study. We
do not have access to this dataset, so the analysis presented here was carried out
by Dr Maik Pietzner at the Medical Research Council Epidemiology Unit of the
University of Cambridge. In Figure 2.10 we can observe the same patterns as in
the previous case: many of the tests are significant and the direction of association
between the selected lipids and the clinical covariates is the same. Moreover,
here too the strength of association between the lipids selected at random and the
clinical covariates is low.
The NASH cohort
The second dataset used for external validation contains measurements for a co-
hort of biopsy proven non-alcoholic steatohepatitis (NASH) patients (Sanders et al.,
2018). NASH is a medical condition that is manifested as an inflammation and
damage of the liver caused by a buildup of fat. It can lead to scarring of the liver,
which is a life-threatening condition commonly known as cirrhosis. This dataset
is formed by 42 patients for whom data are available regarding their BMI, age,
sex, glucose, insulin, TG, total cholesterol, LDL-C, HDL-C, AST, ALT, and ALP
levels, HOMA2-IR (a new, improved measure of HOMA-IR) index, as well as
lipid measurements.
We repeat the same procedure used for the CMS and Fenland data. The output
is shown in Figure 2.11. Again, we observe similar correlations here compared to
our data. However, in this case the uncertainty on the estimates is very high, due
to the fact that the sample size is quite small.
Finally, it is interesting to note that two of the lipids selected by our analysis,
PC(38:6) and PC(36:2), have been previously identified in obesity studies (Hall et
al., 2017), and that TG(50:1) and TG(52:2) have been linked to non-alcoholic fatty
liver disease (Dai et al., 2019) and NASH (Sanders et al., 2018).
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(B) Randomly selected lipids.
FIGURE 2.9: Association between lipid measurements and
outcome parameters after correcting for age and sex. In the
first plot, the considered lipids are the top eight lipids se-
lected both by our multivariate and univariate analysis, that
are also available in the Fenland cohort. In the second plot
are shown five lipids that have not been selected in our anal-
ysis of the CMS data, chosen at random. Cells marked by an
asterisk indicate associations that are significant at level 0.01.
Each row corresponds to a lipid and each column to an out-
come parameter. To aid visualisation, hierarchical clustering
was applied to the rows and columns of the two heatmaps
independently, resulting in different column orderings.48
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(A) Selected lipids.
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(B) Randomly selected lipids.
FIGURE 2.10: Association between lipid measurements and
outcome parameters after correcting for age and sex. In the
first plot, the considered lipids are the top 8 lipids selected
both in the univariate and multivariate analysis, that are also
available in this cohort. In the second plot are shown five
lipids that have not been selected in our analysis of the CMS
data, chosen at random. Cells marked by an asterisk indicate
associations that are significant at level 0.01. Each row corre-
sponds to a lipid and each column to an outcome parameter.
To aid visualisation, hierarchical clustering was applied to
the rows and columns of the two heatmaps independently,
resulting in different column orderings.
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FIGURE 2.11: Association between lipid measurements and
outcome parameters after correcting for age and sex in the
NASH cohort. The lipids presented here are the same lipids
considered in the validation with the Fenland data. Cells
marked by an asterisk indicate associations that are signifi-
cant at level 0.01. Each row corresponds to a lipid and each




We summarise here the main findings of this chapter, as well as the challenges
encountered. Some of the latter provide motivation for the work presented in the
following chapters.
2.8.1 Main findings
We have proposed two ways of building binary predictive models for multi-omic
datasets with the aim of retrieving as many relevant predictive variables as possi-
ble. The variables are selected via EN on each ’omic layer separately, allowing the
user to either have the freedom to choose the number of selected variable, man-
ually tuning the value of the parameter α, or automatically selecting the value
of α that minimises the MR. We have compared these two methods to the two
main competitor methods for multi-omic logistic regression that use an EN-type
penalty, and to a univariate approach. From our simulation studies, we have con-
cluded that there is no one-size-fits-all approach that is able to achieve low MR
in all settings as well as high precision and recall. However, our two suggested
methods give higher values of the recall in all simulation settings, so they should
be preferred in contexts where the interpretability of the model is key.
We have used the proposed methods to define CMS signatures in eight layers
of molecular data, which enable to discriminate between obese individuals and
lean, healthy individuals. The disease signatures found in this way have been
used to estimate the probability of suffering from CMS for a new set of individu-
als, including blood donors and lipodystrophy patients. This results in two main
findings. First, we noticed that, looking at the selected variables only, lipodystro-
phy patients have similar molecular profiles to obese individuals in some of the
layers. This suggests that different types of CMS may have common molecular
pathways. Secondly, some of the blood donors have similar predicted risks (and
rankings) to those of the obese and lipodystrophy individuals. This could be due
to the fact that those donors are affected by some of the metabolic dysfunctions
that characterise CMS. While the dataset considered here is too small to provide
results that can be used in the clinic, our study illustrates that, in the presence of a
larger set of observations, our model could be used to identify blood donors who
show similar molecular profiles to those of CMS patients.
Additionally, we have found that the lipids selected in our analysis are associated
with known CMS risk factors, not only in our data, but also in an external cohort.
This validates and gives additional credibility to our identified CMS signatures.
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Interpretation of the results
While it might be interesting to use models like the one presented here to identify
donors affected by CMS, the results presented in this work cannot be used for
diagnostic purposes and should be considered as explorative. This is because the
sample size is quite small, especially compared to the large number of covariates
considered. Widely accepted practices for studies where prediction models are
developed, validated or updated for prognostic or diagnostic purposes are those
outlined by Moons et al. (2015), which are summarised into the transparent report-
ing of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD)
checklist. Moreover, Riley et al. (2020) give precise indications for sample size
calculation in clinical prediction models. To build a predictive model that can be
used in the clinic, one would need to collect data compliant with those guidelines.
2.8.2 Challenges
This work highlights the power of collecting and analysing together multiple
’omic datasets. At the same time, it brings to light some of the main difficulties of
working with this type of data.
Small sample size
We mentioned above that the results presented here cannot be used for prognos-
tic purposes. The number of patients and seemingly healthy (control) donors
for whom we have data available is very small, especially compared to the large
number of covariates available. This is because collecting such a large amount of
data for each individual is expensive and time consuming. We reiterate that, de-
spite the encouraging validation results presented in Section 2.7, further studies
would be necessary in order to use this model for clinical decision making.
Missing data
As we have seen, data analyses aimed at integrating multiple ’omic datasets are
often plagued by large numbers of missing data. In the case of the study pre-
sented in this chapter, due to the fact that the considered statistical methods can-
not deal with missing data, we are obliged to restrict our analysis to only 96 peo-
ple out of 205. This represents a great loss of information. To our knowledge, this
issue has not yet been addressed for the models presented above and remains
an open problem. In Chapter 3, where we present a novel (unsupervised) inte-
grative algorithm for multi-omic data, we make sure that it is able to exploit all
the information available for each observation. In Chapter 5 we give a detailed
explanation of how missing data can be handled by this method, which is then




Each ’omic layer has different characteristics, which is why treating all layers as
one large dataset is not a good idea, as we have seen when applying naïve EN
to the CMS data. Here, this problem is addressed either by assigning a different
penalty to each layer or by performing variable selection on each layer separately.
Depending on the specific application, one may want to choose one or the other
approach. This is a key point that we shall take into account when developing
novel unsupervised integrative methods for multi-omic data in the next chapters.
Variable selection for multiple high-dimensional datasets
This point is tightly linked to the previous one. The problem of variable selection
for large datasets has been thoroughly explored and tackled by many researchers
in Statistics. However, when presented with multi-omic datasets, the challenge is
to simultaneously perform variable selection on multiple, diverse layers of data.
We have seen in Section 2.1.2 that the scientific community is starting to pro-
pose new ideas to extend existing supervised variable selection methods to multi-
omic studies. We shall see in Chapter 5 how the problem of variable selection for
datasets like this one also affects unsupervised algorithms.
Validation and replicability issues
Finally, we have highlighted the challenges of validating the results obtained in
multi-omic studies. Thanks to the availability of two external cohorts, we have
been able to validate our approach, albeit to a limited degree. A full validation of
the results would require an external cohort with more ’omic layers. While this is
not currently possible, as the cost of high-throughput techniques decreases, more




MULTIPLE KERNEL LEARNING FOR INTEGRATIVE
CLUSTERING OF MULTI-OMIC DATA
Multi-omic integrative clustering is a thriving field, with new statistical and ma-
chine learning methods being produced at fast a pace (Rappoport and Shamir,
2018). We have mentioned in the Introduction that these methods seek to iden-
tify individuals or genes that have similar characteristics across the ’omic layers.
Various successful applications of these approaches to real data have contributed
to the popularity of this field of research; most notably, in the context of precision
medicine, multi-omic clustering methods have been used to identify novel can-
cer subtypes (see e.g. Hoadley et al., 2014; Aure et al., 2017; The Cancer Genome
Atlas Research Network, 2012).
The motivation for the work presented in this chapter stems from the desire to
shed light on the operating characteristics of one such method, cluster-of-clusters
analysis (COCA). Despite being widely used, especially in the context of tumour
subtyping (Hoadley et al., 2014; Aure et al., 2017; The Cancer Genome Atlas Re-
search Network, 2012), the COCA algorithm has never been explicitly laid out
and its properties have never been systematically explored. Moreover, its robust-
ness to the inclusion of noisy datasets is unclear.
Here we rigorously benchmark COCA and combine ideas from COCA and mul-
tiple kernel learning (MKL) in order to propose a new kernel learning integrative
clustering (KLIC) method that addresses the limitations of COCA. Key to our ap-
proach is the result that the consensus matrix returned by consensus clustering
(Monti et al., 2003) is a valid kernel matrix. This insight allows us to make use of
the full range of multiple kernel learning approaches in order to combine consen-
sus matrices derived from different ’omic datasets.
We perform simulation studies to illustrate our proposed approach and compare
it to COCA, as well as other integrative clustering algorithms developed specif-
ically for multi-omic data. Moreover, we show how KLIC and COCA compare
in two real data applications. The first one is multiplatform tumour subtyping,
where the goal is to find clusters of tumours that have similar molecular charac-
teristics, combining information from different ’omic types. Discovering tumour
subtypes can be helpful both to improve prognostic tools and to develop novel
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more effective treatment for each subtype. The second application considered in
this chapter is transcriptional module discovery. In this case, integrating gene ex-
pression and transcription factor binding data, the goal is to find groups of genes
that are co-regulated and co-expressed and therefore may have similar biological
functions.
Chapter outline
Kernel methods are introduced in Section 3.1, with particular focus on kernel
k-means. A review of existing multi-omic integrative clustering algorithms is
presented in Section 3.2. The COCA algorithm and its origin are explained in
Section 3.3. KLIC is introduced in Section 3.4. In Section 3.5 we assess KLIC
on three different types of simulated data, and compare it to COCA and other
competitor methods. The two real data applications are presented in Sections 3.6
(multiplatform tumour subtyping) and 3.7 (transcriptional module discovery).
Finally, in Section 3.8 we summarise the main findings of the chapter and some
of the issues encountered.
3.1 KERNEL METHODS
Much of this chapter concerns kernel methods for clustering of multi-omic data.
For this reason, we give here a short introduction to kernel methods.
We start by giving the definition of kernel function (Rasmussen and Williams,
2006, Chapter 4):
Definition 3.1 Any map δ mapping a pair of inputs x, x′ ∈ X to R is a kernel func-
tion.
From this definition it follows that the covariance functions of GPs presented in
Section 2.1.3 are nothing but symmetric positive semi-definite (PSD) kernel func-
tions. In the context of kernel methods, for instance, the Gaussian covariance
function introduced in Section 2.1.3 is usually called a radial basis function (RBF)
kernel.
Kernel methods proceed by embedding the observations into a higher-dimensional
feature space H endowed with an inner product 〈·, ·〉H and induced norm ‖·‖H,
making use of a map φ : X → H (Figure 3.1).
Using this definition, it is possible to prove that any inner product of feature
maps gives rise to a symmetric PSD kernel (Shawe-Taylor and Cristianini, 2004,
Chapter 3), i.e.






FIGURE 3.1: Using a map φ that maps the original data
points x ∈ X to a different (possibly higher-dimensional)
space H, the two classes (orange and blue) become linearly
separable. The kernel function δ computes the inner prod-
ucts in the feature space H directly from the data points in
X . Therefore, in many applications the map φ does not need
to be explicitly known. Figure freely adapted from Shawe-
Taylor and Cristianini (2004, Chapter 2).
In this context, given a set of N data points X = [x1, . . . , xN ], the N × N matrix
∆ with ijth element equal to the inner product between xi and xj in the feature
spaceH is called Gram matrix.
Kernel methods make it possible to model non-linear relationships between data
points with a low computational complexity, thanks to the so-called kernel trick:
in short, many algorithms can be written so that they only require evaluating
the kernel function on each pair of data points, without having to explicitly rely
on the evaluation of φ on each data point (Murphy, 2012, Chapter 14). For this
reason, kernel methods have been widely used to extend many traditional algo-
rithms to the non-linear framework, such as principal component analysis (PCA;
Schölkopf, Smola, and Müller, 1998), linear discriminant analysis (Mika et al.,
1999; Roth and Steinhage, 2000; Baudat and Anouar, 2000) and ridge regression
(Friedman, Hastie, and Tibshirani, 2001; Shawe-Taylor and Cristianini, 2004).
Moreover, using Mercer’s theorem, it can be shown that for any PSD kernel func-
tion δ, there exists a corresponding feature map, φ : X → H (see e.g. Vapnik,
1999). That is,
Theorem 3.1 For each symmetric PSD kernel δ, there exists a feature map φ taking
value in some inner product space X such that δ(x, x′) = 〈φ(x), φ(x′)〉X .
In practice, it is therefore often sufficient to specify a symmetric PSD matrix ∆
representing the similarities between the data points, in order to allow us to apply
kernel methods such as those presented in the following sections.
In what follows, we show how the kernel trick can be used to derive the ker-
nel version of the k-means clustering algorithm. This provides an example of
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application of the kernel trick, as well as the foundation for the MKL approach
presented in Section 3.4. For a more detailed discussion of kernel methods, see
e.g. Shawe-Taylor and Cristianini (2004).
Kernel k-means clustering
Before moving on to kernel k-means, we first recall the original k-means clustering
algorithm (Steinhaus, 1956). Let x1, . . . , xN indicate the observed data, with xn ∈
RP and znk be the corresponding cluster labels, where ∑k znk = 1 with znk = 1 if
xn belongs to cluster k, znk = 0 otherwise. We denote by Z the N × K matrix with
ijth element equal to zij. The goal of the k-means algorithm is to minimise the
sum of all squared distances between the data points xn and the corresponding




















Now we can show how the kernel trick works in the case of the k-means clus-
tering algorithm (Girolami, 2002). Redefining the objective function of Equation
(3.1a) based on the distances between observations and cluster centres in the fea-




















where we indicated by m̃k the cluster centroids in the feature space H. Using the
kernel corresponding to φ, each term of the sum in Equation (3.2a) can be written
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as a function of δ(xi, xj):
‖φ(xn)− m̃k‖2H = 〈φ(xn)− m̃k, φ(xn)− m̃k〉H

































Therefore, there is no need to evaluate the map φ at every point xi to compute the
objective function of Equation (3.2a). Instead, one just needs to know the values
of the kernel evaluated at each pair of data points δ(xi, xj), i, j = 1, . . . , N.
Defining L as the K× K diagonal matrix with kth diagonal element equal to N−1k
and ∆ the N × N matrix with ijth entry equal to δ(xi, xj), the optimisation prob-









subject to Z1k = 1n, ∀n, k,
znk ∈ {0, 1}, ∀n, k. (3.3a)
The integrality constraints make this problem difficult to solve. However, the cor-
responding linear problem obtained by relaxing the integer constraints of Equa-
tion (3.3a) to 0 ≤ znk ≤ 1 for all n, k can be solved by performing kernel PCA
on the kernel matrix ∆ and setting the matrix H = ZL
1
2 to the K eigenvectors
that correspond to K largest eigenvalues (Schölkopf, Smola, and Müller, 1998).
The clustering solution can be found by first normalising all rows of H to be on
the unit sphere and then performing k-means clustering on the normalised ma-
trix. Other possible approaches to derive a final clustering from H are listed in
Shawe-Taylor and Cristianini (2004, Chapter 8).
3.2 INTEGRATIVE CLUSTERING OF MULTI-OMIC DATA
Many existing statistical and computational tools have been applied to the prob-
lem of clustering multi-omic data and many others have been developed specifi-
cally for this. A recent comprehensive review of integrative clustering algorithms
is the one by Rappoport and Shamir (2018) which includes a benchmark of sev-
eral methods on cancer datasets.
In this section, we review the main integrative clustering algorithms developed
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so far specifically for multi-omic data. Table 3.1 contains a summary of existing
methods. For clarity of exposition, we classify them into consensus clustering
methods, kernel-based algorithms, latent variable models, Bayesian integrative
models, network-based methods, and others. We focus particularly on the first
two classes of methods, since they are more closely related to the novel algorithm
presented here. Alternatively, we have seen in the Introduction that integrative
clustering methods can be broadly divided into joint modelling and two-step ap-
proaches. The former simultaneously consider all datasets together. The latter,
which we consider here, are composed of two steps: first, the clustering structure
in each dataset is analysed independently; then an integration step is performed
to find a common clustering structure that combines the individual ones.
3.2.1 Consensus clustering methods
Methods that belong to this class were initially devised to cluster a single dataset,
with the aim of combining multiple partitionings of the observations into one;
examples include: the consensus clustering (CC) algorithm of Monti et al. (2003),
the ensemble clustering methods of Strehl and Ghosh (2002), and the probabilistic
model of consensus of Topchy, Jain, and Punch (2004).
In the field of integrative ’omics for cancer applications, the most popular clus-
tering algorithm is COCA. As we mentioned in the introduction of this chapter,
COCA has been widely applied to problems related to tumour subtyping and
has grown in popularity since its first introduction by The Cancer Genome Atlas
Research Network (2012). COCA proceeds by first clustering each of the datasets
separately, and then building a binary matrix that encodes the cluster allocations
of each observation in each dataset. This binary matrix is then used as the input to
a CC algorithm (Monti et al., 2003; Wilkerson and Hayes, 2010), which returns a
single, global clustering structure, together with an assessment of its stability. The
idea is that this global clustering structure both combines and summarises the
clustering structures of the individual datasets. Despite its widespread use, to the
best of our knowledge the COCA algorithm has never previously been system-
atically explored. In Section 3.3, we elucidate the algorithm underlying COCA,
and highlight some of its limitations. We show that one key limitation is that the
combination of the clustering structures from each dataset is unweighted, mak-
ing the output of the algorithm sensitive to the inclusion of poor quality datasets,
or datasets that define unrelated clustering structures.
Moreover, Nguyen et al. (2017) developed perturbation clustering for data integra-
tion and disease subtyping (PINS), a two-step algorithm. In the first step, each
dataset Xm, m = 1, . . . , M, is partitioned into Km clusters. From each clustering,
a connectivity matrix of size N × N is defined such that the ijth element is equal
to one if samples i and j belong to the same cluster in dataset m, zero otherwise.
60
3.2. Integrative clustering of multi-omic data
The original similarity matrix is then defined as the average of all connectivity ma-
trices. If this matrix has more than half of its non-diagonal entries equal to either
zero or one, this is interpreted as a strong agreement between the clusterings of
all datasets, and therefore the final clustering is performed applying hierarchical
clustering on the strong similarity matrix, which has ijth element equal to 1 if sam-
ples i and j are clustered together in every layer, 0 otherwise. If, however, there is
no strong agreement between layers, then a matrix of distances between samples
is defined as one minus the original similarity matrix. This matrix of distances is
used as the input of a distance-based clustering algorithm to find a global cluster-
ing of the samples. The goal of the second step of PINS is to find subclusters that
may not have been discovered in the first step. To this end, various indicators are
considered, such as the entropy (Cover and Thomas, 2006) and gap statistic (Tib-
shirani, 2001). Nguyen et al. (2019) developed an improved version of the PINS
algorithm, PINSPlus, which is available on CRAN as an R package.
3.2.2 Kernel-based algorithms
An alternative class of approaches for integrating multiple ’omic datasets is pro-
vided by those based on kernel methods. In these, a kernel function (which de-
fines similarities between different units of observation) is associated with each
dataset. These may be straightforwardly combined in order to define an overall
similarity between different units of observation, which incorporates similarity
information from each dataset. The advantage of using kernels in this setting is
that layers of data of different type (e.g. continuous, binary, multinomial, etc.)
can be summarised into similarity (i.e. Gram) matrices, which, in contrast to the
original data, are directly comparable. Determining an optimal (weighted) com-
bination of kernels is known as multiple kernel learning (MKL); see, for example,
Lanckriet et al. (2004b), Bach, Lanckriet, and Jordan (2004), Yu et al. (2010), Gö-
nen and Alpaydın (2011), Wang et al. (2017), and Strauß et al. (2020). A challenge
associated with these approaches is how best to define the kernel function(s), for
which there may be many choices. We shall expand on this topic in Section 3.4.2.
Speicher and Pfeifer (2015) combined the multiple kernel learning dimensionality
reduction (MKL-DR) approach of Yan et al. (2006) with the locality preserving pro-
jections (LPP) of He and Niyogi (2004), as well as additional regularisation con-
straints, to create a new algorithm named rMKL-LPP. In brief, first they solve the
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ψm ≥ 0, m = 1, 2, . . . , M′,
where M′ ≥ M, ∆̃i, i = 1, . . . , N, are N ×M′ matrices where the element in posi-
tion (j, m) is equal to δm(xi, xj), wij is equal to one if i is in the neighbourhood of j
and/or vice versa, dij is equal to ∑Nn=1 win if i = j, zero otherwise, ζ = [ζ1, . . . , ζN ],
and ψ = [ψ1, . . . , ψM]. rMKL-LPP can perform the integration of a large number
of kernels, while the l1 constraint ensures that overfitting is avoided. Thanks to
this, they get around the problem of choosing the kernel parameters by consid-
ering a set of kernels built with a range of plausible parameter values for each
layer. The MKL approach then up-weights the matrices with “high information
content” and down-weights the others. The regularisation term is included to
avoid assigning non-zero weight to too many kernel matrices. When applying
rMKL-LPP to real data, they use RBF kernels with five different parameters for
each data type. Their software is available as a web server named web-rMKL
(Röder et al., 2019).
Ramazzotti et al. (2018) introduced cancer integration via multikernel learning (CIMLR),
an extension to multi-omic data of the single-cell interpretation via multi-kernel learn-
ing (SIMLR) method presented by Wang et al. (2017) and Wang et al. (2018). Given
a number of clusters K, CIMLR builds a number of different RBF kernels for each
data type, and then combines them to find a weighted similarity matrix ∆̄ that
presents a structure that is as close as possible to a block structure with K blocks.
















subject to RTR = I,
∑
l
θl = 1, θl ≥ 0,
∑
j
∆̄ij = 1, ∆̄ij ≥ 0,
where ‖ · ‖F is the Frobenius norm, θ = [θ1, . . . , θL], ζ and γ are non-negative
tuning parameters, and R is an auxiliary low-dimensional matrix ensuring that
∆̄ is of low rank. The suggested number of kernels per layer, which Ramazzotti
et al. derived empirically, is 55. In particular, they use RBF kernels per data type
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in their real data application. The weighted kernel matrix ∆̄ is then used as input
for kernel k-means clustering.
In a similar spirit, Mariette and Villa-Vialaneix (2018) suggest three unsuper-
vised multiple kernel learning (UMKL) approaches, sparse-UMKL, full-UMKL,
and STATIS-UMKL (named after the STATIS method of Lavit et al., 1994), which
can be used to combine multiple kernels into one in a meaningful way. Each me-
thod summarises the kernels in slightly different ways. The combined kernel is
then used as the input of kernel PCA. Again, the kernels used in the real data
application are Gaussian kernels.
Finally, Rappoport and Shamir (2019) developed an approach called neighbourhood-
based multi-omics clustering (NEMO). Denoting by νim the k nearest neighbours of
xim within layer m, they define a similarity matrix for each layer m = 1, . . . , M.
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The similarity between observations i and j in layer m relative to i and j’s nearest








The final clusters are computed as by performing spectral clustering (Ng, Jordan,
and Weiss, 2002) on the average of all relative similarity matrices. The R imple-
mentation of this method is available as the GitHub package nemo.
What all these approaches have in common is that they use predefined closed
form kernels (e.g. RBF) whose parameters need to be selected by the user. How
to do this best in unsupervised settings is an open question and, as a result, one
often has to feed a large number of kernel matrices to these algorithms, which
can be quite inefficient. In the next section, we show how this problem can be
avoided by defining more meaningful kernel matrices derived from consensus
clustering.
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3.2.3 Latent variable models
One of the first statistical methods applied to integrative clustering for cancer
subtypes was iCluster (Shen, Olshen, and Ladanyi, 2009). iCluster finds a parti-
tioning of the tumours into different subtypes by projecting the available datasets
onto a common latent space, maximising the correlation between data types. The
original formulation assumes that all layers have normally distributed data, and
can be visualised as follows:
X1 = Γ1Π + ε1,
X2 = Γ2Π + ε2,
. . .
XM = ΓMΠ + εM,
where Π is the latent component common to all layers, Γ1, . . . , ΓM are the coeffi-
cient matrices, and ε1, . . . , εM represent the Gaussian noise. The first version of
iCluster only included a LASSO-type penalty on Π; while a subsequent exten-
sion (Shen, Wang, and Mo, 2013) introduced EN and fused LASSO (Tibshirani
et al., 2005) penalties. Other extensions of iCluster include a variance weighted
penalty term, proportional to the error variance associated with each feature so
that features with high variance are more strongly penalised (Shen et al., 2012),
feature selection using lasso regression Shen, Wang, and Mo (2013), integration
of binary, categorical, count, and continuous data types (iClusterPlus; Mo et al.,
2013), and a fully Bayesian version of the model (iClusterBayes; Mo et al., 2018).
Implementations of iCluster and iClusterPlus are available on CRAN and Biocon-
ductor respectively.
Zhang et al. (2012) proposed a similar approach, based on non-negative matrix
factorisation. They add non-negativity constraints to the matrices Π and Γm, m =
1, . . . , M and solve the optimisation problem
minimise





subject to Π ≥ 0,
Γm ≥ 0, m = 1, . . . , M.
Lastly, Wu et al. (2015) suggested to define the likelihood of each type of data Xm
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where Π is a matrix formed by stacking Πm, m = 1, . . . , M. This method is called
low-rank approximation-based multi-omics data clustering (LRAcluster).
As we shall see later in this chapter, a drawback of these methods is that they
assume that the same clustering structure can be found in every data layer.
3.2.4 Bayesian integrative models
The first Bayesian integrative models for ’omic data were developed for the spe-
cific datasets available in each application. For instance, Liu et al. (2007) and Sav-
age et al. (2010) developed methods to integrate expression and ChIP-chip data,
while Rogers et al. (2008) focused on transcriptomic and proteomic expression
data, and Yuan, Savage, and Markowetz (2011) on copy number alterations and
gene expression data.
The first Bayesian method for integrative clustering that can be used for any type
’omic layers to be developed was multiple dataset integration (MDI; see Kirk et al.,
2012; Mason et al., 2016). It is based on Dirichlet-multinomial mixture models
in which the allocation of observations to clusters in one dataset influences the
allocation of observations in another, while allowing different datasets to have
different numbers of clusters.
Similarly, Bayesian consensus clustering (BCC) of Lock and Dunson (2013) is based
on a Dirichlet mixture model that assigns a different probability model to each
dataset. Again, tumour samples belong to different partitions, each given by a
different data type, but here they also adhere loosely to an overall clustering.
More recently, Gabas̆ová, Reid, and Wernisch (2017) developed Clusternomics, a
mixture model over all possible combinations of cluster assignments on the level
of individual datasets that allows to model different degrees of dependence be-
tween clusters across datasets.
Finally, Afrin et al. (2020) introduced a Bayesian directional multi-omic cluster-
ing approach that takes into account the directional dependence between ’omic
datasets. They use a hierarchical Dirichlet mixture model using copulas (Nelsen,
2007; Jaworski et al., 2010; Trivedi and Zimmer, 2007) to model directional de-
pendencies between layers, where directionality is based on the central dogma
(Crick, 1958; Crick, 1970).
The advantage of Bayesian models is that they allow to jointly model multiple
layers in a principled way and are particularly suitable to define models not rely-
ing on the assumption that all layers have the same clustering structure. On the
other hand, inference for these models is often computationally costly, especially
considering that ’omic datasets often have large numbers of features.
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3.2.5 Network-based methods
Wang et al. (2014) developed similarity network fusion (SNF). Initially, a network
is built for each data layer where the observations are represented by nodes and
pairwise correlations between observations form the edges. The networks are
then “fused”, using a method based on message-passing theory, until conver-
gence to a final network. Spectral clustering is then performed on the final net-
work to identify the global clusters. A more efficient version of SNF is the affinity
network fusion (ANF) method proposed by (Ma and Zhang, 2018).
A different approach is suggested by Rappoport, Safra, and Shamir (2020), who
developed multi-omic clustering by non-exhaustive types (MONET). This method
aims to circumvent the problem of differing clustering structures by outputting
a set of modules, each characterised by a set of samples and a set of ’omics in
which those samples are similar. This is achieved with a two-step algorithm.
First, a graph is built for each ’omic layer where the nodes are samples and the
edges are similarities between samples in that layer. Then modules are detected
by looking for subgraphs common to multiple graphs.
3.2.6 Other methods
Kim et al. (2015) proposed an integrative phenotyping framework (iPF) for multi-
omic data. First, all ’omic layers are combined to create one large matrix contain-
ing all measurements. The matrix based on the correlations between features is
used as input for multidimensional scaling (Cox and Cox, 2008). In this way, the
features are mapped to a bidimensional Euclidean space.
Finally, deep learning approaches have recently started to be applied to cancer
applications (Levine et al., 2019). In the context of unsupervised methods, notable
examples include the multimodal deep belief network (DBN) of Liang et al. (2014),
the variational autoencoders (VAEs) for cancer data integration of Simidjievski
et al. (2019), and the pathway based multi-modal sparse autoencoders for clustering of
patient-level multi-omics data (PathMe) of Lemsara, Ouadfel, and Fröhlich (2020).
3.3 CLUSTER-OF-CLUSTERS ANALYSIS
COCA (The Cancer Genome Atlas Research Network, 2012) is an integrative clus-
tering method that was first introduced in a breast cancer study by The Cancer
Genome Atlas Research Network (2012) and quickly became a popular tool in
cancer studies (see e.g. Hoadley et al., 2014 and Aure et al., 2017). It makes use of
CC (Monti et al., 2003), an algorithm that was originally developed to assess the
















































































































































































































































































































































































































































































Chapter 3. Multiple kernel learning for integrative clustering of multi-omic data
3.3.1 Consensus clustering
We recall here the main features of CC in order to be able to explain the function-
ing of COCA. As originally formulated, CC is an approach for assessing the ro-
bustness of the clustering structure present in a single dataset (Monti et al., 2003;
Wilkerson and Hayes, 2010). The idea behind CC is that, by resampling multiple
times the items that we want to cluster, and then applying the same clustering al-
gorithm to each of the subsets of items, we assess the robustness of the clustering
structure that the algorithm detects, both to perturbations of the data and (where
relevant) to the stochasticity of the clustering algorithm. To do this, CC makes
use of the concepts of co-clustering matrix and consensus matrix, which we recall
below:
Definition 3.2 Given a set of items X = [x1, . . . , xN ] that we seek to cluster and a
clustering c = [c1, . . . , cN ] such that ci is the label of the cluster to which item xi has
been assigned, the corresponding co-clustering matrix (or connectivity matrix) is an
N × N matrix C such that
Cij =
{
1 if ci = cj,
0 otherwise.
Definition 3.3 Let X(1), . . . , X(H) be a list of perturbed datasets obtained by resampling
subsets of items and/or covariates from the original dataset X. If I(h) is a subset of the
indices of the observations I = {1, 2, . . . , N}, and X(h) is the dataset containing only the
statistical units corresponding to the indices in set I, then the co-clustering matrix has
element (i, j) defined as follows:
C(h)ij =
{
1 if i, j ∈ I and ci = cj,
0 otherwise.
We denote by C(h) the co-clustering matrix corresponding to dataset X(h) where the items
have been assigned to K classes using a clustering algorithm. The consensus matrix ∆K











where 1(h)ij = 1 if both items i and j are present in dataset X
(h).
Thus, CC performs multiple runs of a (stochastic) clustering algorithm (e.g. k-
means, hierarchical clustering, etc.) to assess the stability of the discovered clus-
ters, with the consensus matrix providing a convenient summary of the CC anal-
ysis. If all the elements of the consensus matrix are close to either one or zero,
this means that every pair of items is either almost always assigned to the same
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cluster, or almost always assigned to different clusters. Therefore, consensus ma-
trices with all the elements close to either zero or one indicate stable clusters. The
CC procedure for a fixed number of clusters K is reported in Algorithm 3.1.
Algorithm 3.1: Consensus clustering (CC).
Input : Dataset X, number of clusters K.
Initialise: Consensus matrix ∆K = 0N×N .
Matrix of resampling counts Dij = 0N×N .
1 for h ∈ {1, . . . , H} do
2 X(h) = resample from the rows and/or columns of X
3 c(h) = divide the items of X(h) into K clusters
4 C(h) = build the co-clustering matrix corresponding to c(h)
5 for i, j ∈ {1, . . . , n} do










10 for i, j ∈ {1, . . . , n} do







Output : Consensus matrix ∆K.
In the framework of consensus clustering, these matrices can also be used to de-
termine the number of clusters, by computing and comparing the consensus ma-
trices ∆K for a range of numbers of clusters K = {Kmin, . . . , Kmax} of interest and
then pick the value of K that gives the consensus matrix with the greater propor-
tion of elements close to either zero or one (Monti et al., 2003).
3.3.2 COCA algorithm
In contrast to consensus clustering (which we emphasise is concerned with as-
sessing clustering stability when analysing a single dataset), the main goal of
COCA is to summarise the clusterings found in different ’omic datasets, by iden-
tifying a “global” clustering across the datasets that is intended to summarise the
clustering structures identified in each of the individual datasets. In the first step,
a clustering cm is produced independently for each dataset Xm, m = 1, . . . , M,
each with a different number of clusters Km. We define K̄ = ∑Mm=1 Km. Then,




1 if cmn = mk,
0 otherwise.
where by mk we denote the kth cluster in dataset m, k = 1, . . . , Km and m =
1, . . . , M. The MOC matrix is then used as input to CC (Algorithm 3.1) together
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with a fixed global number of clusters K. The resulting consensus matrix com-
puted with Algorithm 3.1 is then used as the similarity matrix for a hierarchical
clustering method (or any other distance-based clustering algorithm). The proce-
dure is summarised in Algorithm 3.2.
The global number of clusters K is not always known. In The Cancer Genome
Atlas Research Network (2012), where COCA was introduced, the global num-
ber of clusters was chosen as in Monti et al. (2003), as explained above: CC was
performed with different values of K and then the one that gave the “best” con-
sensus matrices were considered. Instead, Aure et al. (2017) suggest to choose
the value of K that maximises the average silhouette (see Rousseeuw, 1987, and
Section 3.4.4) of the final clustering, since this was found to give more sensible
results.
Algorithm 3.2: Cluster-of-clusters analysis (COCA).
Input : M datasets Xm, number of clusters Km in each dataset, global
number of clusters K̄.
Initialise: MOC = 0K×N .
1 for m ∈ {1, . . . , M} do
2 cm = cluster the items in dataset Xm into Km clusters
3 for n ∈ {1, . . . , N}, k ∈ {1, . . . , Km} do





7 for h ∈ {1, . . . , H} do
8 MOC(h) = resample from the rows and/or columns of MOC
9 c(h) = divide the items of X(h) into K clusters
10 C(h) = build the co-clustering matrix corresponding to c(h)
11 for i, j ∈ {1, . . . , n} do










16 for i, j ∈ {1, . . . , n} do







19 Find final clustering cK̄ using hierarchical clustering on ∆K̄.
Output : Cluster labels cK̄.
Because the construction of the MOC matrix just requires the cluster allocations,
COCA has the advantage of allowing clusterings derived from different sources
to be combined, even if the original datasets are unavailable or unwieldy. How-
ever, this method is unweighted, since all the clusters found in the first step have
the same influence on the final clustering. Moreover, the objective function that
is optimised by the algorithm is unclear.
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In what follows, we describe an alternative way of performing integrative clus-
tering, that takes into account not only the clusterings in each dataset, but also
the information about the similarities between items that are extracted from dif-
ferent types of data. Additionally, the new method allows weights to be given
to each source of information, according to how useful it is for defining the final
clustering.
3.4 KERNEL LEARNING INTEGRATIVE CLUSTERING
Before introducing the new methodology, we recall the main principles behind
the methods that we use to combine similarity matrices.
3.4.1 Multiple kernel k-means clustering
Gönen and Margolin (2014) extended the kernel k-means approach (Section 3.1)
to the MKL setting. We consider multiple datasets X1, . . . , XM each with a dif-
ferent mapping function φm : RP → Hm and corresponding kernel δm(xi, xj) =
〈φm(xi), φm(xj)〉Hm and kernel matrix ∆m. Then, if we define
φθ(xi) = [θ1φ1(xi)
′, θ2φ2(xi)′, . . . , θMφM(xi)′]′,
where θ ∈ RM+ is a vector of kernel weights such that ∑m θm = 1 and θm ≥ 0,
the kernel function of this multiple feature problem is a convex sum of the single
kernels:





















where 1M indicates a vector of ones of length M. The optimisation strategy pro-
posed by Gönen and Margolin (2014) is based on the idea that, for some fixed
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vector of weights θ, the problem is equivalent to the one of Equation (3.2a), where
we had only one kernel. Therefore, they develop a two-step optimisation strat-
egy: (i) given a fixed vector of weights θ, solve the optimisation problem as in
the case of one kernel (Equation 3.3), with kernel matrix ∆θ and then (ii) min-
imise the objective function with respect to the kernel weights, keeping the as-
signment variables fixed. This is a convex quadratic programming (QP) problem
that can be solved with any standard QP solver up to a moderate number of
kernels M. They also generalise this approach to a localised multiple kernel k-
means, by assigning sample-specific weights, in order to remove sample-specific
noise. This is achieved by defining a matrix of weights Θ, where each row corre-
sponds to an observation and each column to one of the datasets. We indicate
by θim the weight of observation xi in dataset m and by θm = [θ1m, . . . , θNm]
the vector of weights of dataset m. The mapping function is then φΘ(xi) =
[θi1φ1(xi)′, θi2φ2(xi)′, . . . , θiMφM(xi)′]′, and the corresponding kernel matrix ∆Θ
has element (i, j) defined as






















where ◦ is the Hadamard product. Here too the objective function of Equation
(3.8a) can be optimised using a two-step procedure, that iteratively (i) solves a
standard kernel k-means problem with kernel ∆Θ, keeping the weight matrix Θ
fixed and then (ii) optimises the objective function with respect to Θ. Again,
the first step reduces to solving one optimisation problem with a single kernel
(Equations 3.3) and in the second step one just needs to solve a QP problem.
3.4.2 Identifying consensus matrices as kernels
Traditionally, the integration of multiple ’omic datasets via MKL has been made
using closed form kernels. Lanckriet et al. (2004a), for instance, use the linear,
diffusion, fast Fourier transform, and RBF kernels (Shawe-Taylor and Cristianini,
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2004), among others, to perform ribosomal and membrane protein classification
in yeast. Because it is not possible to know a priori which kernel is best, they use
more than one kernel per data layer. Similarly, we have seen that Ramazzotti et
al. (2018) generated a large number of RBF kernels for each data type, each with
different parameters, and let the algorithm average over those. As our simulation
studies show (Section 3.5), however, the choice of the kernel parameters is crucial.
Xing et al. (2003) developed an algorithm that learns the desired similarity be-
tween points in RP when provided by the user with some examples of similar
(or dissimilar) data points. This is known as metric learning (Kulis, 2013; Bellet,
Habrard, and Sebban, 2013). Unfortunately this information is often not available
in unsupervised situations. Therefore, how to best define kernels for each data
layer remains an open question.
To address this, we prove that the consensus matrices defined in Section 3.3 are
PSD, and hence that they can be used as input for any kernel-based clustering
method, including the integrative clustering method presented in the next sec-
tion.
Given any N × N co-clustering matrix C, we can reorder the rows and columns
to obtain a block-diagonal matrix:
C =

J1 0 0 . . . 0




0 0 0 . . . JK

where K is the total number of clusters and Jk, k = 1, . . . , K, is an Nk×Nk matrix of
ones, with Nk being the number of items in cluster k. It is straightforward to show
that the eigenvalues of a block diagonal matrix are simply the eigenvalues of its
blocks. Since each block is a matrix of ones, the eigenvalues of each block are non-
negative, and so any co-clustering matrix C is PSD. Moreover, given any set of λm,
m = 1, . . . , M non-negative, and co-clustering matrices Cm, m = 1, . . . , M, then
∑Mm=1 λmCm is PSD. Indeed, if λ is a non-negative scalar, and C is PSD, then λC
is also PSD and the sum of PSD matrices is a PSD matrix. Since every consensus
matrix is of the form ∑m λmCm, we can conclude that any consensus matrix is
PSD.
In practice, when generating consensus matrices, computers often incur small
round-off errors, which results in consensus matrices that are not PSD. Some of
the most commonly used methods to convert similarity matrices into valid ker-
nels are discussed by Chen et al. (2009). Among other things, they consider:
- to use indefinite kernels, simply ignoring the fact that ∆ is indefinite;
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- to perform a spectrum clip, i.e. given the eigenvalue decomposition ∆ =
UTΛU, where Λ is the diagonal matrix Λ = diag(λ1, . . . , λN) and λ1, . . . , λN
are the eigenvalues of ∆, modify Λ as follows:
Λclip = diag(max{λ1, 0}, . . . , max{λN , 0});
- a spectrum flip:
Λflip = diag(|λ1|, . . . , |λN |);
- a spectrum square:
Λsquare = ΛTΛ;
- or a spectrum shift:
Λshift = Λ + |min{λmin, 0}|IN ,
where λmin is the smallest eigenvalue of ∆, a is a constant such that a ≥ 1
and IN is the N × N identity matrix.
Here we use the spectrum shift, which is employed in many other applications.
For example, in kernel ridge regression, shifting the eigenvalues of the kernel
matrix corresponds to applying regularisation equivalent to that of Equation (2.2)
(Shawe-Taylor and Cristianini, 2004, Chapter 3). In addition to that, in Section
3.5 we introduce cophenetic correlation coefficients, which we use to quantify
how well defined is the clustering structure contained in a similarity matrix. It is
interesting to note that the cophenetic correlation coefficient of a similarity matrix
remains unchanged after a spectrum shift.
3.4.3 KLIC algorithm
We have shown above that any PSD matrix defines a feature map φ : RP → H
and is therefore a valid kernel matrix. The integrative clustering method that we
introduce here is based on the idea that we can identify the consensus matrices
produced by Algorithm 3.1 as kernels. That is, one can perform consensus clus-
tering on each dataset to produce a consensus matrix ∆m for each m ∈ {1, . . . , M}.
This is a kernel ∆m, where the ijth element corresponds to the similarity between
items i and j. Therefore, these matrices ∆m can be combined through the (lo-
calised) multiple kernel k-means algorithm described in Section 3.4.1. This al-
lows a weight to be obtained for each kernel, as well as a global clustering c of
the items. We refer to this as the KLIC (kernel learning integrative clustering) al-
gorithm (see Figure 3.2 and Algorithm 3.3). We note that this algorithm could
also be applied using more than one similarity matrix per dataset, and also using
kernel matrices other than (or in addition to) consensus matrices.
74












FIGURE 3.2: Schematic representation of KLIC. For each
data layer, a kernel is formed using consensus clustering. All
kernels are then combined in a weighted manner through
localised multiple kernel k-means to obtain the final cluster
labels.
Algorithm 3.3: Kernel learning integrative clustering (KLIC).
Input : M datasets Xm, maximum number of clusters K.
1 for m ∈ {1, . . . , M} do
2 ∆m = compute kernel for Xm
3 end
4 for k ∈ {1, . . . , K} do
5 [wk, ck] = apply multiple kernel k-means to ∆1, . . . , ∆M
6 sk = calculate average silhouette of ck
7 end
8 Choose k such that sk ≥ sj, ∀j 6= k.
9 return k, wk, ck.
Output : Best number of clusters k, set of kernel weights w = [w1, . . . , wM],
cluster labels c = [c1, . . . , cN ]
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3.4.4 Choice of the number of clusters
Many approaches exist in the literature to choose the number of clusters (see e.g.
Milligan and Cooper, 1985; Tibshirani, 2001; Yeung, Haynor, and Ruzzo, 2001;
Dudoit and Fridlyand, 2002; Kaufman and Rousseeuw, 1990). Here we restrict
our attention to the metrics that have either been developed specifically for con-
sensus/kernel matrices or that have been successfully used in contexts similar to
the one considered here.
Area under the cumulative distribution function
For a given kernel matrix ∆, the empirical cumulative distribution function (CDF)
is
CDF(x) =
∑i<j 1(∆ij < x)
N(N − 1)/2
where 1 is the indicator function, ∆ij denotes the ijth entry of the consensus/kernel
matrix, and N is the number of rows and columns of ∆. Monti et al. (2003) suggest
to use the change in the area under the CDF between two consecutive numbers
of clusters to choose the best value of K. The area under the CDF corresponding









where Ñ = N(N − 1)/2 and x(1), . . . , x(Ñ) indicate the entries of the consensus
matrix ∆(K) sorted in increasing order. Monti et al. (2003) observed that, as K is
increased the value of A(K) markedly increases as long as K < Ktrue, where Ktrue
is the true number of clusters. Instead, for K > Ktrue the increase in area under
the CDF is negligible. Therefore, one can choose the number of clusters to be the




A(K) if K = 2,
A(K+1)/A(K)-1 if K > 2,
is “large”.
Proportion of ambiguous clustering
Şenbabaoğlu, Michailidis, and Li (2014) suggest to use a different measure based
on the empirical CDF: the proportion of ambiguous clustering (PAC). This is de-
fined as the fraction of sample pairs with consensus index values falling in the
interval (x1, x2) ∈ (0, 1), that is
PACK(x1, x2) = CDFK(x2)−CDFK(x1)
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The number of clusters K corresponding to the minimum observed value of PACK
is selected. However, they do not give any indication on how to choose the thresh-
olds x1 and x2 except that they should be chosen near zero and one.
Silhouette
Another metric of cluster assessment that has been previously used in the context
of integrative clustering (Wang et al., 2014) is the silhouette, a measure of the com-
pactness of the clustering structure originally suggested by Rousseeuw (1987).
There are two ways of defining the silhouette of a cluster, based respectively on
the similarities and dissimilarities between the data. Here we briefly explain the
former.
Given some cluster assignment labels c = [c1, . . . , cN ] and some measure of the
dissimilarity between the data points ∆ij for all i, j = 1, . . . , N, we can define the
following quantities: an is the average similarity of xn to all the objects in cluster
cn and, for each ci 6= cn, ∆n,ci is the average similarity of n to all objects belonging
to cluster ci. Moreover, let us indicate by bn the maximum ∆n,ci over all i such that
ci 6= cn. Then, for each observation n = 1, . . . , N, we can calculate
sn =

1− an/bn, if an < bn,
0, if an = bn,
an/bn − 1, if an > bn.
This quantity takes values between −1 and 1, with higher values indicating that
xi has been allocated to an appropriate cluster and negative values suggesting
that xi has been misclassified.
The silhouette can be easily used in the context of MKL, defining the similarity
between data points as the ijth entry of the kernel matrix ∆. Thus, we run our
algorithms for combining the kernel matrices with different number of clusters
from Kmin to Kmax. We consider the overall average silhouette width s̄ = ∑Nn=1 sn
as a measure of the compactness of clusters and we choose the value of K that
gives the highest value of s̄.
3.5 SIMULATION STUDY
To assess the KLIC algorithm described in Section 3.4 and to compare it to COCA,
we perform a range of simulation studies.
We generate several synthetic datasets, each composed of data belonging to six
different clusters of equal size. Each dataset has total number of observations
equal to 300. Each observation x(k)n is generated from a bivariate normal with
mean kτ for each variable, where k denotes the cluster to which the observation
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belongs and τ the separation level of the dataset. Higher values of τ give clearer
clustering structures. The variance covariance matrix is the identity matrix.
FIGURE 3.3: Consensus matrices of the synthetic data with
different levels of noise going from “no cluster separability”
to “high cluster separability”. Blue indicates high similarity.
The colours of the bar to the right of each matrix indicate the
cluster labels.
We consider the following settings:
Setting A: similar datasets. We generate four datasets that have the same clus-
tering structure and cluster separability τ. We denote the datasets by A, B, C,
D. The goal of this experiment is to show that using localised kernel k-means on
multiple consensus matrices leads to better results than those obtained using just
one consensus matrix. We also repeat this experiment adding to each dataset 13
covariates that have no clustering structure, i.e.
x(k)1 , . . . , x
(k)
50 ∼ N ([kτ, kτ, 0, . . . , 0︸ ︷︷ ︸
13
], I15), ∀k = 1, . . . , 6
where I15 is the 15× 15 identity matrix.
Setting B: datasets with different levels of noise. In this case we consider four
datasets that have the same clustering structure, but different levels of cluster
separability τ. We denote the datasets by 0 for “no cluster separability”, 1 “low
cluster separability”, 2 “medium cluster separability”, and 3 “high cluster separa-
bility” (Figure 3.3). We use this example to show how the weights are allocated to
each consensus matrix and why it is important to assign lower weights to datasets
that are noisy or not relevant.
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Setting C: datasets with nested clusters. We also investigate how the algorithm
copes with the ambiguous situation of nested clusters. To this end, we generate
two datasets with the same value of the parameter s setting the distance between
cluster centres. The first one has six clusters, while the second one only has three
clusters, each of them containing two of the clusters of the other dataset (Figure
3.3, second row).
We repeat each experiment 100 times. For each synthetic dataset, we use consen-
sus clustering (Algorithm 3.1) to obtain the consensus matrices. For simplicity,
we always let K = 6 in settings A and B, and either K = 3 or K = 6 in setting
C, as specified below. As for the clustering algorithm, we use k-means clustering
with Euclidean distance, which we found to work well in practice. Appendix B
contains additional simulation settings. In particular, we consider a wide range
of separability values for the setting with four similar datasets. Moreover, we per-
form a short sensitivity analysis of the choice or tuning options for the k-means
algorithm.
In the remainder of this section, we first apply the developed methods to the syn-
thetic datasets and then compare the performances of our method for integrative
clustering to COCA and other competitor methods.
3.5.1 Assessment of KLIC
We apply KLIC (Algorithm 3.3) to the synthetic datasets generated for settings A,
B, and C.
Setting A: similar datasets. First, we run the kernel k-means algorithm on each
of the consensus matrices that have the same clustering structure and noise level.
Then, we use Algorithm 3.3 to run KLIC on multiple datasets.
We use the adjusted Rand index (ARI) of Hubert and Arabie (1985) as a measure
of the similarity between the output of each clustering method and the true parti-
tion of the data. To compute the ARI, given two partitions U = {U1, . . . , UK} and
V = {V1, . . . , VL}, we summarise the overlapping between each pair of subsets
Ui and Vj in a contingency table where νij = |Ui ∩Vj| (Table 3.2).
Class v1 v2 . . . vL Sums
u1 ν11 ν12 . . . ν1L ν1·





uk νk1 νk2 . . . νKL νK·
Sums ν·1 ν·2 . . . ν·L N
TABLE 3.2: Contingency table of two partitions of the data.
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This is the corrected-for-chance version of the Rand index (Rand, 1971) that is
simply the number ns of pairs of elements that are in the same subsets in both
partitions U and V, plus the number nd of pairs of elements that are in different





In Figure 3.4a are reported the box plots of the ARI obtained combining the four
datasets together using KLIC (column “A+B+C+D”). Figure 3.4b shows the box
plots of the average weights assigned by the KLIC algorithm to the observations
in each dataset.
We observe that, as expected, combining together more datasets enables the clus-
tering structure to be more accurately recovered than just taking the matrices one
at a time. This is because localised kernel k-means allows to give different weights
to each observation. Therefore, if data point n is hard to classify in dataset d1, but
not in dataset d2, we will have θnd1 < θnd2 . However, on average the weights are
divided equally between the datasets. This reflects the fact that all datasets have
the same dispersion and, as a consequence, they contain on average the same
amount of information about the clustering structure.
Setting B: datasets with different levels of noise. Here we use the datasets shown
in Figure 3.3, that have the same clustering structure (six clusters of the same size
each) but different levels of cluster separability. We consider four different set-
tings, each time combining three out of the four synthetic datasets. Figure 3.5a
shows the box plots of the ARI obtained using kernel k-means on the datasets
taken one at a time (columns “0”, “1”, “2”, “3”) and the ARI obtained using KLIC
on each subset of datasets (columns “0+1+2”, “0+1+3”, “0+2+3”, “1+2+3”). As ex-
pected, the consensus matrices with clearer clustering structure give higher val-
ues of the ARI on average. Moreover, the ARI obtained combining three matrices
with different levels of cluster separability is on average the same or higher as in
the case when only the “best” matrix is considered. This is because larger weights
are assigned to the datasets that have clearer clustering structure. In Figure 3.5b
are reported the box plots of the average weights given by the localised multiple
kernel k-means to the observations in each dataset. It is easy to see that each time
the matrix with best cluster separability has higher weights than the other two.
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Setting C: datasets with nested clusters. For the CC step, we use the true number
of clusters for each dataset. However, since the localised kernel k-means algo-
rithm works only with a fixed number of clusters, we try both with K = 3 and
K = 6. The ARI and the average weights assigned to each matrix are reported in
Figure 3.6. For K = 6, the weights assigned to each matrix are not as we expected:
the matrix with three clusters is weighted slightly more highly than the other one.
To investigate this phenomenon, we introduce an additional way to score how
strong the signal is in each dataset. We use the cophenetic correlation coefficient,
a measure of how faithfully hierarchical clustering would preserve the pairwise
distances between the original data points (Sokal and Rohlf, 1962; Brunet et al.,
2004). Given a dataset X = [x1, x2, . . . , xN ] and a similarity matrix ∆ ∈ RN×N , we
define the dendrogrammatic distance between xi and xj as the height of dendrogram
at which these two points are first joined together by hierarchical clustering and
we denote it by ηij. The cophenetic correlation coefficient ρ is calculated as
ρ =
Σi<j(∆ij − ∆̄)(ηij − η̄)√
∑i<j(∆ij − ∆̄)Σi<j(ηij − η̄)
,
where ∆̄ and η̄ are the average values of ∆ij and ηij respectively. The cophe-
netic correlation coefficient of a consensus matrix can be interpreted as an indi-
cation of the level of its dispersion or, equivalently, of the stability of the cluster-
ing used in CC. If the clusters are invariant under subsampling of the data fea-
tures/observations, then the consensus matrix has all entries equal to either one
or zero, and cophenetic correlation coefficient equal to one. On the other hand, if
clusters vary at each iteration of consensus clustering, the entries of the consen-
sus matrix are scattered between zero and one, and the corresponding cophenetic
correlation coefficient is negative. The consensus matrices shown in Figure 3.3,
for instance, have increasing cophenetic correlation going from left (lower cluster
separability) to right (higher cluster separability). We find that in this case the
consensus matrices with K = 3 have slightly higher cophenetic correlation than
the ones with K = 6 with the same level of cluster separability s. This explains
why higher weights are assigned to the former. This suggests that, in ambigu-
ous cases, localised kernel k-means assigns higher weights (on average) to the
kernels with highest cophenetic correlation. Intuitively, the sum of within-cluster
distances in the feature space is zero when each pair of data points has similarity
one if both data points are in the same cluster, and zero otherwise. Minimising
that sum thus corresponds to finding the weights and cluster allocations that lead
to a weighted kernel that is as close as possible to a kernel with cophenetic corre-
lation one.
We also report the results obtained setting either K = 3 or K = 6 at each step of
KLIC, i.e. consensus clustering of each dataset and MKL (Figure 3.7).
81
Chapter 3. Multiple kernel learning for integrative clustering of multi-omic data
(A) Adjusted Rand index
(B) Weights
FIGURE 3.4: Results of applying KLIC to four similar
datasets. On the left is the ARI of KLIC applied to each
dataset separately (columns “A”, “B”, “C”, and “D”) and to
all four datasets together (column “A+B+C+D”). The ARI is
higher in the last column because KLIC can combine infor-
mation from all the datasets to find a global clustering. On
the right are the kernel weights associated to each dataset,
when applying KLIC to all four datasets together. The al-
gorithm is able to recognise that each dataset contains the
same amount of information regarding the global clustering,




(A) Adjusted Rand index.
(B) Weights.
FIGURE 3.5: Results of applying KLIC to datasets with dif-
ferent levels of noise (“0” indicates the dataset that has no
cluster separability, “1” the dataset with low cluster separa-
bility, and so on). (A) ARI of KLIC applied to each dataset
separately (columns “0”, “1”, “2”, and “3”) and to subsets of
three of those datasets (columns “0+1+2”, “0+1+3”, “0+2+3”,
and “1+2+3”). (B) Kernel weights associated to each dataset
in each of the experiments with multiple datasets, ordered
by cluster separability. For example, the first subset is
“0+1+2” so the weights marked as “1st” are those assigned
to dataset “0”, “2nd” are those assigned to “1” and so on.
For each subset of datasets the weights of the noisier datasets
(“1st” and “2nd”) are lower than those of the “best” dataset
in the subset (“3rd”). This is reflected in an increased ARI
in each subset, compared to applying KLIC to those datasets
separately.
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(A) True number of clusters for CC, K = 3 for global clustering.
(B) True number of clusters for CC, K = 6 for global clustering.
FIGURE 3.6: Results of applying KLIC to datasets that have
nested clusters. Left: ARI of KLIC applied to the datasets
with three and six clusters separately (columns “3” and “6”
respectively) and to those two datasets combined (column
“3+6”). Centre: the weights assigned to each dataset. Right:
cophenetic correlation coefficients of the consensus matrices
built with K = 3 (for the dataset with three clusters) and
K = 6 (for the dataset with six clusters). Higher weights
are given to the kernels with higher cophenetic correlation,
irrespectively of their number of clusters.
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(A) K = 3 at each step.
(B) K = 6 at each step.
FIGURE 3.7: Results of applying KLIC to datasets that have
nested clusters. Left: ARI of KLIC applied to the datasets
with three and six clusters separately (columns “3” and “6”
respectively) and to those two datasets combined (column
“3+6”). Centre: the weights assigned to each dataset. Right:
cophenetic correlation coefficients of the consensus matrices
built with K = 3 (top) and K = 6 (bottom). Higher weights
are given to the kernels with higher cophenetic correlation,
irrespectively of their number of clusters.
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3.5.2 Comparison between KLIC, COCA, and other methods
We compare the performance of KLIC to the one obtained using COCA, as well as
to two other comparable integrative clustering algorithms for which implemen-
tations are readily available; namely, iCluster and Clusternomics. Additionally,
we compare to localised multiple kernel k-means using standard RBF kernels. We
use the same synthetic datasets as in the previous section.
For COCA, we use the k-means algorithm with Euclidean distance, fixing the
number of clusters to be equal to the true one, to find the clustering labels of
each dataset. Many other clustering algorithms can be used, but we found that
this is the one that gives the best results among the most common ones. To find
the global clustering, we build the consensus matrices using 1000 resamplings
of the data, each time with 80% of the observations and all the features. The
final clustering is done using hierarchical clustering with average linkage on the
consensus matrix. The iCluster model is fitted using the tune.iCluster2 function
of the R package iCluster (Shen, 2012), which helps selecting the parameters for
the penalty terms, with number of clusters set to six. For Clusternomics we use
the contextCluster function of the R pacakge clusternomics (Gabas̆ová, Reid,
and Wernisch, 2017), providing the true number of clusters both for the partial
and global clusterings.
To assess the impact of the choice of the RBF kernel parameters on the final clus-
tering, we consider two ways to set the free parameter of the RBF kernel. In one
setting we fix σ = 1, a common default value. In the second setting, σ is tuned for
each dataset to maximise the average ARI between the clustering obtained with
kernel k-means on the RBF kernel and the true clusters (more information about
this procedure can be found in Appendix B). Although this procedure clearly
could not be applied in practice (where the true clustering is unknown), it is used
here to determine a putative upper bound on the performances of MKL with this
kernel.
Setting A: similar datasets. We combine four datasets that have the same clus-
tering structure and cluster separability. In Figure 3.8a is shown the ARI of all
considered methods applied to 100 sets of data of this type. In the first setting,
where only variables relevant for the clustering are present, the localised mul-
tiple kernel k-means with RBF kernel has the highest median ARI, followed by
COCA and KLIC. To cluster the data that include noisy variables, we replace the
k-means algorithm by the sparse k-means feature selection framework of Witten
and Tibshirani (2010) in COCA and KLIC, using the R package sparcl (Witten
and Tibshirani, 2018). Thanks to this, the performances of these two methods
are not affected by the presence of irrelevant variables. COCA, in particular, has
the highest median ARI, followed by KLIC. This shows that both methods work
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well in the case of multiple datasets that have the same clustering structure and
level of noise and, in contrast to the four other methods considered here, can be
straightforwardly modified to deal with the presence of irrelevant features.
Setting B: datasets with different levels of noise. We also compare the behaviour of
all methods in the presence of multiple datasets with the same clustering struc-
ture, but different levels of cluster separability. The ARI is shown in Figure 3.8b.
We observe that, in each of the four simulation settings, KLIC and the optimised
version of localised multiple kernel k-means with RBF kernel have the highest
ARI scores. The reason for this is that COCA, iCluster, and Clusternomics are not
weighted methods, so their ability to recover the true clustering structure is de-
creased by adding noisy datasets. Instead, we have shown in the previous section
that KLIC allows to give lower weights to the noisiest datasets, achieving better
performances. We emphasise that the optimal values of the RBF parameters have
been determined making use of the true cluster labels, which is not possible in
real applications. The performance achieved when the RBF kernel parameter, σ,
is fixed to 1 may be therefore be more representative of what can be achieved in
practice.
Overall, these comparisons suggest that KLIC may be a good default choice, since
it can be run in such a way that it is robust to both the inclusion of noisy variables
(via the choice of an appropriate clustering algorithm) and of noisy datasets.
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(A) Similar datasets.
(B) Datasets with different level of noise.
FIGURE 3.8: Comparison between KLIC, COCA, and other
integrative clustering algorithms. The labels “RBF opt.” and
“RBF fixed” refer to the MKL method using an RBF kernel
with either σ optimised or dixed at 1 (see text). (A) ARI
obtained with each clustering algorithm using four datasets
having the same clustering structure and cluster separabil-
ity (as in Figure 3.4). (B) ARI obtained with each clustering
algorithm for each of the subsets of heterogeneous datasets
considered in Figure 3.5. The high ARI obtained with KLIC
in all settings shows the advantage of using this method, es-
pecially when some of the datasets are noisy.
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3.6 MULTIPLATFORM ANALYSIS OF 12 CANCER TYPES
We consider here the multiplatform integrative analysis of 3,527 tumour sam-
ples performed by Hoadley et al. (2014) that was mentioned in the Introduc-
tion. In this study, 11 tumour subtypes were identified using COCA, from sam-
ples of 12 different tumour types glioblastoma multiforme (GBM), serous ovar-
ian carcinoma (OV), colon (COAD) and rectal (READ) adenocarcinomas, lung
squamous cell carcinoma (LUSC), lung adenocarcinoma (LUAD), breast cancer
(BRCA), acute myelogenous leukemia (AML), endometrial cancer (UCEC), re-
nal cell carcinoma (KIRC), bladder urothelial adenocarcinoma (BLCA), and head
and neck squamous cell adenocarcinoma (HNSC). To do so, they applied dif-
ferent clustering algorithms to each data type separately: DNA copy number,
DNA methylation, mRNA expression, miRNA expression, and protein expres-
sion. They then combined the five sets of clusters obtained in this way using
COCA. The final clusters are highly correlated with the tissue-of-origin of each
tumour sample, but some cancer types coalesce into the same clusters. The clus-
ters obtained in this way were shown to be prognostic and to give independent
information from the tissue-of-origin.
Here, we use the same data to try to replicate their analysis, and compare the
clusters obtained with COCA to those obtained with KLIC. To facilitate future
analyses by other researchers, we have made available our scripts for processing
and analysing these datasets using R, which include scripts that seek to replicate
the original analysis of Hoadley et al. (2014), at https://github.com/acabassi/
klic-pancancer-analysis.
In order to replicate the analysis performed by Hoadley et al. (2014), we prepro-
cessed the DNA copy number, DNA methylation, mRNA expression, miRNA
expression, and protein expression data in the same way as Hoadley et al. (2014)
did. We then clustered the tumour samples independently for each dataset, using
the same clustering algorithm as in the original paper. We compared the clusters
we obtained to those reported by Hoadley et al. (2014) for different number of
clusters, and we found that the best correspondence was given by choosing the
same number of clusters as in the original paper, except for the miRNA expres-
sion data, for which we found the best number of clusters to be seven (instead of
15). Figure 3.9 shows the MOC matrix formed by these clusters and the resulting
COCA clusters. As can be seen from the Figure, each dataset has some missing
observations. The corresponding entries in the MOC matrix were set to zero. We
chose the number of clusters that maximises the silhouette, as suggested by Aure
et al. (2017), which is ten.
We then applied KLIC to the preprocessed data, building one consensus matrix
for each dataset, using the same clustering algorithm and number of clusters as
for COCA, and combining them as described in Algorithm 3.3. We assigned
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weight zero to every missing observation, as explained in Section 5.1.1. The
weighted consensus matrix is shown in Figure 3.10. The weights assigned on
average to the observations in each dataset are as follows: copy number 31.4%,
methylation 19.2%, miRNA 17.8%, mRNA 16.4%, protein 15.2%.
Similarly to what was observed by Hoadley et al. (2014), both the clusters ob-
tained using COCA and KLIC correspond well with the tissue-of-origin classifi-
cation of the tumours. However, there are a few differences between the two: the
coincidence matrix is shown in Figure 3.11. Further details on how we tried to
replicate the data analysis of Hoadley et al. (2014) and how we applied KLIC to
these data can be found in Appendix B.
COCA clusters
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FIGURE 3.9: Multiplatform analysis of 12 cancer types. Ma-
trix of clusters of the pan-cancer data: each row corresponds
to a cluster in one of the dataset, and each column corre-
sponds to a tumour sample. Coloured cells show which tu-
mours belong to each cluster. Gray cells indicate missing
observations.
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FIGURE 3.10: Multiplatform analysis of 12 cancer types.
Left: weighted similarity matrix, where the rows and
columns correspond to cancer samples. Higher values of
similarity between samples are indicated in blue. Right: fi-
nal clusters obtained using KLIC.
478 0 1 0 3 110 23 46 0 0
0 460 0 0 31 11 16 28 0 0
0 0 445 0 0 2 28 0 3 0
0 0 1 323 1 0 1 4 0 0
0 7 1 0 264 7 2 12 0 2
0 1 0 0 0 18 20 2 0 214
10 46 0 0 12 21 5 171 3 2
7 1 0 21 18 157 101 32 0 0
0 0 0 0 5 32 124 0 0 0








































































































FIGURE 3.11: Multiplatform analysis of 12 cancer types. Co-
incidence matrix comparing the clusters given by COCA
(rows) and KLIC (columns).
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3.7 TRANSCRIPTIONAL MODULE DISCOVERY
Recall from the Introduction that transcriptional modules are groups (i.e. clus-
ters) of genes that share a common biological function and are co-regulated by a
common set of transcription factors. It has been recognised that integrative clus-
tering methods can be useful for discovering transcriptional modules, by combin-
ing gene expression datasets with datasets that provide information about tran-
scription factor binding (Ihmels et al., 2002; Savage et al., 2010).
Here we consider transcriptional module discovery for yeast (Saccharomyces cere-
visiae). We integrate the expression dataset of Granovskaia et al. (2010), which
contains measurements related to 551 genes whose expression profiles have been
measured at 41 different time points of the cell cycle, with the ChIP-chip dataset
of Harbison et al. (2004), which provides binding information for 117 transcrip-
tional regulators for the same genes. The latter was discretised as in Savage et al.
(2010) and Kirk et al. (2012).
We clustered the 551 genes based on the gene expression and transcription fac-
tor data using KLIC. For each dataset, the consensus matrices were obtained as
explained in Section 3.3. The clustering algorithms used in this step were par-
titioning around medoids (PAM) with the correlations between data points as dis-
tances for the gene expression data (Kaufman and Rousseeuw, 1990) and Bayesian
hierarchical clustering (BHC) for the transcription factor data (Heller and Ghahra-
mani, 2005; Cooke et al., 2011). BHC is a fast approximate inference method for a
class of model-based clustering techniques called Dirichlet process mixture models,
which are introduced in Chapter 4. As we discuss in Chapter 4, one of the ad-
vantages of these methods is that they do not require the number of clusters to
be set by the user. The consensus matrices were then used as input to KLIC. The
algorithm was run with number of clusters ranging from 2 to 20. We found that
the silhouette is maximised by setting the number of clusters to four. Figure 3.12
shows the weighted kernel matrix given by KLIC where the rows and columns
are sorted by final cluster. Next to it are reported the data, where the observations
are in the same order as in the kernel matrix. The clusters obtained independently
on each dataset are also shown on the right of each plot. The kernel matrices of
each dataset and corresponding weights and cophenetic correlation coefficients
can be found in Appendix B.
We also applied COCA to this dataset, with the initial clusters for each dataset
obtained with the same clustering algorithms as those used for the consensus
matrices. The metrics used to choose the number of clusters for the initial cluster-
ing of the expression data are reported in Appendix B. For the final clustering the
number of clusters was chosen in order to maximise the silhouette, considering
all values between two and ten. This resulted in choosing the 10-cluster solution.
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In order to assess the quality of the clusters, we make use of the gene ontology
term overlap (GOTO) scores of Mistry and Pavlidis (2008). Each score is an in-
dication of the number of annotations that, on average, are shared by genes be-
longing to the same clusters. These are available for three different ontologies:
biological process (BP), molecular function (MF) and cell component (CE). More
formally, denoting by annotgi the set of all direct annotations for each gene and
all of their associated parent terms, the GOTO similarity between two genes gi, gj
is the number of annotations that the two genes share:
simGOTO(gi, gj) = |annotgi ∩ annotgj|.
To assess the quality of clusters, the overall GOTO scores associated with each of
the biological process, molecular function, and cellular component ontologies of




Nk(Nk − 1) ∑gi ,gj∈k
GOTO(gi, gj),
where Nk is the number of genes in cluster k, the overall GOTO score is defined












where K is the total number of non-singleton clusters and N = ∑Kk=1 Nk.
We report in Table 3.3 the GOTO scores of both KLIC and COCA clusters, for
both number of clusters selected by KLIC (four) and COCA (ten). We also show
the scores obtained clustering each dataset separately. We observe that, while
in the case of four clusters no information is lost by combining the datasets, by
dividing data into ten clusters one obtains more biologically meaningful clusters.
Moreover, KLIC does a better job at combining the datasets, by better exploiting
the information contained in the data and down-weighting the kernel of the ChIP
dataset, which contains less information. More details about the kernel matrices
and weights can be found in Appendix B.
3.8 DISCUSSION
In this chapter, the focus has shifted from supervised to unsupervised integra-
tion of multi-omic data. Some of the challenges encountered here (e.g. the large
number of missing values, the high dimensionality of the data) are the same as
in Chapter 2. These were taken into account and addressed in this chapter. How-
ever, this work has also brought to light some difficulties that are specific to clus-
ter analysis, which are summarised here.
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(A) Weighted kernel matrix.
(B) ChIP data. (C) Expression data.
FIGURE 3.12: Transcriptional module discovery, KLIC out-
put. (A) Weighted kernel matrix obtained with KLIC, where
each row and column corresponds to a gene, and final clus-
ters. (B) Transcription factor data, where each row repre-
sents a gene and each column a transcription factor, black
dots correspond to transcription factors that are believed to
be able to bind to the promoter region of the corresponding
gene with high confidence; clusters obtained using BHC on
the transcription factor data and weight assigned by KLIC to
each data point. (C) Gene expression data, where each row
is a gene and each column a time point, clusters obtained us-
ing PAM on the gene expression data, and weights assigned
by KLIC to each data point.
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Clusters Dataset(s) Algorithm GOTO BP GOTO MF GOTO CE
8 ChIP BHC 6.09 0.90 8.33
4 Expression PAM 6.12 0.91 8.41
4 ChIP+Expression COCA 6.12 0.91 8.41
4 ChIP+Expression KLIC 6.12 0.91 8.41
10 ChIP+Expression COCA 6.28 0.93 8.51
10 ChIP+Expression KLIC 6.32 0.95 8.53
TABLE 3.3: Gene ontology term overlap scores for different
sets of data, clustering algorithms and numbers of clusters.
BP stands for biological process ontology, MF for molecular
function, and CE for cell component.
3.8.1 Main findings
In the first part of the chapter we have given the algorithm for COCA, a widely
used method in integrative clustering of genomic data, highlighting the main is-
sues of using this method. We have also presented KLIC, a novel approach to in-
tegrative clustering, that allows multiple datasets to be combined to find a global
clustering of the data and is well-suited for the analysis of large datasets, such as
those often encountered in genomics applications. A defining difference between
KLIC and COCA is that, while COCA performs a combination of the clusters
found in each dataset, KLIC uses the similarities between data points observed
in each dataset to perform the integrative step. Moreover, KLIC weights each
dataset individually, which allows more informative datasets to be up-weighted
relative to less informative ones, as demonstrated in our simulation study. Finally,
we have used KLIC to integrate multiple ’omic datasets, in two different real
world applications, finding biologically meaningful clusters. The results com-
pare favourably to those obtained with COCA.
3.8.2 Challenges
The challenges typically encountered in clustering analysis concern the choice of
the number of clusters and evaluating clustering results.
Choice of the number of clusters
Every clustering algorithm (except BHC) used in this chapter to produce consen-
sus matrices requires the user to input a fixed number of clusters a priori. This
can be problematic when the number of clusters is not known and the metrics
commonly used to select K give ambiguous indications. In the next chapter we in-
troduce a way of deriving kernel matrices from Bayesian mixture models which,
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on top of being more sophisticated than the heuristic approaches used here, are
able to take into account the uncertainty around the number of clusters.
Evaluating clustering results
Another recurring issue in cluster analysis is the evaluation of the clustering re-
sults. In simulation settings, when the true partition of the data is known, we
were able to compare our clustering to the true one via the ARI. Moreover, ex-
ternal information was available for the transcriptional module discovery, which
allowed us to make sure that our clusters are biologically meaningful. In many
real applications, however, external information is not easily accessible. This is
the case of the pan-cancer example, where expert knowledge would be required
to validate the clinical importance of the cancer subtypes obtained using KLIC.
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SUMMARISING AND COMBINING POSTERIOR
SIMILARITY MATRICES DERIVED FROM MULTIPLE
’OMIC DATASETS
Here we propose a new method to summarise the posterior similarity matrices
(PSMs) derived from the Markov chain Monte Carlo (MCMC) output of Bayesian
model-based clustering. The idea is to see the posterior similarity matrix as a
kernel matrix. Consequently, we are able to use kernel methods such as the ker-
nel k-means algorithm presented in Chapter 3 to find a summary clustering of
any posterior similarity matrix. Moreover, if we are in a setting where, as in the
previous chapter, we have multiple different types of data for the same type of
observations, we can initially perform Bayesian model-based clustering analyses
on each dataset independently, and then combine and summarise all the poste-
rior similarity matrices to obtain a global clustering of the data with the multiple
kernel k-means algorithms presented in Chapter 3. We additionally show how
we may include a response variable in order to perform outcome-guided (OG) in-
tegrative analyses, using SVMs. Both the unsupervised and the outcome-guided
algorithms assign a weight to each dataset, that is output together with the global
cluster assignment.
This work therefore contributes to the many ways of summarising the cluster-
ings sampled from the posterior distribution that have already been proposed
(Fritsch and Ickstadt, 2009; Wade and Ghahramani, 2018). Our approach per-
forms equally well in the case of one dataset and has the advantage of being
easily extended to the case of multiple data sources.
From a different perspective, this work also suggests a new, rational way to de-
fine kernels for performing clustering tasks of ’omics datasets. In Chapter 3, we
generated kernels via consensus clustering. However, it has been shown by Şen-
babaoğlu, Michailidis, and Li (2014) that CC has several limitations and should
be used with caution. To give an instance, in one of the experiments performed
in Şenbabaoğlu, Michailidis, and Li (2014), data were generated from a unimodal
distribution, but the consensus matrix obtained via CC showed a clear clustering
structure. Moreover, Lanckriet et al. (2004a) applied MKL methods to the prob-
lem of genomic data fusion, trying different kernels for each data source. We
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showed in Chapter 3 that the choice of the kernel parameters is crucial and, to the
best of our knowledge, there is currently no general strategy for choosing kernels
that are optimal for clustering analyses. Therefore, how to define good “cluster-
ing kernels” in general remains an open problem. Using PSMs as kernels ensures
that the similarities between data points reflect our model the clustering structure
inferred using Bayesian model-based clustering.
We apply the methods developed here to the same real datasets considered in
the previous chapter: multiplaform tumour subtyping and transcriptional mod-
ule discovery. These two applications help us show that the methodologies pre-
sented in this chapter can lead to finding more refined tumour subtypes and more
meaningful partitions of yeast genes.
Chapter outline
The chapter is organised as follows. In Section 4.1 we introduce the problem of
summarising PSMs and prove that they are valid kernel matrices. In Section 4.2
we introduce the concept of outcome-guided integration of multi-omic datasets
and explain how kernels methods can be used to combine multiple PSMs, both
in the unsupervised and outcome-guided framework. In Section 4.3 we present
some simulated examples of integration of posterior similarity matrices. In Sec-
tions 4.4 and 4.5 we show how our methodology can be applied to the datasets
presented in Chapter 3. Section 4.6 summarises the main findings and challenges
of this chapter.
4.1 SUMMARISING POSTERIOR SIMILARITY MATRICES
In this section, we briefly recall the concept of Bayesian mixture modelling and
introduce the problem of summarising the posterior distribution on the cluster al-
location. Then, we explain how the output of the MCMC algorithms for Bayesian
mixture models can be used to obtain valid kernel matrices. This allows us to:
- use the kernel k-means algorithm to summarise a PSM and find a summary
clustering of the data;
- combine multiple PSMs to perform integrative clustering of multiple datasets
using the multiple kernel k-means algorithms presented in Chapter 3;
- use an external response variable to determine the weight of each dataset in
the integrative setting, by using predictive kernel methods such as SVMs.
The SVM-based algorithms used for the last point are explained in detail in Sec-
tion 4.2.
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zn xnπ φk
n = 1, . . . , N k = 1, . . . , K
FIGURE 4.1: Finite mixture model.
In order to understand what PSMs are and why the question of how to summarise
PSMs arises, we give a brief introduction to Bayesian mixture models and MCMC
schemes. We then show that PSMs are valid kernel matrices.
4.1.1 Bayesian mixture models
Statistical methods for clustering can be divided into two main categories: heuris-
tic approaches and model-based techniques. The former include the clustering
algorithms used in the previous chapter, such as k-means (Hartigan and Wong,
1979) and hierarchical clustering (Kaufman and Rousseeuw, 1990). The latter are
the focus of this chapter and are known as mixture models (McLachlan and Peel,
2004; Fraley and Raftery, 2002).






where fX is a parametric density that depends on the parameter(s) φk and πk
are mixture weights such that ∑k πk = 1. These models are often fitted via
the expectation-maximisation (EM) algorithm (Dempster, Laird, and Rubin, 1977),
which gives as output point estimates for the parameters of each mixture compo-
nent as well as cluster membership probabilities for each observation.
In the Bayesian framework, we assign a prior distribution to the set of all param-
eters π = [π1, . . . , πk] and φ = [φ1, . . . , φk] of Equation (4.1). This allows us to
take into account the uncertainty around the values of the model parameters (see
e.g. Rogers and Girolami, 2016, Chapter 10). In mathematical terms, a Bayesian
mixture model with K components is defined as
xn|zn, φ ∼ FX (xn|φzn)











where H is the prior distribution for the mixture parameters, and FX is the proba-
bility distribution corresponding to the parametric density fX, and zn ∈ {1, . . . , K}
are the cluster assignments of the data points xn, with n = 1, . . . , N.
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The posterior distributions of these models are usually not available in closed
form. Inference on their parameters can be performed either via deterministic
approximate inference methods, or using MCMC schemes (Gelfand and Smith,
1990). Deterministic approximate inference methods include the BHC algorithm
introduced in Chapter 3 (Heller and Ghahramani, 2005), variational Bayes ap-
proaches (Bishop, 2006; Blei and Jordan, 2006), the sequential updating and greedy
search (SUGS) algorithm of Wang and Dunson (2011), among others (for a more
complete list of methods see Crook, Gatto, and Kirk, 2019). Here we restrict our
attention to MCMC schemes, which are used to construct a Markov chain that has
as the posterior distribution of the model given the data as its invariant density.
Once the chain has reached convergence, the MCMC are effectively samples from
the posterior distribution of our model.
Another advantage of adopting the Bayesian viewpoint when dealing with mix-
ture models is that we can seek to infer the number of mixture components, rather
than having to specify this a priori. One way of doing this is to make use of re-
versible jump MCMC (Green, 1995), which allows us to sample from parameter
spaces of varying dimensions and can therefore be used to jump between mix-
tures with different numbers of components (Richardson and Green, 1997). An-
other approach is to choose a number of components K that is large compared
to the number of observations. Not all the components of the mixtures need to
be occupied, therefore K only places an upper bound on the number of clusters.
Rousseau and Mengersen (2011) showed that in these so-called overfitted mixture
models, in the posterior distribution the components in excess are left empty (pro-
vided that a “reasonable” prior is specified). Alternatively, one can consider the
limit K → ∞ in Equation (4.2), giving rise to a Dirichlet process mixture model
(DPMM; Rasmussen, 2000; Neal, 2000) that is a mixture model having a Dirichlet
process (DP) as the prior on the mixture components.
We recall here the definition of DP (Ferguson, 1973):
Definition 4.1 Let (Ω,B) be a measurable space with state space Ω and σ-field B and
let H be a probability measure on (Ω,B). A Dirichlet process is a random probability
measure G on (Ω,B) such that for any finite partition (T1, . . . , TF) of Ω, it holds
(G(T1), . . . , G(TF)) ∼ Dirichlet (αH(T1), . . . , αH(TF)) .
We indicate this by
G ∼ DP (α, H) ,
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α
GH φzn xn
n = 1, . . . , N
FIGURE 4.2: Dirichlet process mixture model.
where α ∈ R+ is called the concentration parameter and H is the base measure. The
resulting mixture model can be written as
xn|φn ∼ FX(xn|φn)
φn|G ∼ G
G|α, H ∼ DP (α, H)
where φn, n = 1, . . . , N are the mixture parameters for observation xn, with n =
1, . . . , N. Observations that have the same value of φn belong to the same cluster.
Constructive representations of the Dirichlet prior include the stick-breaking con-
struction of Sethuraman (1994) and the Chinese restaurant process, which has
been attributed to Jim Pitman (see Aldous, 1985). In this work, we use the R
package PReMiuM of Liverani et al. (2015) where the stick breaking construction
is used, the DPMSysBio Matlab1 toolbox of Žurauskienė, Kirk, and Stumpf (2016)
which exploits the Chinese restaurant process. We also use MDI (Kirk et al., 2012),
which makes used of the overfitted mixtures of Rousseau and Mengersen, 2011.
Throughout this thesis, we employ the C implementation of MDI, rather than the
original Matlab package, because it is more efficient and therefore more suitable
for the large datasets considered in this thesis (Mason et al., 2016).
Before proceeding with the application of DPMMs to real data problems, it is im-
portant to note that, while these models do not require the specification of the
number of clusters K, they do involve a parameter α that influences the prior ex-
pectation of the number of clusters. Moreover, the rich-get-richer property of these
models means that, a priori, users expect to see a small number of large clusters
(Vlachos, Korhonen, and Ghahramani, 2009). Other known issues of DPMMs are
that MCMC schemes are used to fit these models, which can be computationally
costly and may get stuck in local modes (Jain and Neal, 2004).
Profile regression
Later in this chapter, we also use an extension of DPMMs, known as profile regres-
sion (Molitor et al., 2010; Papathomas et al., 2011; Liverani et al., 2015). The idea
1https://uk.mathworks.com/products/matlab.html
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of profile regression is that, if a response yn is available for each n = 1, . . . , N,
the observations dn = (xn, yn) are jointly modelled as the product of the response
model and a covariate model. The resulting likelihood is
p(dn|φn) = fY (yn|φn) fX (xn|φn) ,
where fY is a parametric density and φn includes the parameters of both fX and
fY (Figure 4.3). This can be useful in situations where a response variable that is
believed to be associated to the clustering structure of interest is available. In fact,
the inclusion of this response into the model allows us to influence the clustering,





n = 1, . . . , N
FIGURE 4.3: Profile regression.
4.1.2 Posterior similarity matrices
When using MCMC methods in order to perform Bayesian clustering on a dataset
X = [x1, . . . , xN ], one obtains a vector of cluster assignments c(b) = [c
(b)
1 , . . . , c
(b)
N ]
from the posterior distribution for each iteration of the algorithm b = 1, . . . , B
(see, for example, Neal, 2000). From this, it is possible to obtain a Monte Carlo
estimate of the probability that observations i and j belong to the same cluster as
follows:













where 1 is the indicator function. We denote by ∆ the PSM that is the matrix that
has ijth entry ∆ij equal to the right hand side of Equation (4.3).
Many ways to find a final clustering using the using the MCMC cluster allocation
samples have been proposed (Binder, 1978; Dahl, 2006; Fritsch and Ickstadt, 2009;
Medvedovic and Sivaganesan, 2002; Wade and Ghahramani, 2018). A simple so-
lution is to choose, among the c(b), the one that maximises the posterior density.
The problem with this approach is that many clusterings are associated with very
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similar posterior densities (Fritsch and Ickstadt, 2009). A more principled ap-
proach is to define a loss function L(c, ĉ) measuring the loss of information that
occurs when estimating the true clustering c with ĉ (Binder, 1978). The optimal
clustering c∗ is then defined as the one minimising the posterior expected loss:
c∗ = arg min
ĉ




L(c, ĉ)p (c|X) .
Binder (1978), for instance, suggested choosing the clustering ĉ that minimises
the loss function
LBinder(c, ĉ) = ∑
i<j
[
l11(ci = cj)1(ĉi 6= ĉj) + l21(ci 6= cj)1(ĉi = ĉj)
]
,
where l1 and l2 are positive constants determining whether assigning observa-
tions that belong to the same clusters to different clusters is penalised more highly
than assigning observations that belong to different clusters to the same cluster
(l1/l2 > 1) or vice versa (l1/l2 < 1). If l1 = l2, then









More recently, Wade and Ghahramani (2018) proposed an alternative to Binder’s
loss function based on the variation of information of Meilă (2007):
LVI(c, ĉ) = H(c) + H(ĉ)− 2I(c, ĉ),
where H(c) and H(ĉ) represent the entropy of clusterings c and ĉ respectively,
I(c, ĉ) is the mutual information between clusterings c and ĉ. Defining by Ci the
set of elements that belong to cluster i in clustering c, Ĉj the set of elements that






































where KN and K̂N represent the number of clusters in c and ĉ respectively.
Dahl (2006) advanced the idea to choose, among all the clustering vectors c(b), the
one that minimises the least-squared distance to the PSM:











This turned out to be equivalent to minimising Binder’s loss function (Equation
4.1.2). A similar approach was developed by Wang and Porter (2018) using non-
negative matrix factorisation. Fritsch and Ickstadt (2009) improved on the meth-
ods of Binder and Dahl by maximising the posterior expected ARI of Hubert and
Arabie (1985).
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Moreover, Medvedovic and Sivaganesan (2002) applied the complete linkage ap-
proach of Everitt (1993) to the matrix of pseudo-distances 1− ∆, while Molitor
et al. (2010) used the PAM algorithm (Kaufman and Rousseeuw, 1990).
All these methods are only applicable with one PSM. In what follows we describe
a new way to find a clustering using PSMs that also allows us to summarise mul-
tiple similarity matrices ∆m and find a global clustering.
4.1.3 Identifying posterior similarity matrices as kernel matrices
Posterior similarity matrices are computed as the element-by-element average of
the B co-clustering matrices C(b), defined as:
C(b)ij =
{




derived from each iteration of the MCMC chain: C(b)ij indicates whether the statis-
tical units i and j are assigned to the same cluster at iteration b. Therefore, PSMs
are co-clustering matrices like those considered in Chapter 3 and the argument
that we used in Section 3.4 to prove that any co-clustering matrix is a valid kernel
holds for PSMs too.
4.2 COMBINING POSTERIOR SIMILARITY MATRICES
Section 4.2.1 deals with the unsupervised integration of multiple PSMs derived
from different ’omic layers. In Section 4.2.2 is introduced the concept of outcome-
guided integration.
4.2.1 Unsupervised integration
Having shown that PSMs are valid kernels, it follows that unsupervised integra-
tion can be performed using KLIC, in the same way as in Chapter 3 for consensus
matrices. This can be useful for many reasons. First, MCMC schemes are com-
putationally intensive: while it is possible in principle to define mixtures that ac-
commodate multiple ’omic datasets, it is often infeasible to run MCMC chains for
the full multi-omic datasets. Being able to perform inference on each ’omic layer
separately and to combine the PSM at a later time requires less time and compu-
tational power. On top of that, as is the case for consensus matrices, assigning
different weights to each kernel allows us to assess how much each dataset con-
tributed to the final clustering. This can give an idea of how much information is
present in each data type about the clustering structure.
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4.2.2 Outcome-guided integration
The problem with combining multiple kernels is that, as we have seen in Chapter
3, it is not always clear whether they all define the same clustering structure. To
overcome this issue, we also propose an outcome-guided algorithm to summarise
multiple PSMs. The idea is that, instead of choosing the weight of each kernel in
an unsupervised way, if we have a variable available which is closely related
to the outcome of interest, we should weight more highly the kernels in which
statistical units that have similar outcomes are closer to each other. This allows
us to uncover the clustering structure in the data that is most similar to the one
defined by the response variable, in a similar spirit to that of profile regression.
Suppose that, in addition to the PSMs ∆1, . . . , ∆M, we also have a categorical re-
sponse variable yn associated with each observation xn. As we explained above,
we would like to use this information to guide our clustering algorithm. We can
use the SimpleMKL algorithm described in the remainder of this section to find
the kernel weights θ1, . . . , θm and then use kernel k-means on the weighted kernel
∆ = ∑Mm=1 θm∆m to find the final clustering (Figure 4.4).
We refer to the approach presented here as outcome-guided KLIC, as opposed to the
unsupervised version of KLIC introduced in Chapter 3. Approaches of this type
are also referred to as semi-supervised (Bair and Tibshirani, 2004; Koestler et al.,
2010). However, we avoid using this term here, since it is more commonly used to
indicate machine learning approaches that combine large amounts of unlabelled
data with a few labelled data points (Yu et al., 2006).
Related methods
The importance of exploiting clinical information when performing clustering of
’omic data has been highlighted by multiple publications (see e.g. Ahmad and
Fröhlich, 2017; Chaudhary et al., 2018). However, to the best of our knowledge,
the only approach that takes a comparable approach to ours is the outcome-
weighted integrative clustering method of Arora et al. (2020), called survClust,
which was developed to identify cancer subtypes using multi-omic and survival





)T W (xi − xj)]1/2 ,
where W is a P× P diagonal weight matrix. The diagonal entries of of the weight
matrix are indicated by wp, p = 1, . . . , P and are computed as the logarithm of
the absolute value of the hazard ratio, obtained by fitting a univariate Cox pro-
portional hazards model (Cox, 1972) for each feature p. As a result, wp = 0
if feature p is not associated with survival and wp is large if there is evidence
that feature p is associated with survival. Once these weighted distances are
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FIGURE 4.4: Schematic representation of outcome-guided
KLIC. Each colour indicates a different dataset/kernel. First,
a mixture model is fit on each dataset separately. The result-
ing PSMs are valid kernels that can be used as input to sim-
pleMKL, if a response variable is available, to determine the
kernel weights. The weighted kernel is then used as input to
kernel k-means to find the final clustering of the data. The
same can be done with any other type of kernels, including
those generated via CC.
calculated, a clustering is obtained by projecting the data into a lower dimen-
sional space and clustering the projected data points via the k-means algorithm.
There are several differences between survClust and the outcome-guided version
of KLIC. First, survClust can only be used with survival data, while our approach
assumes that the response variable is categorical (and extensions to continuous
responses should be straightforward, as we explain later in this section). Sec-
ondly, outcome-guided KLIC assigns different weights to each ’omic layer, while
survClust’s weights are feature specific.
The remainder of this section is dedicated to introducing SVMs and explaining
how they can be used to extend KLIC to perform outcome-guided integration.
Support vector machines
We briefly recall here the concept of SVM (Boser, Guyon, and Vapnik, 1992) that
is widely used for solving problems in classification and regression (Schölkopf
and Smola, 2001; Bishop, 2006).
In its simplest form, this method is applied to a binary classification problem,
in which the data points x1, . . . , xN ∈ RP in the training set are assigned to two
classes indicated by the target values yn ∈ {−1, 1}, n = 1, . . . , N. We consider a
feature map φ : RP → X and the associated symmetric PSD kernel δ : X ×X →
R such that δ(x, xj) = 〈φ(xi), φ(xj)〉X . Suppose that there exist some values of αn
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satisfies f (xn) + b > 0 if yn = 1 and f (xn) + b < 0 otherwise. f is a function that
lives in a function spaceH endowed with the norm ‖·‖H. Then, this function can
be used to classify new data points x according to the sign of f (x) + b.
For support vector machines, the parameters αn and b are chosen so as to max-
imise the margin, i.e. the distance between the decision boundary given by Equa-
tion (4.4) and the point xn that is closest to the boundary (Figure 4.5) . It can be
shown that this can be achieved by solving the QP problem (see e.g. Bishop, 2006;





‖ f ‖2H (4.5a)
subject to yn
[
f (xn) + b
]
≥ 1, ∀n.
However, in real applications, it is usually not possible to separate the two classes
perfectly. Hence, in order to take into account misclassifications, it is necessary
to introduce a penalty term that is linear with respect to the distance of the mis-
classified points to the classification boundary (Bennett and Mangasarian, 1992).




0, if xn is correctly classified,
|yn − f (xn)|, otherwise.
The optimisation problem of Equation (4.5) then becomes
minimise
f , b, {ξn}
1
2





f (xn) + b
]
≥ 1− ξn, ∀n,
ξn ≥ 0, ∀n,
where C > 0 is a parameter that controls the penalisation of misclassifications.
The objective functions (4.5a) and (4.6a) are quadratic, so any local optimum is
also a global optimum. One of the most popular approaches to solve this type
of problems is sequential minimal optimisation (Platt, 1999). For more details about
SVMs see, for instance, Bishop (2006).
Multiple kernel learning for support vector machines
In the multiple kernel learning framework for SVMs, we consider again M differ-
ent feature representations, with mapping functions φm and corresponding kernel
functions δm and feature spacesXm. We replace the kernel δ of Equation (4.4) with
a convex combination of kernels δm (Lanckriet et al., 2004a):




θm fm(x) + b
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FIGURE 4.5: Illustration of a support vector machine. Data
points are represented in the feature space X , each colour
indicates one of the two classes. The decision boundary is
represented by the dashed black line. Left: the two classes
are separable. The red double arrow indicates the margin,
which is the distance between the decision boundary and the
data point that is closer to the boundary. Right: the classes
are not separable. ξ = 0 for all data points that are correctly
classified, 0 < ξ < 1 for those that lie within the margin
but on the correct side of the boundary, ξ > 1 for the points
that are on the incorrect side of the boundary. Figure freely
adapted from Bishop (2006, Chapter 7).
where θm ≥ 0, ∑m θm = 1 and fm = ∑n δm(x, xn). Rakotomamonjy and Bach
(2007) proposed then to solve the optimisation problem
minimise


















≥ 1− ξn, ∀n,




θm ≥ 0, ∀m
using the convention that x/0 = 0 if x = 0 and ∞ otherwise. The algorithm of
Rakotomamonjy and Bach takes the name of simpleMKL and is based on the idea
that one can iteratively solve a standard SVM problem (4.6a) for a fixed value of θ
and then update the vector of weights θ using the gradient descent method on the
objective function J(θ). Since the objective function is smooth and differentiable
with Lipschitz gradient, it can be easily optimised with the reduced gradient al-
gorithm (Luenberger and Ye, 1984, Chapter 11). If the standard SVM problem is
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solved exactly at each iteration, then convergence to the global optimum is guar-
anteed (Luenberger and Ye, 1984).
Multi-class multiple kernel learning
SVMs can be used also when the target value yn takes more than two different
values. The most commonly used approaches are called one-versus-one (Knerr,
Personnaz, and Dreyfus, 1990) and one-versus-the-rest (Vapnik, 1999). In the first
one, we consider in turn each class as the “positive” case (with target value +1),
and all the others as the “negative” cases (with target value −1). This way, if yn





The second approach is to train one SVM for each pair of classes and then assign
a point x to the class to which it is assigned more often.
Rakotomamonjy et al. (2008) extended the SimpleMKL algorithm to the case of a
response with K > 2 classes. Both these approaches can be used with the Sim-
pleMKL algorithm, defining a new cost function J(θ) as the sum of all the cost




where S indicates the set of all partial SVMs and each Js is defined as in Equation
(4.7a).
Just like the methodology introduced in Chapter 3, none of the approaches pre-
sented here explicitly rely on the fact that the ∆m are PSMs or consensus matrices.
Hence, any other type of matrix can be used, as long as it is symmetric, posi-
tive semi-definite and the entries ∆mij can be interpreted as some measure of the
similarity between xi and xj.
4.3 SIMULATION STUDY
Here we show how the methods presented above perform in practice. We gen-
erate four synthetic datasets, each composed of data belonging to six different
clusters of equal size. Each observation x(k)n ∈ {0, 1, 2}10 belonging to cluster k is
drawn from a multivariate categorical distribution such that, for each covariate
j = 1, . . . , 10,
x(k)nj ∼ Categorical(π1k, π2k, π3k),
109
Chapter 4. Summarising and combining posterior similarity matrices
where πik, i = 1, 2, 3 are such that πik = wρik + (1− w)/3, with [ρ1k, ρ2k, ρ3k] ∼
Dirichlet(0.01). Each dataset has a different value of w ∈ [0, 1]. Higher values
of wd give clearer clustering structures. The response variable is binary, with
P(yn = 1|zn = k) = θk, where θk ∈ {0.01, 0.1, 0.15, 0.85, 0.9, 0.99}. We repeat each
experiment 100 times. For each synthetic dataset, we use the MCMC algorithm
for Dirichlet process mixture models implemented in the R package PreMiuM of
Liverani et al. (2015) to obtain the PSMs. We use unsupervised discrete mixtures
(Liverani et al., 2015, Section 3.2) except in one setting (detailed below) where the
profile regression model of Molitor et al. (2010) is employed, using a discrete mix-
ture with categorical response. In both cases we use the default hyperparameters,
which we found to work well in practice.
We consider four different simulation settings:
Setting A: same structure in every dataset. The clustering structure in every dataset
is the same and is related to the outcome of interest. Each dataset has a different
level of cluster separability, obtained setting w = 0.2, 0.4, 0.6, 0.8. As in Chapter
3, we refer to the dataset generated with w = 0.2, which has almost no cluster
separability, as dataset 0, the one generated with w = 0.4, which has low cluster
separability, as 1, and so on. One set of PSMs used for this setting is shown in
Figure 4.6.
Setting B: same structure in every dataset with extra covariates. As in setting A, the
clustering structure in each dataset is the same and each dataset has a different
level of cluster separability. In this case, however, each dataset contains some
additional covariates that have no clustering structure.
Setting C: one irrelevant dataset. The dataset with highest cluster separability
has a clustering structure that is unrelated to the response variable, all the other
datasets are the same as in setting A.
Setting D: profile regression. This is the same as setting C, but profile regression
is used to derive the PSMs.
In Section 4.3.1 we show that the kernel k-means approach applied to a PSM de-
rived from a single dataset performs similarly to standard clustering methods.
Additionally, in Section 4.3.2 we apply the developed methods to the synthetic
datasets in the unsupervised and outcome-guided framework.
4.3.1 Summarising posterior similarity matrices
Before using the PSMs with the kernel-based integrative clustering methods, we
carry out some simulation studies to ensure that the kernel k-means algorithm
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FIGURE 4.6: PSMs of the datasets used for setting A. The
rows and columns correspond to the statistical units. The
coloured bar on the right of each PSM represents the true
clusters. The values of w used to generate these matrices
are, from left to right, 0.2, 0.4, 0.6, and 0.8.
performs equally well at summarising the MCMC output as the other methods
from the literature. The advantage is that the kernel k-means can be extended to
combine multiple datasets.
We use the synthetic datasets described in setting A above and compare the ker-
nel k-means algorithm to the methods implemented in the R package mcclust
(Fritsch and Ickstadt, 2009). All these methods take a PSM ∆ as input and find
the clustering c∗ that maximises the posterior expected Rand index (PEAR). This is
achieved by choosing the clustering c∗ that maximises the following quantity:






∑i<j I{c∗i =c∗j } + ∑i<j ∆ij
]




The clusterings c∗ taken into consideration by these methods can be chosen in
different ways. We use hierarchical clustering with 1− ∆ as distance matrix with
average and complete linkage. The maxpear function tries all the possible num-
bers of clusters between one and a maximum number of clusters Kmax specified
by the user. We consider both 6 and 20 as values for Kmax. We also use the maxpear
function to try with all the clusterings in the MCMC output and take the one that
maximises the quantity of Equation (4.8). We repeat this procedure using the
minVI function of the R package mcclust.ext of Wade and Ghahramani (2018),
where the selected c∗ is the one that minimises the lower bound for the posterior
expected variation of information (Equation 4.1.2) from Jensen’s inequality.
Figure 4.7 shows the box plots of the adjusted Rand index obtained repeating
the experiment with 100 different sets of synthetic data calculated for each of
the considered clustering algorithms and for all values of w. We can see that
the kernel k-means on average performs better than the other methods when the
number of clusters is known and that it performs similarly to the others when the
number of clusters is chosen to maximise the average silhouette.
111







































































FIGURE 4.7: ARI for the kernel k-means applied to one
dataset at a time, for different values of ρ compared to
maximising the PEAR as suggested by Fritsch and Ickstadt
(2009) and to minimising the VI as suggested by Wade and
Ghahramani (2018). For both methods, we try different set-
tings, namely: performing hierarchical clustering on the ma-
trix 1−∆ with average (“avg”) and complete (“comp”) link-
age, with maximum number of clusters equal to either 6 or
20, as well as considering all the clusterings samples that are
appear in the MCMC output (“draws”). For kernel k-means,
the results obtained fixing the number of clusters to six and




We assess the MKL-based unsupervised and outcome-guided integrative approaches
in the four settings described above. For each setting we consider four different
subsets of data, each combining three out of our four synthetic datasets. In what
follows, we indicate by “0+1+2” the integration of the datasets generated with
values of w equal to 0.2, 0.4, and 0.6 respectively, and similarly for the other com-
binations of datasets. Here we show the ARI between the clusterings found via
MKL integration and the true cluster labels, the weights assigned to each dataset
in each setting are instead reported in Appendix C.
Setting A: same structure in every dataset. The ARI obtained by combining the
datasets in the unsupervised and outcome-guided frameworks is shown in the
first row of Figure 4.8. The values of the ARI obtained in the previous section
on each dataset separately are also reported. In all settings we set the number
of clusters to the true value, six. The unsupervised integration performed using
localised multiple kernel k-means allows to reach values of the ARI that are close
to those of the “best” dataset (i.e. the dataset that has the highest value of cluster
separability) among the three datasets in each subset. This is because the unsu-
pervised MKL approach considered here assigns higher weights to the datasets
that give rise to kernels with higher values of ρ, which in this case correspond
to higher values of w. Moreover, even higher values of the ARI are achieved via
outcome-guided integration, as a result of taking into account the outcome when
weighting the datasets. In this case, the kernels that help separate the classes in
the response have higher weights than the others.
Setting B: same structure in every dataset with extra covariates. In the second row
of Figure 4.8 are shown the results obtained for setting B, where the PSMs are
obtained exploiting (an adaptation of) the variable selection strategy of Chung
and Dunson (2009) implemented in the R package PReMiuM. Despite the fact that
the ARI of dataset 2 is lower than in the previous case, the integration results
are better than in Setting A. Again, this is due to the fact that most informative
kernels are weighted more highly than the other ones.
Setting C: one irrelevant dataset. This simulation study helps us to show that the
outcome-guided approach favours the clustering structures that agree with the
structure in the response. For this reason, we use a dataset with high cophenetic
correlation coefficient whose clustering structure is not related to the response.
The results are presented in the third row of Figure 4.8. Again, localised multiple
kernel k-means assigns higher weights to the datasets that are more easily sepa-
rable, i.e. datasets that give rise to kernels having higher cophenetic correlation
coefficients. Note that here higher values of w correspond to higher cophenetic
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correlation. In this situation, this causes the ARI of the subsets of kernels that in-
clude dataset 3 to drop to zero. In the outcome-guided case, instead, the dataset
that has the highest level of cluster separability but is not related to the outcome
of interest has (almost) always weight equal to zero.
Setting D: profile regression. Lastly, we consider the case where profile regres-
sion is used, instead of regular DPMMs (fourth row of Figure 4.8). We see that,
as expected, the ARI is higher than in the previous cases for the clustering ob-
tained with each dataset taken separately, except of course for dataset 3, that has
a different clustering structure. This is reflected in an improvement of the ARI of
the unsupervised and outcome-guided integration, for all considered subsets of







































































































































































































FIGURE 4.8: Simulation study, ARI obtained by summaris-
ing the PSMs one at a time using kernel k-means (left), com-
bining different subsets of three PSMs in an unsupervised
fashion using localised multiple kernel k-means (centre), and
combining the same subsets making use of a response vari-
able and multi-class SVMs to determine each PSM’s weight
and using kernel k-means for the final clustering (right).
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4.4 MULTIPLATFORM ANALYSIS OF TEN CANCER TYPES
We apply the methodology developed in this chapter to the pan-cancer data pre-
sented in Chapter 3, combining the data layers both in the unsupervised and
outcome-guided frameworks. We make use of the C implementation of MDI (Ma-
son et al., 2016) to produce PSMs for each data layer separately. In order to be
able to do so, we only include in our analysis the tumour samples that have no
missing values; this reduces the sample size to 2,421 and the number of tumour
types available for the analysis to ten. A mixture of Gaussians is used for the con-
tinuous layers (DNA copy number, miRNA, and protein expression), while the
multinomial model is used for the methylation data, which are categorical. Due
to the high number of features, it is not possible to produce a PSM for the full
mRNA dataset, so we exclude it from the analysis presented here. In Appendix
C, however, we show how the variable selection method developed in Chapter 2
can be employed in this case to reduce the size of each data layer and integrate
all five data types.
Unsupervised integration
We combine the PSMs of the four data layers via multiple kernel k-means with
number of clusters going from 2 to 50. We choose the number of clusters that
maximises the silhouette, which is 9 (Appendix C). The resulting clusters are
shown in Figure 4.9. Six out of the nine clusters contain almost exclusively sam-
ples from one tissue: most samples of renal cell carcinoma are in cluster 2, al-
most all statistical units in clusters 1 and 4 are breast cancer samples, most serous
ovarian carcinoma samples are in cluster 3, bladder urothelial adenocarcinoma
samples in cluster 8, and endometrial cancer samples in cluster 9. Cluster 5, in-
stead, is formed by the colon and rectal adenocarcinoma samples together, and
corresponds exactly to cluster 7 of Hoadley et al. Moreover, lung squamous cell
carcinoma, lung adenocarcinoma, and head and neck squamous cell carcinoma
are divided into two clusters. Cluster 8 contains the remaining samples. In Fig-
ure 4.10 are reported the average values of the silhouette when the number of
clusters goes from 2 to 50. (the maximum is attained at K = 15) and the weights
assigned to each PSM by the multiple kernel k-means algorithm. The average
weights assigned to each data layer are: 6.9% to the copy number data, 7.5% to
the methylation data, 7% to the miRNA expression data, and 78.7% to the protein
expression data.
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(A) Clusters and weighted kernel.
0 330157158 1 1 7 3 0
372 0 21 2 3 2 20 0 0
0 0 26 0 258 0 0 1 0
0 0 9 3 0 0 4 184 0
0 0 6 0 1 178 44 0 0
0 0 3 0 0 97 104 0 1
0 0 7 0 3 107 33 0 0
0 0 98 1 0 1 8 0 1
0 0 3 1 0 0 2 0 110





































































FIGURE 4.9: Unsupervised multiplatform analysis of ten
cancer types. (A) Left: weighted kernel. The rows and
columns correspond to cancer samples. Higher values of
similarity between samples are indicated in blue. Right: fi-
nal clusters, tissues of origin, and COCA clusters. (B) Coin-
cidence matrix comparing the tissue of origin of the tumour
samples (rows) with the clusters (columns).
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FIGURE 4.10: Unsupervised multiplatform analysis of ten
cancer types. (A) Average silhouette for number of clusters
going from 2 to 50. (B) Weights assigned by the multiple
kernel k-means algorithm to each observations in each layer,
where “CN” stands for copy number and “RPPA” for reverse
phase protein array.
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Outcome-guided integration
We obtain the weights for the outcome-guided integration via the SimpleMKL
algorithm, which are as follows: DNA copy number 35.9%, methylation 13.5%,
miRNA expression 33.8%, and protein expression 16.8%. We then cluster the data
using kernel k-means with number of clusters going from 2 to 50. The silhouette is
maximised at K = 27 (Appendix C). The clusters obtained in this way are shown
in Figure 4.12. It is interesting to note that, in this case, each cluster contains al-
most exclusively tumour samples from the same tissue. The only exceptions are
clusters 4 and 22, which contain both lung and head/neck squamous cell carci-
noma samples, and clusters 14 and 25 in which colon and rectal adenocarcinomas
are clustered together, like in the unsupervised case. Each tumour type, except for
ovarian and bladder cancers, is divided into multiple subclusters. Further anal-
ysis would be required to assess whether these clusters are clinically relevant.
Interestingly, we observe a distinction between luminal (i.e. estrogen receptor-
positive and HER2-positive) and basal breast cancer samples (the former are in
clusters 8, 9, 17, 19, 23, 24, 27, while the latter are in cluster 13). This was also
observed by Hoadley et al.
In Figure 4.11 are reported the average values of the silhouette when the number
of clusters goes from 2 to 50. The maximum is at K = 27. Note that the clusterings
and corresponding values of the silhouette may vary depending on the initiali-
sation of kernel k-means. Due to this, slightly different clustering solutions may
be found in different runs of the algorithm. However, we find that the results are




























































FIGURE 4.11: Outcome-guided multiplatform analysis of
ten cancer types. Average silhouette for number of clusters
going from 2 to 50.
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(A) Clusters and weighted kernel.
0 0 0 0 0 14 0 0 0 1 0 1 1 1 1 0 0 0 0 0 98 99 97 96 91 91 66
0 163101 77 69 8 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
0 0 0 0 0 12 0 0 0 0 0 0 0 76 70 66 58 0 0 0 0 0 1 0 2 0 0
0 0 0 0 0 6 0 0 0 1 0 4 4 0 0 0 0 87 90 36 0 0 0 0 1 0 0
0 0 0 0 0 0 0 0 73 62 53 13 1 0 0 0 0 1 0 0 0 0 0 0 2 0 0
0 0 0 0 1 4 0 0 1 11 5 66 50 0 0 0 0 7 2 0 0 0 0 1 2 0 0
0 0 0 0 0 0 56 59 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 27 23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 1 90 0 0 10 3 4 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

















































































































































































FIGURE 4.12: Outcome-guided multiplatform analysis of
ten cancer types. (A) Left: weighted kernel. The rows and
columns correspond to cancer samples. Higher values of
similarity between samples are indicated in blue. Right: fi-
nal clusters, tissues of origin, and COCA clusters. (B) Coin-
cidence matrix comparing the tissue of origin of the tumour
samples (rows) with the clusters (columns).
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4.5 TRANSCRIPTIONAL MODULE DISCOVERY
We now revisit the transcriptional module discovery example of Chapter 3. To
produce the PSMs for the two datasets, we use the DPMSysBio Matlab package
of Žurauskienė, Kirk, and Stumpf (2016). For each dataset, we run 10,000 itera-
tions of the MCMC algorithm and summarise the output into a PSM. The PSMs
obtained in this way are reported in Appendix C.
We combine the PSMs using KLIC. The average weights assigned by KLIC to each
PSM and the values of the average silhouette for different numbers of clusters are
reported in Appendix C. We set the number of clusters to 25, which is the value
that maximises the silhouette. The final clusters are shown in Figure 4.13 next
to the two datasets and the combined PSM. In order to determine whether our
clustering is biologically meaningful, we use the GOTO scores defined in Chapter
3, which are reported in Table 4.1. The two datasets combined achieve higher
GOTO scores than those of the clusters obtained using each dataset separately.
We also compare these GOTO scores to those obtained with the two methods
used in Chapter 3: COCA and KLIC used to combine kernels derived from CC.
Both have lower GOTO scores than the novel approach presented in this chapter.
For COCA, this is result not unexpected, since the method is unweighted and has
previously been shown to perform less well than KLIC. The difference between
the two variants of KLIC only lies in how the kernels are constructed. These
scores therefore suggest that kernels generated from probabilistic models can lead
to more accurate results than those built using consensus clustering.
Dataset(s) GOTO BP GOTO MF GOTO CC
ChIP data 6.18 0.97 8.54
Expression data 7.07 1.04 8.90
ChIP+Expression data: COCA 5.74 0.90 8.19
ChIP+Expression data: CC + KLIC 6.60 0.96 8.66
ChIP+Expression data: PSM + KLIC 7.15 1.05 8.93
TABLE 4.1: Gene ontology term overlap scores. BP stands
for Biological Process ontology, MF for Molecular Function,
and CC for Cellular Component. The number of clusters
used for every method is 25.
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(A) Expression data. (B) ChIP-chip data.
(C) Weighted kernel.
FIGURE 4.13: Transcriptional module discovery, integration
of the Harbison et al. (2004) and Granovskaia et al. (2010)
datasets. (A) Expression data. Each row corresponds to a
gene and each column to a different time point. (B) ChIP-
chip data. Each row corresponds to a gene and each column
to a transcriptional regulator. (C) Weighted kernel. The rows
and columns correspond to the genes. Higher values of simi-
larity between genes are indicated in blue. To the left of each
plot is shown the final clustering, obtained by integrating





The main findings of this chapter are summarised here. We also describe some
challenges encountered, which open new research questions to be explored in the
future.
4.6.1 Main findings
We have presented a novel method for summarising a sample of clusterings from
the posterior distribution of an MCMC algorithm for Bayesian clustering, based
on kernel methods. We have also extended this method to allow us to integrate
multiple PSMs. This can be done either in an unsupervised or in an outcome-
guided way. The former weights each PSM according to how well defined is
the clustering structure that it describes. The latter gives more importance to the
PSMs that assign higher similarities to the groups of observations that belong to
the same class, according to the response variable of choice; this allows to uncover
more meaningful partitions of the data, and simultaneously find out which PSMs
(or kernels, more in general) are useful for the application at hand.
We have used simulation examples to show that our method gives comparable
performances in terms of proportion of correct co-clustering as existing tech-
niques when just a single dataset is being clustered, in the unsupervised setting.
We have also demonstrated that the integration of multiple datasets gives bet-
ter results than using one dataset at a time, if they all describe the same clus-
tering structure. In situations where the clustering structure is not the same in
all datasets, the outcome-guided version of KLIC can be used, if a (categorical)
response variable related to the output of interest is available, to assign higher
weights to the PSMs defining partitions of the data similar to the one described
by the response. The simulation examples demonstrate that this feature can be
extremely useful when not all the PSMs have the same clustering structure.
Finally, we have applied the novel methods to two real data applications. The
pan-cancer data analysis shows that the outcome-guided integration of multiple
PSMs can potentially be used in the context of tumour subtype discovery. The
yeast example demonstrates that the proposed method is able to identify groups
of genes that are co-expressed and co-regulated that are more biologically mean-
ingful than those determined via state-of-the-art integrative algorithms.
4.6.2 Challenges
In this chapter we have overcome the issue of choosing the number of clusters
encountered in Chapter 3 making use of DPMMs, that do not require knowing
the value of K. However, evaluating clustering results remains a complex task,
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and two new questions arise as a result of the analyses presented in this chapter,
which we now discuss.
Mixing of the MCMC chains
Implementing MCMC schemes for DPMMs that work on large datasets is not
a trivial task. The most evident problem is that MCMC is computationally de-
manding. For the mRNA dataset available for the pan-cancer analysis, for in-
stance, running the C implementation of MDI on Cambridge University’s high-
performance computing cluster would have taken a prohibitively long time. An-
other, less apparent issue, is the mixing of the MCMC chains. Again, this is eas-
ily observable in the cancer subtyping applications. The figures reported in Ap-
pendix C used to assess MCMC convergence show very poor mixing: in most
cases, even if the cluster allocations differ slightly at each iteration, the number
of clusters remains constant. This means that the parameter space has not been
explored correctly, and successive samples are not independent. Although not
the focus of this work, this motivates the use of more scalable sampling schemes
for problems of this type. This is an area of active research; some recent publi-
cations on scalable inference for DPMMs via MCMC include those of Chang and
Fisher III (2014), Ge et al. (2015), and Ni et al. (2020).
Comparing partitions
We have seen in the simulation studies reported in Section 4.3 and in the analysis
of the pan-cancer data in Section 4.4 that the outcome-guided version of KLIC
can identify subclusters in the data. In multi-omic applications the standard way
of comparing partitions of the data is to use the ARI (see e.g. Kirk et al., 2012;
Lock and Dunson, 2013; Gabas̆ová, Reid, and Wernisch, 2017). This index only
indicates whether two partitions are similar overall or not, but is not suitable to
compare two partitions of the data in situations where one of the two subdivides
one or more classes into smaller subsets. A different way of assessing the similar-
ity of two clusterings needs to be developed for this.
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INTEGRATIVE CLUSTERING OF MULTI-OMIC
CARDIOMETABOLIC SYNDROME DATA
In this chapter, we continue the CMS data analysis of Chapter 2, applying the un-
supervised and outcome-guided integration algorithms introduced in Chapters
3 and 4 respectively to it. The goal here is to find clusters of individuals who
have similar features and check whether any blood donors belong to the same
clusters as some of the CMS patients. This may help identify seemingly healthy
individuals who may be at risk of developing CMS.
As we have seen, the CMS dataset has a large number of missing values. There-
fore, we first need to explain how KLIC can cope with incomplete datasets.
The data analysis presented here provides an example of why variable selection is
of fundamental importance in cluster analysis (Fop and Murphy, 2018); especially
for high-dimensional data. In particular, we show that if DPMMs are fitted on the
full CMS ’omic layers, it becomes impossible to pick out the clustering structure in
each layer that separates people affected by CMS from the others. This is because
the large number of irrelevant variables in each layer, which have either different
or no clustering structure, “hide” the signal that we are interested in. Addition-
ally, we show that current MCMC algorithms are prohibitively slow and get stuck
in local modes, when dealing with such high-dimensional datasets. However, us-
ing only the features selected via penalised logistic regression in Chapter 2, we
are able to fit DPMMs on each layer and integrate them using our MKL approach
to find meaningful clusters. This shows that variable selection improves not only
the interpretability of the model, but also the quality of the final clusters.
Chapter outline
First, the unsupervised and outcome-guided KLIC algorithms are extended in or-
der to analyse incomplete multi-omic datasets in Section 5.1. Then, both methods
are applied to the CMS data in Section 5.2. The main findings and challenges of
this chapter are summarised in Section 5.3.
5.1 HANDLING MISSING DATA
We have seen in Chapter 2 that multi-omic datasets often have missing observa-
tions. This section is dedicated to giving further details about how missing data
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can be handled by using unsupervised and outcome-guided KLIC. For simplicity,
throughout this chapter we consider the data of layer m to be missing for indi-
vidual n even if only one of the features is missing. In this way, we can easily
extend the algorithms of unsupervised and outcome-guided KLIC to the case of
incomplete data. More sophisticated techniques would have to be developed in
order to define similarities between incomplete ’omic measurements that utilise
all available data, however this falls outside of the scope of this chapter.
5.1.1 Unsupervised KLIC
The optimisation problem that is solved to find the optimal clustering and weights











where ◦ is the Hadamard product. As stated in Chapter 3, one can optimise the
objective function of Equation (5.1a) with a two-step procedure, that iteratively
(i) solves a standard kernel k-means problem with kernel δΘ, keeping the weight
matrix Θ fixed and then (ii) optimises the objective function with respect to Θ.
Again, the first step reduces to solving one optimisation problem with a single
kernel and in the second step one just needs to solve a QP problem (Gönen and








(IN − HHT) ◦ ∆m
]
θm
subject to Θ ∈ RN×M+ ,
Θ′1M = 1N .
We now extend the formulation of Gönen and Margolin (2014) so that clustering
can be performed even if not all kernels include information for all pairs of ob-
servations. We do so by making sure that each kernel matrix is of size N × N,
where the rows and columns corresponding to the observations that do not have
complete information available in the corresponding data layer are filled with ze-
ros. More precisely, we define by Im ⊂ {1, . . . , N} the set of the missing values
in each dataset m = 1, . . . , M and make sure that the corresponding kernel ∆m is
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such that
∆mij = 0 ∀i ∈ Im, j 6= i,
∆mii = 1 ∀i ∈ Im.




∆′m 0 0 0
0 1 0 0
0 0
. . . 0
0 0 0 1
 ,
where ∆′m is the mth kernel matrix for the available data and the observations are
ordered such that the missing ones are at the bottom of the matrix for presenta-
tional purposes. Therefore, it is a valid kernel matrix.
Moreover, it is possible to cancel the influence of the missing observations on








(In − HHT) ◦ ∆m
]
θm
subject to Θ ∈ RN×M+ ,
Θ′1M = 1N ,
θmi = 0 ∀i ∈ Im, m = 1, . . . , M. (5.3a)
This corresponds to adding |I1| + · · · + |IM| equality constraints, each one on
a different variable, or, equivalently, to removing a number |I1| + · · · + |IM| of
variables from the optimisation problem. Therefore, (5.3) is a QP problem.
The objective function (3.8) can then be minimised by iterating between steps (i)
and (ii) as in the previous case, with the additional constraints (5.3a) in step (ii).
5.1.2 Outcome-guided KLIC
The outcome-guided KLIC algorithm only outputs one overall weight for each
data layer. Therefore, the strategy used for unsupervised KLIC cannot be applied
to this case. Instead, we infer the kernel weights using only the statistical units
that have no missing observations. Then, we define a weight matrix Θ ∈ RN×M
containing sample-specific weights, as follows:
- for the observations that have no missing values, the weight of each layer
corresponds to the weight assigned by the SVM to that layer;
- for the remaining statistical units, the weights of the incomplete or missing
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layers are assigned zero weight, whereas the others have the SVM weights,
normalised in order to sum to one.







where θm, m = 1, . . . , M, are the columns of Θ.
5.2 APPLYING KLIC TO THE CARDIOMETABOLIC SYNDROME DATA
We now apply unsupervised and outcome-guided KLIC to the CMS dataset pre-
sented in Chapter 2.
In order to apply KLIC to the CMS data, we want to use the MDI implementation
in the C programming language of DPMMs, introduced in Chapter 4, to build a
PSM for each data layer. However, we found that the MCMC chains do not reach
convergence on the full datasets (for further details see Appendix D). For this
reason, we only include in the models the variables selected via separate EN in
Chapter 2, which constitute the molecular signature of CMS. The convergence as-
sessment for the MCMC chains and the resulting PSMs are reported in Appendix
D.
The importance of variable selection in model-based clustering has been high-
lighted by numerous publications; for a review see Fop and Murphy (2018). In
the context of integrative ’omics, in particular, we mentioned in Chapter 3 that the
iCluster integrative method (Shen, Olshen, and Ladanyi, 2009) has been extended
to perform variable selection (Kim et al., 2017). Variable selection for DPMMs has
also been the object of several publications (e.g. Tadesse, Sha, and Vannucci, 2005;
Kim, Tadesse, and Vannucci, 2006).
Fop and Murphy (2018) divide variable selection methods for clustering algo-
rithms into two categories: filter methods carry out the variable selection step sep-
arately from the clustering, while in wrapper methods clustering and variable selec-
tion are performed jointly. The former are easier to implement and less computa-
tionally intensive, the latter have been shown to give better results. The approach
followed here falls into the first category of methods. Given the high dimension-
ality of the data, performing variable selection via penalised logistic regression as
a pre-filtering step is extremely advantageous: it improves both the quality of the
inference and lowers its computational cost.
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5.2.1 Unsupervised integration
First, we perform unsupervised integration on the eight PSMs obtained for the
CMS data. Figure 5.1 shows the weighted kernel and final clusters, as well as a
comparison of the clusters to our classification of the individuals in the study into
donors, controls, lipodystrophy and obese individuals. In Figure 5.2 are reported
the average values of the silhouette when the number of clusters goes from 2 to
45 (the maximum is attained for K = 8) and the weights assigned to each PSM
by the multiple kernel k-means algorithm. The average weights assigned to each
layer are as follows: ChIP-seq monocytes 15.31%, ChIP-seq neutrophils 1.45%,
RNA-seq monocytes 2.33%, RNA-seq neutrophils 12.28%, methylation mono-
cytes 31.06%, methylation neutrophils 1.98%, metabolites 2.19%, lipids 33.40%.
Interestingly, even though we built the PSMs using the variables that discriminate
the obese individuals from the control donors, the lipodystrophy patients occupy
only two clusters, one of them containing more than half of the obese individuals.
This seems to confirm once again that the two extreme phenotypes considered in
this study may have some commonalities on the molecular level.
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(A) Clusters and weighted kernel.
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FIGURE 5.1: Unsupervised integration of the CMS data. (A)
Left: weighted kernel. The rows and columns correspond to
individuals in the study. Higher values of similarity between
samples are indicated in blue. Right: cohorts and final clus-
ters. (B) Coincidence matrix comparing the cohort of each
individual (rows) with the clusters (columns).
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FIGURE 5.2: Unsupervised integration of the CMS data. (A)
Average silhouette for number of clusters going from 2 to
45. (B) Weights assigned by the multiple kernel k-means al-
gorithm to each observation in each layer.
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5.2.2 Outcome-guided integration
We now use the same PSMs as in the previous section as input to outcome-guided
KLIC. As a response, we use a binary variable that is equal to one for individuals
who belong to one of the two extreme phenotype groups, and is equal to minus
one for the blood donors. Note that we have already used the cohort information
in the variable selection step, and therefore we cannot exploit this example to
evaluate the quality of the inference obtained via outcome-guided KLIC. Figure
5.3 shows the weighted kernel and final clusters, and a comparison between the
clusters and cohorts. In Figure 5.4 are reported the average values of the silhou-
ette when the number of clusters goes from 2 to 45 (the maximum is attained for
K = 9) and the matrix of weights. The weights assigned by the simpleMKL to
each data layer are as follows: ChIP-seq monocytes 6.17%, ChIP-seq neutrophils
43.94%, RNA-seq monocytes 29.95%, RNA-seq neutrophils 8.13%, methylation
monocytes 5.50%, methylation neutrophils 0.35%, metabolites 4.04, lipids 1.92%.
As expected, most of the extreme phenotype individuals belong to the same clus-
ter. It is also interesting to note that the individuals in cluster 2 have consistently
higher similarities with the extreme phenotype cluster (number 3) than the re-
maining ones. This might suggest that the donors in cluster 2 should be analysed
in greater detail to ascertain if they have CMS or are at greater risk of developing
it.
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(A) Clusters and weighted kernel.
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FIGURE 5.3: Outcome-guided integration of the CMS data.
(A) Left: weighted kernel. The rows and columns corre-
spond to individuals in the study. Higher values of simi-
larity between samples are indicated in blue. Right: cohorts
and final clusters. (B) Coincidence matrix comparing the co-
hort of each individual (rows) with the clusters (columns).
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FIGURE 5.4: Outcome-guided integration of the CMS data.
(A) Average silhouette for number of clusters going from 2
to 45. (B) Weights assigned by the algorithm to each obser-




In this chapter, we have seen how the statistical methods proposed in this thesis
can handle missing data and be applied to a large multi-omic dataset such as the
novel CMS dataset presented in Chapter 2. We summarise here the main findings
and challenges of this chapter.
5.3.1 Main findings
After using penalised logistic regression to identify a molecular signature of CMS
in each ’omic layer, we were able to build a PSM for each layer using MCMC
schemes for DPMMs. This allowed us to apply unsupervised and outcome-guided
KLIC to this dataset, after showing that both algorithms can easily incorporate in-
formation from statistical units that have incomplete data.
The results obtained in this chapter illustrate the difference between unsuper-
vised and outcome-guided approaches. As we have seen in Chapters 3 and 4,
most integrative algorithms for the stratification of multi-omic data are unsu-
pervised. Only a few methods have been recently developed which exploit a
response variable for clustering purposes (see Arora et al., 2020). However, the
work presented in this chapter shows how very different clusterings can be ob-
tained using the same input data (in this case, the same PSMs), depending on
whether the integration is unsupervised or outcome-guided. It is important to
note, moreover, that the DPMMs were fitted using the variables representing the
molecular signature of CMS: this was not sufficient to make the unsupervised
integration find a partition that differentiates between extreme phenotype indi-
viduals and the others. In general, different clustering structures can be found in
rich datasets like the one used here and, even if unsupervised KLIC has a mean-
ingful way of assigning weights to each PSM, doing so in an unsupervised way
does not guarantee to find the most relevant clustering structure for the problem
at hand. Conversely, making use of a response variable that is associated to the
population structure that is to be uncovered can dramatically improve the use-
fulness of the data partition found. In situations where response variable is not
available, it is still crucial to be aware that different weightings of the ’omic lay-
ers can be considered, each yielding a different output, and to be able to monitor
the impact of each data layer on the final clustering. This suggests that the re-
sults obtained using clustering methods that do not explicitly determine optimal
weights for each data layer (e.g. COCA; The Cancer Genome Atlas Research Net-
work, 2012) or do not take into consideration a response variable (e.g. iCluster,
Clusternomics, and even unsupervised KLIC; Shen, 2012; Gabas̆ová, Reid, and
Wernisch, 2017; Cabassi and Kirk, 2020b) might be limited.
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5.3.2 Challenges
The methods and results presented in this chapter could be improved and ex-
tended in two main directions, which we explain here.
Loss of information in outcome-guided KLIC
In the first step of outcome-guided KLIC, where the kernel weights are defined,
only the statistical units that have complete measurements on each data layer are
used. Therefore, information from incomplete observations is discarded at this
step. It would be useful to develop a way to include information relative to all
the available data at this stage of the analysis.
Interpretation of the results
Further analysis and expert knowledge would be required to gain a deeper un-
derstanding of the two partitions of the data that we have identified here. In par-
ticular, it would be interesting to determine whether the individuals belonging to




We present here the main findings of this thesis (Section 6.1), some possible future
research areas (Section 6.2) and concluding remarks (Section 6.3).
6.1 MAIN FINDINGS
The flow of genetic information within a cell and its influence on phenotype is
complex, and yet to be fully understood. As opposed to more traditional ap-
proaches such as, for example, GWAS, multi-omic studies take an holistic ap-
proach and aim at disentangling the interactions between multiple types of ’omics
and understanding their effect on many aspects of an organism’s life. The impor-
tance of ’omic studies combining different layers of information has been high-
lighted by several high-profile publications (Hasin, Seldin, and Lusis, 2017; Kar-
czewski and Snyder, 2018). In this thesis, we have developed novel statistical
methods that can be used to combine and extract information from multi-omic
datasets, and have used them to draw meaningful biological and clinical infor-
mation from three real-world datasets. Compared to existing approaches, the
methods developed here put more emphasis on monitoring how much impact
each data layer has on the final output, while ensuring that the corresponding
algorithms are not computationally prohibitive for very large datasets, such as
those that are often encountered in practice.
6.1.1 Supervised integration
The supervised integration of multi-omic data can be used to learn predictive and
classification models in a wide range of applications. In this thesis, we have fo-
cused on binary classification, taking as an example the classification of patients
according to their disease status. ’Omic datasets are usually high-dimensional,
with more covariates than data points. For this reason, penalised likelihood ap-
proaches are often used to build predictive models for this type of data. The chal-
lenge is then how to apply these methods to multi-omic datasets and/or extend
them methods while taking into account the fact that different ’omic layers have
different characteristics (e.g. level of noise, number of covariates, percentage of
relevant covariates). Throughout this thesis, we have also put emphasis on the
importance of variable selection in the supervised integration of multi-omic data.
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Identifying a subset of relevant features for the problem at hand not only makes
predictive models more interpretable, but is also useful for other downstream
analyses (e.g. clustering).
In the first part of Chapter 2, we introduced two ways of building binary classi-
fication models for large multi-omic datasets, while selecting a set of covariates
that are jointly predictive of the outcome of interest. Both approaches are com-
posed of two steps: first, variables are selected in each ’omic layer, then all the
selected variables are combined into a joint model. The difference between the
two is that, in one case, the user can manually pick the penalty parameters, de-
pending on how many variables they want to select. In the other one, the penalty
parameters are selected automatically in order to minimise the CV error. In both
cases, the MR rates observed in the simulation studies are comparable to those
of state-of-the-art competitor methods. At the same time, the number of rele-
vant variables identified by the two-step approaches is higher than for the other
methods, indicating that the former are more suitable for multi-omic signature
identification.
The supervised approaches to multi-omic integration developed in this thesis will
enable other researchers to build predictive models for large multi-omic datasets.
This could help build binary classification models and identify sets of relevant
’omic features in a variety of multi-omic studies. To make this easier, we have
made our code for our novel approaches publicly available, and have extended
the functionalities of the main competitor method to the logistic regression frame-
work.
6.1.2 Unsupervised integration
In applications where the goal is to find clusters of individuals or genes that share
similar characteristics across multiple ’omics, unsupervised integration is often
used. Statistical methodologies that combine multiple ’omic layers in an un-
supervised fashion are currently being produced at a fast pace (Rappoport and
Shamir, 2018). However, the objective function that is optimised by these meth-
ods is not always clear. Another challenge of unsupervised clustering is how to
determine to what extent each data type should impact the final clustering, given
that the level of noise and cluster separability can greatly vary across layers and
that different layers may contain contrasting information. For most unsupervised
integrative algorithms for multi-omic data, even determining a posteriori which
data layer influenced the final output the most is often an arduous task. A no-
table example of unsupervised integrative clustering algorithm suffering from
these problems is COCA, a widely-used tool in cancer applications (The Cancer
Genome Atlas Research Network, 2012).
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In Chapter 3, we laid out for the first time the algorithm behind COCA and sys-
tematically explored its properties. We then proceeded to suggest a novel me-
thod for the unsupervised integration of multiple ’omics based on multiple ker-
nel learning, named KLIC. Contrary to existing approaches, the KLIC algorithm
explicitly assigns a weight to each omic layer, up-weighting the most informative
ones. We showed that KLIC can be run on large datasets and that the clusters
found by KLIC more accurately reflect the true clustering structure than those of
the main competitor methods, across a range of simulation settings. This hap-
pens for two main reasons: firstly, the main competitor methods assign too much
weight to noisy datasets; secondly, the way in which kernels are built in KLIC
makes it more robust than the other methods to the inclusion of noisy variables.
The version of KLIC used in Chapter 3 employs consensus matrices as kernels.
However, we also pointed out that any other PSD matrix whose entries represent
similarities between the statistical units can be used. This turned out useful in
Chapter 4, where clever ways to summarise and combine PSMs were sought. In-
deed, after proving that PSMs are PSD matrices, we were able to use the KLIC al-
gorithm to summarise the output of MCMC schemes run on each data layer inde-
pendently. Thanks to this, we also managed to overcome the problem of choosing
the number of clusters when building the kernel matrices. In fact, we explained
how to build PSMs (and therefore kernel matrices) from DPMMs, which do not
require fixing the value of K.
We also showed that, having proven that PSMs are valid kernel matrices, kernel
methods can be applied to them to summarise the output of just one MCMC
sample with the same accuracy as the other methods from the literature.
The unsupervised version of KLIC will allow researchers to perform unsuper-
vised integrative clustering of multi-omic data in a principled way, defining simi-
larities in between observations based on either heuristic clustering algorithms or
model-based techniques, depending on the user’s needs, and assigning a differ-
ent weight to each data layer. It will also allow to include external information, as
long as it can be put in the form of a PSD matrix. The R packages coca and klic
have been designed to make this as simple as possible.
6.1.3 Outcome-guided integration
It has recently become evident that high-dimensional ’omic datasets can be used
to define multiple partitions of the data. For this reason, it is essential to deter-
mine at the beginning of the analysis what is the purpose of clustering in the
application at hand and what type of partition is sought. In order to pick out the
most relevant population structure, a response variable that is known to be re-
lated to the outcome of interest can be used to guide the clustering. In the context
of multi-omic integration, this has been done for example by Arora et al. (2020),
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who developed an outcome-weighted strategy for cancer patients stratification,
making use of survival information to guide the clustering.
In Chapter 4, KLIC is extended to take into account a categorical response vari-
able. To this end, SVMs are used to define the kernel weighting, so that the ker-
nels presenting a clustering structure similar to the partition induced by the re-
sponse are up-weighted. We demonstrated through simulation studies that this
approach is particularly useful in two situations. Firstly, if one of the layers has
a clear clustering structure that is unrelated to the response variable, the corre-
sponding kernel matrix is down-weighted. Secondly, this approach can help un-
cover a more refined partition of the data than the one reported by the response
variable.
We have shown in Chapter 5 that, with the same input, the unsupervised and
outcome-guided versions of KLIC can produce completely different outputs. This
suggests that, whenever possible, a response variable should be used to partition
multi-omic datasets. Therefore, outcome-guided KLIC could be used in the future
to make sure that gene and patient stratification are performed in a meaningful
way.
6.1.4 Real data applications
While the contributions of this thesis are mainly methodological, the three real
data applications presented in this thesis also generated interesting insight.
Cardiometabolic syndrome data
The first real-world application presented in this thesis was aimed at finding
a molecular characterisation of CMS, a set of metabolic dysfunctions that are
known to be associated with higher risk of type 2 diabetes and CVD. For this,
eight ’omic layers were available, for a set of 184 blood donors and 21 individuals
affected by this syndrome.
The second part of Chapter 2 is dedicated to the supervised analysis of the CMS
dataset, which is divided into three steps.
- Multivariate signature identification. The two-step logistic regression methods
introduced in the first part of Chapter 2 are used to identify a molecular sig-
nature in each layer and to subsequently fit a ridge-penalised logistic regres-
sion model. The predicted probabilities of each individual to belong to the
group of CMS patients showed that obese and lipodystrophy individuals
have similar molecular profiles; this seems to validate the hypothesis that
different types of CMS have common molecular pathways. Moreover, the
predictive model could also be used in the future to identify blood donors
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who have a high probability of having CMS for prevention and diagnostic
purposes.
- Univariate differential analysis. We compared our molecular signatures to
those obtained by a univariate approach often used by practitioners. As
expected, only a few features were selected by the univariate approach, due
to the fact that the multiple testing correction makes the selection criterion
quite stringent, and that it is unable to identify synergies between different
features that are together predictive of CMS.
- Validation via external cohorts. The analysis of the Fenland cohort validated
our lipidomics signature of CMS. Additionally, the NASH cohort showed
a similar pattern of associations between known CMS risk factors and the
selected lipids to the one observed in our novel dataset.
Overall, our multi-omic analysis allowed us to identify a set of molecular features
that can help discriminate between extreme phenotype and healthy individuals,
with greater accuracy than standard univariate approaches. Further results re-
ported in Appendix A validate our conclusions. Once again, we reiterate that
these are only explorative analyses; a larger number of observations must be col-
lected and analysed before using these results in the clinic.
In Chapter 5, unsupervised and outcome-guided KLIC are applied to the CMS
dataset, to show the importance of variable selection in clustering, and to demon-
strate how unsupervised and outcome-guided KLIC can handle missing data.
The analysis of the CMS data presented in Chapter 5 also constitutes an example
of why it is important to use a response variable to guide the clustering algorithm.
Indeed, different clustering structures can be found in the CMS data, even after
selecting the variables that are predictive of patient status via penalised logistic
regression. Therefore, using a response to guide the kernel weighting allows us
to find the most relevant one.
Multiplatform analysis of 12 cancer types
Multi-omic clustering methods have been widely applied to cancer studies, yield-
ing many interesting results. Most notably, these have been used to identify new
cancer subtypes, which can help develop more effective and less invasive treat-
ment for each novel subtype.
Here, we focused in particular on reproducing the clustering obtained by Hoadley
et al. (2014) of a pan-cancer dataset comprise measurements of five different ’omic
types. The analysis of Hoadley et al. identified 11 major subtypes, showing that
some cancer types were split into multiple clusters, while other (similar types
of) cancers merged into the same cluster. The unsupervised analyses of the pan-
cancer data presented in Chapters 3 and 4 confirmed the tumour subtyping de-
fined by Hoadley et al., with only a few discrepancies.
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In addition to that, the outcome-guided integration of the pan-cancer data pre-
sented in Chapter 4 demonstrated that a more refined set of cancer subtypes may
be discovered in this dataset. This demonstrates that outcome-guided KLIC could
be applied in cancer subtyping and other precision medicine applications to un-
cover new subclusters.
Transcriptional module discovery
The goal of transcriptional module discovery is to find clusters of genes that are
co-regulated and have the same biological function. The dataset that we used for
this purpose contains gene expression and binding information for a large num-
ber of transcriptional regulators, in a species of yeast called Saccaromyces cerevisiæ.
This dataset has already been analysed by others (Kirk et al., 2012; Savage et al.,
2010).
In this thesis, the application of unsupervised KLIC to the yeast dataset served
two main purposes. Firstly, showing the importance of selecting the correct clus-
tering algorithm when doing consensus clustering and of checking that the result-
ing consensus matrix accurately reflects the amount of information present in the
data (Chapter 3). Secondly, it demonstrated the advantage of using model-based
clustering algorithms to construct the kernel matrices (Chapter 4).
6.2 FURTHER RESEARCH AREAS
Ideas for future research areas can be divided into two main topics: the extension
of current methods, aimed at widening their applicability, and, for the unsuper-
vised approaches, the improvement of current strategies for the evaluation and
comparison of clustering results.
6.2.1 Model extensions
We can identify two types of model extensions that would make the proposed
methods applicable to a wider range of datasets: the ability to handle missing
values and to take as input different types of responses.
Handling missing values
The two medical applications presented in this thesis clearly highlighted the prob-
lem of missing data. Indeed, it is not trivial to measure and record large number
of ’omic features for a set of individuals; this is in large part due to the fact that
technical issues in the collection and processing of the ’omic data are not uncom-
mon (see e.g. Troyanskaya et al., 2001).
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We showed in Chapter 3 how missing values can be easily handled when us-
ing KLIC, assigning them no weight. Conversely, the two-step logistic regression
methods developed in Chapter 2 and the DPMMs used in Chapter 4 cannot han-
dle incomplete data. This led to a significant reduction of the sample size of each
dataset and consequent loss of information.
As for the regression methods, a workaround is used in Seyres et al. (2020) to
make sure that predictions are made for every individual included in the study,
where models are fitted for any possible combination of ’omic layers. This way,
all the available data are leveraged.
For DPMMs, instead, in order to handle missing values one could resort to the
multiple imputation strategy suggested by Molitor et al. (2010) and Lunn et al.
(2012, Chapter 9). The idea is to use the MCMC sampler to perform multiple
imputation for the missing values.
Handling continuous and survival outcomes
The outcome-guided integration method of Chapter 4 can currently be used with
categorical responses only. An extension to continuous responses should be straight-
forward, since the SVMs used in Chapter 4 can be easily adapted to the regression
setting (see e.g. Bishop, 2006, Chapter 7). Similarly, the ability to use survival data
to guide the kernel weighting would greatly increase the applicability of this ap-
proach, as many multi-omic studies use this as the response variable (see e.g.
Zhao et al., 2015). This extension, however, would require developing and imple-
menting new ways to compute the kernel weights.
On a related note, the two-step EN-type approaches of Chapter 2 have only been
implemented and tested within the logistic regression framework. Implementing
equivalent two-step approaches with linear regression and related models should
be uncomplicated. A thorough assessment of the properties of these methods
would then be required to ensure that they do not differ from those of the logistic
regression framework considered here.
6.2.2 Evaluation and comparison of clustering results
Evaluating and comparing the output of clustering algorithms is a complex task.
We divide the main questions arising from this thesis into three main points,
which are all tightly linked.
Assessment of the similarity of two partitions
Following the introduction of the outcome-guided integration of multi-omic data
in Chapter 4, it became apparent that the ARI is not a suitable measure to as-
sess the similarity of two partitions, if one of the two is a more refined partition
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than the other; empirical simulation studies could be used to prove this. Thus,
a different metric need to be defined to assess the quality of a clustering in these
situations.
Choice of the number of clusters
Using KLIC with consensus matrices requires choosing the number of clusters in
each layer, in order to run CC, and in the final clustering. In Chapter 4, we solved
the problem of choosing the number of clusters in the individual layers thanks to
DPMMs. However, there remains the question of how to best pick the value of
K for the global clustering. The silhouette can be a valuable tool, but it does not
always give a clear answer, as shown by the outcome-guided integration of the
pan-cancer data. For this reason, alternative strategies need to be devised.
Assessment of cluster quality
Finally, it is important to keep in mind that, before and after choosing the number
of clusters, expert knowledge is required to assess the quality of clusters in real
data applications.
6.3 CONCLUSIONS
In recent years, multi-omic analyses have allowed researchers to greatly improve
their understanding of the flow of genetic information within a cell and how this
affects different aspects of life. These analysis have driven the development of a
large number of novel statistical and machine learning techniques. In this thesis,
we have developed a set of tools that fall into this category, each tackling some of
the challenges encountered in state-of-the-art approaches.
The work presented in this thesis has clearly demonstrated the importance of be-
ing able to monitor and/or determine how much each data layer contributes to
the final output of every integrative multi-omic analysis, irrespectively of whether
it is supervised or unsupervised. It has also highlighted the value of making use
of a response variable associated to the outcome of interest in clustering applica-
tions, to guide the ’omic weighting process. The methodologies developed here
allow to make a deliberate choice in terms of how much importance is given to
each ’omic type, in different ways depending on whether a supervised, unsuper-
vised, or outcome-guided approach is adopted. Additionally, balancing the so-
phistication of the techniques employed with the use of computationally efficient
strategies (such as, for instance, always processing each data layer separately in
the first step of each of the developed algorithms, in order to reduce the dimen-
sionality of the data matrices involved) allowed us to keep the computational
burden within reasonable bounds.
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The diversity of high-throughput datasets is expected to further increase in the
future. As well as increasing the potential for exciting discoveries, this will exac-
erbate the challenges of multi-omic integration discussed in this work (in terms
of interpretability of the statistical models, computational cost, and so on) and
bring new ones. In addition to the insights provided in this thesis, we hope that
the techniques developed here (and corresponding implementations) will con-
tribute to future scientific discoveries by other scientists and that they can be a




APPENDIX TO CHAPTER 2
This appendix contains additional information on the work presented in Chapter
2. In Section A.1 we report the results of additional simulation studies for the pe-
nalised regression models considered in Section 2.3 and give more details about
the choice of the parameter α for the first of our proposed approaches, where
α is kept fixed. In Section A.2 we give more details about the biochemical pa-
rameters available for the CMS study. Section A.3 contains further details on the
comparison between obese individuals and control donors presented in Section
2.5 (comparison 1) as well as the results obtained for the comparison between the
lipodystrophy patients and the control donors (comparison 2).
A.1 ADDITIONAL SIMULATION STUDIES
We present here the results of three additional simulation settings. In the first
one, only two penalised layers are combined. The other two are similar to the
one presented in Section 2.3, with the number of penalised covariates increased
from 2 to 10 and 100.
A.1.1 Penalised covariates only
Table A.1 contains the values of the parameters P1, P2, PN , Pr1 , P
r
2 , β1, β2, βN of the
first additional simulation study. These are the same as those presented in Section
2.3, except that here PN = 0 in all settings.
P1 P2 PN Pr1 P
r
2 β1 β2 βN
Setting A 1000 1000 0 10 10 0.5 0.5 0.5
Setting B 100 1000 0 3 30 0.5 0.5 0.5
Setting C 100 1000 0 10 10 0.5 0.5 0.5
Setting D 100 1000 0 20 0 0.3 - 0.3
Setting E 20 1000 0 3 10 1 0.3 1
Setting F 20 1000 0 15 3 0.5 0.5 0.5
TABLE A.1: Values of P1, P2, PN , Pr1 , P
r
2 , β1, β2, βN used for the
simulation study with penalised covariates only.
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Since there are no covariates that are not penalised here, we also add the results
obtained with a different univariate method. The idea is that for each variable a
Mann-Whitney test is performed: if significant differences are observed between
the two classes with confidence level 0.05, after adjusting for multiplicity using
the Benjamini-Hochberg procedure, then that variable is selected. The variables
selected in this way are then used to fit a ridge-penalised regression model.
In addition to that, for each method in each setting, we report the number of
datasets for which each method is run successfully. When sIPF fails, this is due to
the fact that all evaluations of the error surface have the same value. Results for
the datasets affected by this problem are missing; these are only a small fraction of
the total number of the generated datasets. Moreover, the two-step methods that
fit a ridge regression model on the selected variables fail when only one variable
is selected, since the glmnet implementation of logistic regression does not work
with only one regressor.
The results are shown in Figures A.1 and A.2. In the case of diagonal covariance
(Figure A.1), naïve EN has the highest MR, both within and out-of-sample. The
number of variables selected by this method extremely low, so it is not surprising
to observe higher precision and lower recall compared to the other methods. The
low number of selections is due to the fact that naïve-EN, like sIPF-EN, is able
to identify sets of features from different layers that together are predictive of
outcome status. As in the simulation setting presented in Chapter 2, the two-step
EN-type methods have very low values of within-sample MR, but similar values
of out-of-sample MR to sIPF-EN in the first four settings. Interestingly, in settings
E and F, which are highly unbalanced, sIPF-EN greatly outperforms the other two
algorithms both in terms of out-of-sample MR and precision.
In the non-diagonal covariance case, similar outcomes are observed. The main
difference is that naïve-EN has lower MR and higher recall in this setting. In both
cases, the two univariate methods behave similarly, selecting fewer variable than
the other methods (as expected) and achieving a low MR only in Setting E.
A.1.2 Higher number of non-penalised covariates
We repeat the experiments presented in Chapter 2, replacing the value of PN to
10 (Figures A.3 and A.4) and 100 (Figures A.5 and A.6).
The patterns are similar to those observed in Chapter 2, with the number of se-
lected variables and values of the recall becoming more and more different be-
tween the joint models (naïve-EN and sIPF-EN) and the two-step approaches as
PN increases. The univariate method cannot be run in the setting where PN = 100,
since the number of predictors is higher than the number of statistical units in the
screening step, and a linear regression model cannot be fit.
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FIGURE A.1: Simulation study comparing different variants
of elastic-net for multi-omic data. The covariance matrix
used here is the diagonal matrix Σ0. MR is the out-of-sample
misclassification rate, MR CV the within-sample misclassifi-
cation rate.
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FIGURE A.2: Simulation study comparing different variants
of elastic-net for multi-omic data. The covariance matrix
used here is the block matrix Σ1. MR is the out-of-sample
misclassification rate, MR CV the within-sample misclassifi-
cation rate.
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FIGURE A.3: Simulation study comparing different variants
of elastic-net for multi-omic data. The covariance matrix
used here is the diagonal matrix Σ0. MR is the out-of-sample
misclassification rate, MR CV the within-sample misclassifi-
cation rate. The non-penalised covariates are not included
when computing precision and recall.
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FIGURE A.4: Simulation study comparing different variants
of elastic-net for multi-omic data. The covariance matrix
used here is the block matrix Σ1. MR is the out-of-sample
misclassification rate, MR CV the within-sample misclassifi-
cation rate. The non-penalised covariates are not included
when computing precision and recall.
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FIGURE A.5: Simulation study comparing different variants
of elastic-net for multi-omic data. The covariance matrix
used here is the diagonal matrix Σ0. MR is the out-of-sample
misclassification rate, MR CV the within-sample misclassifi-
cation rate. The non-penalised covariates are not included
when computing precision and recall.
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FIGURE A.6: Simulation study comparing different variants
of elastic-net for multi-omic data. The covariance matrix
used here is the block matrix Σ1. MR is the out-of-sample
misclassification rate, MR CV the within-sample misclassifi-
cation rate. The non-penalised covariates are not included
when computing precision and recall.
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A.1.3 Choice of α
We compare different values of α for the two-step approach proposed in Chapter
2, where α is kept fixed. We consider α = 0.1, 0.5 and 1 and all the simulations
settings compared so far: only two penalised layers (Figures A.7 and A.8), two
non-penalised covariates (Figures A.9 and A.10), few non-penalised covariates
(Figures A.11 and A.12), and high number of non-penalised covariates (Figures
A.13 and A.14).
The number of selected variables, precision and recall are as expected: the num-
ber of selected variables and the recall decrease while the precision increases as
as the value of α is increased. The MR, however, does not follow a clear pattern.
Table A.2 shows how the out-of-sample MR varies in each simulation setting for
increasing values of α.
PN 0 0 2 2 10 10 100 100
Covariance Σ0 Σ1 Σ0 Σ1 Σ0 Σ1 Σ0 Σ1
Setting A = ↓ = ↓ ↓ ↑ ↑ ↓
Setting B = ↓ = ↓ ↓ ↓ = =
Setting C = ↓ = ↓ ? ↓ = =
Setting D = ↓ ↑ = = = = =
Setting E ↓ ↓ = = ↑ = = ↓
Setting F ↓ ? = = ↑ ↓ ↑ ↓
TABLE A.2: Variation in the median MR of the separate EN
approach with fixed α when the parameter α is increased.
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FIGURE A.7: Simulation study comparing different values
of α. The covariance matrix used here is the diagonal matrix
Σ0 and PN = 0. MR is the out-of-sample misclassification
rate, MR CV is the within-sample misclassification rate.
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FIGURE A.8: Simulation study comparing different values
of α. The covariance matrix used here is the block matrix Σ1
and PN = 0. MR is the out-of-sample misclassification rate,
MR CV is the within-sample misclassification rate.
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FIGURE A.9: Simulation study comparing different values
of α. The covariance matrix used here is the diagonal matrix
Σ0 and PN = 2. MR is the out-of-sample misclassification
rate, MR CV is the within-sample misclassification rate.
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FIGURE A.10: Simulation study comparing different values
of α. The covariance matrix used here is the block matrix Σ1
and PN = 2. MR is the out-of-sample misclassification rate,
MR CV is the within-sample misclassification rate.
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FIGURE A.11: Simulation study comparing different values
of α. The covariance matrix used here is the diagonal matrix
Σ0 and PN = 10. MR is the out-of-sample misclassification
rate, MR CV is the within-sample misclassification rate.
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FIGURE A.12: Simulation study comparing different values
of α. The covariance matrix used here is the block matrix Σ1
and PN = 10. MR is the out-of-sample misclassification rate,
MR CV is the within-sample misclassification rate.
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FIGURE A.13: Simulation study comparing different values
of α. The covariance matrix used here is the diagonal matrix
Σ0 and PN = 100. MR is the out-of-sample misclassification
rate, MR CV is the within-sample misclassification rate. The
non-penalised covariates are not included when computing
precision and recall.
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FIGURE A.14: Simulation study comparing different values
of α. The covariance matrix used here is the block matrix
Σ1 and PN = 100. MR is the out-of-sample misclassification
rate, MR CV is the within-sample misclassification rate. The
non-penalised covariates are not included when computing
precision and recall.
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A.2 DESCRIPTION OF EACH BIOCHEMICAL PARAMETER
The biochemical parameters measured for the CMS study are the following:
- Alanine amino-transferase (ALT), an enzyme found primarily in the liver and
kidney. It is considered to be a biomarker for liver health. Elevated levels
of ALT often suggest the existence of liver disease (Lala and Minter, 2018).
- Aspartate amino-transferase (AST), an enzyme produced mainly by the liver,
but is also found in small quantities in other organs. As for ALT, high levels
of AST are usually associated to liver damage or other medical problems
(Lala and Minter, 2018).
- Glucose, a sugar that is critical for the functioning of a number of tissues
of the human body. In healthy individuals, blood glucose level is tightly
regulated and remains constant. High blood glucose levels are usually due
to diabetes (Wasserman, 2009).
- Low-density lipoprotein cholesterol (LDL-C), also known as “bad cholesterol”.
Elevated levels of LDL-C correlate with the extent and progress of athero-
sclerosis. In healthy individuals this constitutes around 60%-70% of blood
cholesterol (Hamilton, 1997).
- High-density lipoprotein cholesterol (HDL-C), also known as “good choles-
terol”. In healthy individuals this constitutes around 20%-30% of blood
cholesterol. High levels of HDL-C are correlated with better cardiovascular
health (Sirtori, 2006).
- Triglycerides (TG), the main constituent of body fat in humans. The triglyc-
erides present in the blood enable the transfer of adipose fat and blood
glucose from the liver and vice versa. High levels of triglycerides in the
bloodstream have been linked to atherosclerosis, heart disease, and stroke
(Nordestgaard et al., 2007; Sarwar et al., 2007; Talayero and Sacks, 2011).
- Total cholesterol, which includes LDL-C, HDL-C, and tryglicerides.
- High sensitivity C-reactive protein (hsCRP). Increased levels of C-reactive pro-
tein in the blood indicate the presence of an inflammation. Since athero-
sclerosis is believed to be a long-term mild inflammatory process, the high
sensitivity C-reactive can detect slightly increased levels of C-reactive pro-
tein and, for this reason, it is used to predict a person’s risk of myocardial
infarction and stroke (Ridker, 2001).
- Insulin, a hormone produced by the pancreas in response to carbohydrates
consumed in the diet. It promotes the absorption of carbohydrates from the
blood into liver, fat and skeletal muscle cells. Obesity has been shown to
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be associated with an increased risk of developing insulin resistance (Kahn,
Hull, and Utzschneider, 2006).
- Free fatty acid (FFA) are fatty acids circulating in the plasma. Increasing lev-
els of obesity are often associated with increasing levels of circulating FFA
(Gordon, 1960; Reaven et al., 1988).
- Leptin, a hormone that helps regulate the balance between food intake and
energy expenditure by inhibiting hunger. Obese individuals are known to
be less sensitive to leptin (de Gusmao Correia and Haynes, 2004).
- Adiponectin, a hormone produced in adipose tissue that is involved in reg-
ulating glucose levels and fatty acid breakdown. Low levels of adiponectin
are asociated with diabetes and cardiovascular disease (Oh, Ciaraldi, and
Henry, 2007).
Furthermore, the following quantities were computed:
- Leptin to adiponectin ratio (LAR), a marker of atherosclerosis susceptibility
(Kieć-Klimczak, Malczewska-Malec, and Huszno, 2008).
- Homeostasis model assessment of insulin resistance (HOMA-IR) score, a way of
quantifying insuline resistance, a pathological condition in which cells fail
to respond normally to the hormone insulin. In states of insulin resistance,
the same amount of insulin does not have the same effect on glucose trans-
port and blood sugar levels (Katsuki et al., 2001).
- Adipose tissue insuline resistance (ADIPO-IR) score, a measure of adipose tis-
sue insulin sensitivity. Low insulin sensitivity is associated with type 2 dia-
betes (Søndergaard et al., 2017).
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A.3 ADDITIONAL DATA ANALYSIS
A.3.1 Obese individuals versus control donors
We report here some additional results of the first comparison, that were omitted
from Chapter 2 for the sake of brevity.
Comparison of multivariate and univariate variable selection
In Section 2.6 is reported a Venn diagram representing the intersection between
the number of variables selected by the elastic-net (considering both the median
and maximal sets of variables over multiple runs of 10-fold CV) and those se-
lected via univariate testing for the lipidomics layer. Table A.3 contains the same
information for all layers.
Signature validation
In order to validate our multivariate signatures of CMS, we check whether there
is an association between our selected variables and the anthropometric and bio-
chemical parameters. To do so, we fit the following regression model, that ad-
justs for age and sex, for each pair of anthropometric/biochemical parameter and
’omic measurement:
parameteri = β0 + βage × agei + βfemale × 1(femalei) + β’omic × ’omici + ε,
where i = 1, . . . , N and 1 is the indicator function.
Figures A.17 and A.19 show the coefficients of the selected metabolites and lipids
in each of these regressions. Those marked with a star correspond to those for
which the null hypothesis is rejected for the test H0 : β’omic = 0 versus H1 :
β’omic 6= 0 at significance level 0.01. We control the FDR by adjusting the p-values
using the Benjamini-Hochberg procedure.
The coefficients of regression model of Equation (2.3) for the ChIP-seq, RNA-
seq, and methylation data are shown in Figures A.15, A.16, and A.17. In these
datasets, the number of tests that are significant at level 0.01 after correcting for
multiple testing using the Benjamini-Hochberg procedure is low. The ChIP-seq
and methylation variables have no significant associations, while the RNA-seq
only a few.
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−1 −0.5 0 0.5 1
(B) Neutrophils.
FIGURE A.15: Association of the selected ChIP-seq peaks
with the anthropometric and biochemical parameters. Cells
marked with a star represent associations that are statisti-
cally significant with a confidence level of 0.01 after correct-
ing for multiple testing using the Benjamini-Hochberg pro-
cedure.
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−1 −0.5 0 0.5 1
(B) Neutrophils.
FIGURE A.16: Association of the selected RNA-seq tran-
scripts with the anthropometric and biochemical parame-
ters. Cells marked with a star represent associations that
are statistically significant with a confidence level of 0.01





























































































−1 −0.5 0 0.5 1
(B) Neutrophils.
FIGURE A.17: Association of the selected methylation sites
with the anthropometric and biochemical parameters. Cells
marked with a star represent associations that are statisti-
cally significant with a confidence level of 0.01 after correct-
ing for multiple testing using the Benjamini-Hochberg pro-
cedure.
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−1 −0.5 0 0.5 1
FIGURE A.18: Association of the selected metabolites with
the anthropometric and biochemical parameters. Cells
marked with a star represent associations that are statisti-
cally significant with a confidence level of 0.01 after correct-
ing for multiple testing using the Benjamini-Hochberg pro-
cedure.
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−1 −0.5 0 0.5 1
FIGURE A.19: Association of the selected lipids with the
anthropometric and biochemical parameters. Cells marked
with a star represent associations that are statistically sig-
nificant with a confidence level of 0.01 after correcting for
multiple testing using the Benjamini-Hochberg procedure.
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A.3.2 Lipodystrophy patients versus control donors
Figure A.20 shows the average values of the selected variables for comparison 2
(lipodystrophy patients versus control donors). Interestingly, lipodystrophy and
obese individuals have similar average values in neutrophils for ChIP-seq and
RNA-seq data, but the same is not true for the other datasets.
In Figure A.21 are reported the probabilities of being a case, i.e. lipodystrophy pa-
tient, for each individual and each layer, as well as those given by a ridge regres-
sion on the clinical covariates. The probability given by the full model including
all the selected variables is also reported. Moreover, the rankings of each person
by probability of being a case for each layer and the set of clinical covariates are
reported, together with the final, average ranking. The results are comparable to
those obtained when using the obese individuals for the training set, where all
patients have high probabilities and rankings.
Table A.4 contains the number of variables selected by the multivariate and uni-
variate analyses and their intersections.
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FIGURE A.20: Signature identification. Penalised logistic re-
gression model trained on the lipodystrophy patients and
control donors. Average values of the selected variables for
each group of people. Each column corresponds to one of
the selected variables.
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(F) Combined rankings, α = 1.
FIGURE A.21: Probabilities of belonging to the class of
lipodystrophy patients and ranking of each person accord-
ing to those probabilities. Both quantities are shown on each
dataset separately and considering all the data types jointly.
The model is trained on the lipodystrophy patients and con-
trol donors. Each column corresponds to one of the individ-
uals who have no missing data, each row corresponds to one
of the layers. The columns are sorted by probability of being
a case in (A), (C), and (E) and final ranking in (B), (D), and





APPENDIX TO CHAPTER 3
This appendix contains additional information on the work presented in Chapter
3. In Section B.1 additional figures and results for the simulation studies of Sec-
tion 3.5 are reported. In Sections B.2 and B.3 are reported additional figures and
analyses for the two biological applications of Sections 3.6 and 3.7 respectively.
B.1 SIMULATION STUDY
In Section B.1.1 we explain how the RBF parameter was tuned for the simulation
studies. Additional settings for the comparison between KLIC, COCA and other
clustering algorithms are presented in Section B.1.2.
B.1.1 Choice of the parameter of the radial basis function kernels
In order to find the best possible value of σ for each synthetic dataset, we generate
100 dataset for each value τ (the parameter that indicates the separation between
cluster means) considered in our simulation setting, which are: τ = 1.5 in set-
ting A (similar datasets); τ = 0, 1, 2, 3 in setting B (datasets with different levels
of noise); τ = 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 in the additional simulation settings pre-
sented below (Section B.1.2). For each dataset, we build one kernel for each of the
following values of σ: 0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 15. We then use
kernel k-means to cluster the data and compute the ARI between the clustering
obtained in this way and the true cluster labels (Figure B.2). Finally, we choose
the value of σ maximising the average ARI for each value of τ.
FIGURE B.1: Kernels obtained for the same datasets as those
used for Figure 3.3 using RBF kernels.
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FIGURE B.2: ARI between the clusters obtained with kernel
k-means on RBF kernels for different values of the character-
istic length scale parameter and separation between clusters.
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B.1.2 Additional simulation settings
For simulation setting A (four datasets with the same level of cluster separability)
only the results obtained with τ = 1.5 are reported in the main paper. For com-
pleteness, we show here the corresponding figures for a range of other values of
τ in Figures B.3 and B.4.
(A) τ = 0. (B) τ = 0.5.
(C) τ = 1. (D) τ = 1.5.
FIGURE B.3: Comparison between KLIC, COCA, and other
clustering algorithms. ARI obtained using four datasets hav-
ing the same clustering structure and cluster separability (as
in Figure 3.4).
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(A) τ = 2. (B) τ = 2.5.
(C) τ = 3. (D) τ = 3.5.
(E) τ = 4.
FIGURE B.4: Comparison between KLIC, COCA, and other
clustering algorithms. ARI obtained using four datasets hav-
ing the same clustering structure and cluster separability (as
in Figure 3.4).178
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B.2 MULTIPLATFORM ANALYSIS OF 12 CANCER TYPES
In Section B.2.1 we explain the steps we took to try to replicate the data prepro-
cessing and cluster analysis of Hoadley et al., 2014. In Section B.2.2 we give more
details on the input and output of KLIC for this particular application.
B.2.1 Replicating the analysis of Hoadley et al., 2014
For each type of data we followed as closely as possible the procedures presented
in the supplementary material of Hoadley et al., 2014. We present here the steps
that we followed. The agreement between the clustering analysis presented here
and the clustering presented in the original Hoadley et al. paper ranged from
excellent (for the protein and mRNA datasets) to quite poor (for the miRNA
dataset).
Protein expression We used hierarchical clustering with Ward’s agglomeration
method and Pearson’s correlation as the distance. Our clusters match exactly
those of Hoadley et al. (i.e. the ARI is equal to one, see Figure B.5).
mRNA expression For mRNA expression, we proceeded as indicated by Hoadley
et al., 2014. We chose the genes present in 70% of samples and then selected
the 6,000 most variable genes. Then we used the ConsensusClusterPlus R pack-
age with settings maxK=20, innerLinkage ="average" finalLinkage="average",
distance="pearson", and corUse= "pairwise.complete.obs". The ARI is 0.917
(see Figure B.6).
DNA methylation We used hierarchical clustering with Jaccard’s distance and
Ward’s agglomeration method. Hoadley et al., 2014 chose to divide the data into
19 clusters, so we did the same. Comparing our clusters to those of Hoadley et al.,
2014, we obtained an ARI of 0.680 (see Figure B.7).
DNA copy number The clusters for the somatic copy number dataset were found
using hierarchical clustering with Euclidean distance and Ward’s method. The
number of clusters was set to eight in the original manuscript based on the cophe-
netic distances and therefore we did the same here. The adjusted Rand index
(ARI) comparing the clustering found in the present analysis with the clustering
found in the original analysis of Hoadley et al. is 0.333 (see Figure B.8).
miRNA expression In the original manuscript the clusters of the miRNA-seq
data were determined using a software program called Cluster 3 (De Hoon et
al., 2004). The same software was used to scale the data. Since it is was not
possible to retrieve the clusters presented in the paper using this software, we
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used R to scale the data as was done by Cluster 3, namely applying a logarithmic
transformation to the data and then median-centring. We found the final clusters
using agglomerative hierarchical clustering in R (agnes command). We selected
the number of clusters that maximises the silhouette, which is eight. The ARI is


























FIGURE B.5: Protein expression clusters. High values are in-
dicated in blue and low values in orange. C: Clusters found
in this analysis. H: Clusters found in the original analysis of
Hoadley et al. ARI between C and H: 1.
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FIGURE B.6: mRNA expression clusters. High values are
indicated in blue and low values in orange. The dataset con-
tains 600 genes but here we show only 100 of them. C: Clus-
ters found in this analysis. H: Clusters found in the original
analysis of Hoadley et al. ARI between C and H: 0.917.
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FIGURE B.7: DNA methylation clusters. Blue cells corre-
spond to methylated loci. Missing values are indicated in
grey colour. Only 100 CpG loci are shown here, but the full
dataset contains 2,043. C: Clusters found in this analysis. H:
Clusters found in the original analysis of Hoadley et al. ARI
between C and H: 0.680.
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FIGURE B.8: Somatic copy number clusters. High values
are indicated in blue and low values in orange. C: Clusters
found in this analysis. H: Clusters found in the original anal-
ysis of Hoadley et al. ARI between C and H: 0.333.
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FIGURE B.9: miRNA expression. C: Clusters found in
this analysis. H: Clusters found in the original analysis of
Hoadley et al. ARI between C and H: 0.255.
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B.2.2 Output of KLIC
The kernels corresponding to each dataset are shown in Figure B.10, for each of
them we also report the cophenetic correlation coefficient. Figure B.11a shows
the weights associated to each observation in each dataset. Figure B.11b shows
the correspondences between the clusters obtained using KLIC and the tumour
tissues. Most clusters correspond quite well with one or two tissue types (e.g.
cluster 10 contains almost exclusively samples of renal cell carcinoma and cluster
6 contains colon and rectal adenocarcinomas), but not all. Finally, Figure B.11c
shows the average silhouette for all the number of clusters considered: the opti-
mal values are between six and ten.















FIGURE B.10: Pan-cancer data: kernel matrices.
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0 0.2 0.4 0.6 0.8 1
Clusters
1 2 3 4 5 6 7 8 9 10
(A) Weights.
488 1 5 8 119 28 185 0 0 0
0 445 1 3 0 24 0 0 2 0
0 0 0 0 0 1 4 0 0 324
0 0 280 1 7 12 5 0 0 0
0 1 178 34 2 3 20 0 0 0
0 0 2 258 5 2 3 0 0 0
0 3 0 1 2 3 2 0 183 1
7 0 1 20 158 103 34 2 0 20
0 0 0 5 32 124 0 0 0 0
0 0 0 0 16 18 1 147 0 0
0 0 1 0 2 2 1 67 0 0














































































































































FIGURE B.11: Multiplatform analysis of 12 cancer types, out-
put of KLIC. (A) Weights. Low weights are indicated in
white and higher weights in green. Grey cells correspond to
missing values, which have zero weight. (B) Matrix show-
ing the correspondences between the clusters obtained by
using KLIC and the tumour tissues. (C) Average silhouette.
The maximum is obtained for seven clusters. All numbers of
clusters comprised between six and ten have similar values.186
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B.3 TRANSCRIPTIONAL MODULE DISCOVERY
This section is structured as follows. First, we give further details regarding
the application of KLIC and COCA to transcriptional module discovery using
Bayesian Hierarchical Clustering as the clustering algorithm for the ChIP data.
Then, we consider other algorithms that could have been applied to this dataset
and compare the new results with those reported in the main paper. Finally, we
give more details about the choice of the number of clusters for PAM.
B.3.1 Clustering algorithms for the ChIP data
The ChIP dataset is quite sparse. The data were discretised so that only transcrip-
tion factors that are believed with high confidence to be able to bind to a gene’s
promoter region are marked as “ones”; all the others are “zeros”. For this rea-
son, in addition to BHC, we considered two clustering algorithms that are able
to take into account this feature of the data. However, we show that these meth-
ods often cluster genes with few transcription factors (i.e. observations for which
most variables are zero) together, while the other genes end up in separate small
clusters that are less stable under subsampling of the data. This leads to con-
sensus matrices that have high cophenetic correlation coefficients but carry little
information. We show that combining the corresponding kernels to that of the
expression data does not always give more meaningful clustering solutions than
those obtained on each data type separately. This highlights the importance of
the kernel matrices as an intermediate diagnostic tool for KLIC, which can help
choosing the right clustering algorithms.
Bayesian Hierarchical Clustering
Bayesian hierarchical clustering (Heller and Ghahramani, 2005) is a method for
agglomerative hierarchical clustering. The idea is that, similarly to classical ag-
glomerative clustering algorithms, at the start each data point is considered as a
different cluster; then, at each step, two clusters are merged. The main difference
between classical hierarchical clustering and BHC is that in BHC merging is done
based on Bayesian hypothesis testing, where the alternative hypotheses are “all
data in clusters ci and cj were generated from the same probabilistic model” and
“the data in ci and cj has two or more clusters in it”. The pair of clusters that is
selected for merging is the one with highest probability of the merged hypothesis.
Figure B.12b shows the clusters found on all the data (on the left) as well as the
consensus matrix obtained by applying BHC to 200 random subsamples of 95%
of the data. This shows that, while the clustering algorithm works well on the full
dataset, different clustering structures are found in the data subsamples, giving a
fuzzy similarity matrix. This is due to the fact that most clusters are very small,
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and are hard to identify when only a subset of the data is available. The output of
COCA obtained with this clustering algorithm is shown in Figure B.13, the output
KLIC is shown in the main paper. Higher weights are assigned on average to the
expression data, with an average of 0.58.
PAM with Gower’s distance
Another clustering algorithm that could have been applied to this dataset is PAM
with Gower’s distance (Gower, 1971). In this case, all variables are binary and
therefore Gower’s distance is equivalent to Jaccard’s distance. For two multivari-
ate binary observations xi and xj, this is defined as one minus the Jaccard index:
J =
M11
M01 + M01 + M11
,
where M11 is the number of variables where xi and xj both have value of 1, M01
is the number of variables where xi is 0 and xj is 1 and viceversa for M01. This
distance is particularly suited for this dataset because here the ones correspond to
transcription factors that are believed with high confidence to be able to bind to
the promoter region of the corresponding gene, whereas zeros are transcription
factors for which we are not able to reject the hypothesis that they do not bind to
that promoter region. Thus, in a sense, ones carry more information than zeros.
The consensus matrix obtained by subsampling 200 times 95% of the data is
shown in Figure B.12c, the output of COCA and KLIC in Figures B.13 and B.14
respectively. Details on how the number of clusters was chosen are given in Sec-
tion B.3.2. As usual, the number of clusters for KLIC and COCA was chosen in
order to maximise the silhouette. KLIC selected K = 3 and COCA K = 10. GOTO
scores for the clustering found with PAM algorithm and Gower’s distance, as
well as those given by KLIC and COCA for three and ten clusters are reported in
Table B.1. Higher weights are assigned to the ChIP data, with an average of 0.78.
Greedy Bayesian non-parametric clustering algorithm
The last clustering algorithm that we considered is a greedy approximation to the
Gibbs sampling algorithm for Dirichlet process mixture models of Neal, 2000. In
the greedy version of the algorithm used here at each iteration cluster allocations
are made in a deterministic fashion, assigning each observation to the cluster
with highest probability, instead of sampling the cluster labels according to their
conditional probabilities.
Figure B.12d shows the consensus matrix, Figures B.13 and B.14 show the output
of COCA and KLIC respectively. (Note that, for brevity, we refer to this method
as GBNP, which stands for greedy Bayesian non-parametric algorithm.) Higher
weights are assigned to the ChIP data points, with an average of 0.59.
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(A) Expression data, PAM.
Cophenetic correlation coefficient:
0.971.
(B) ChIP data, BHC.
Cophenetic correlation coefficient:
0.103.
(C) ChIP data, PAM.
Cophenetic correlation coefficient:
0.996.
(D) ChIP data, GBNP.
Cophenetic correlation coefficient:
0.931.
FIGURE B.12: Transcriptional module discovery. Left: orig-
inal data, where each row is a gene and each column a fea-
ture. The rows are sorted by cluster. Centre: cluster obtained
on the data. Right: consensus matrices, where each row and
column corresponds to a gene.
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(A) BHC
(B) PAM with Gower’s distance.
(C) GBNP.
FIGURE B.13: Transcriptional module discovery, output of
COCA. MOCs and final clusters obtained using different
clustering algorithms to generate the consensus matrix of the
transcription factor data.
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(A) PAM with Gower’s distance
(B) GBNP
FIGURE B.14: Transcriptional module discovery, output of
KLIC. Weighted similarity matrices obtained using different
clustering algorithms to generate the consensus matrix of the
transcription factor data. To the right of each similarity ma-
trix are shown the final clusters, the weights assigned to each
observation in each cluster by multiple kernel k-means, the
original datasets, and the clusters obtained on each dataset.
191









































































































































































































































































































B.3. Transcriptional module discovery
B.3.2 Choice of the number of clusters
In order to choose the number of clusters when using PAM, we considered mul-
tiple metrics: the average silhouette (Rousseeuw, 1987), the gap statistic (Tibshi-
rani, 2001), and the original and modified versions of Dunn’s index (Dunn, 1974;
Halkidi, Batistakis, and Vazirgiannis, 2001). We considered all number of clusters
from two to 20. These are shown in Figures B.15 and B.16. For the expression data,
we chose four clusters since three of the chosen metrics have a peak at K = 4. For
the ChIP data, there is no consensus among the metrics, so we selected K = 8
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(D) Dunn’s modified index.
FIGURE B.15: Expression data. Metrics used to choose the
number of clusters.
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(D) Dunn’s modified index.




APPENDIX TO CHAPTER 4
This appendix contains additional figures and results for the simulation studies
and biological applications presented in Chapter 4.
C.1 SIMULATION STUDY
In Sections C.1.2 and C.1.2 are presented additional figures related to the simula-
tion studies of Section 4.3. In Section C.1.3 are explored new simulation settings.
C.1.1 Synthetic data
In Figure C.1 is shown one of the datasets used for the simulation studies of Sec-
tion 4.3, with value of w set to 0.8 and number of covariates equal to 20. The first
ten covariates determine six different clusters, the remaining covariates have no















FIGURE C.1: One of the datasets used for the simulation
studies. The data are categorical, taking values 0, 1, or 2, the
response is binary. The rows are separated by cluster, the
cluster labels are indicated on the right of the data matrix.
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C.1.2 Integrative clustering
Figures C.2 and C.3 show the weights assigned to each dataset by the unsuper-
vised and outcome-guided methods for the integration of multiple PSMs pre-





















































































































































































































FIGURE C.2: Weights assigned to each PSM for each subset




































































































































































































FIGURE C.3: Weights assigned to each PSM for each subset
of datasets by the outcome-guided integration method.
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C.1.3 Additional simulation settings
First, we consider a variation of simulation setting B of Section 4.3. Then we
repeat the simulation studies of Chapter 3 with a different response variable.
Different number of covariates
We present here the results obtained for simulation setting B, with different num-
bers of irrelevant covariates. Figure C.4 shows the adjusted Rand index and Fig-
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(B) Setting B, 5 covariates without clustering structure.
FIGURE C.4: ARI obtained by summarising the PSMs one
at a time using kernel k-means (left), combining different
subsets of three PSMs in an unsupervised fashion using lo-
calised multiple kernel k-means (centre), and combining the
same subsets making use of a response variable and multi-
class SVMs to determine each PSM’s weight and using ker-


























































































































































(B) Setting B, 5 covariates without clustering structure.
FIGURE C.5: Weights assigned to each PSM for each sub-
set of datasets by the unsupervised (above) and outcome-
guided (below) integration methods for PSMs.
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Using the true cluster labels as response variable
We repeat the simulation study presented in Chapter 4 using the true cluster
labels as the response variable, both for the outcome-guided integration (in all
simulation settings) and to generate the PSMs with profile regression (in Setting
D). Although the true cluster labels are not available in practice, this simulation
study is used here to determine a putative upper bound on the performances of
outcome-guided integration.
The ARI is reported in Figure C.6. As expected, the outcome-guided integration
has higher values of the ARI in all settings, compared to the case where the out-
come is a binary variable. Moreover, in Setting D the ARI of each PSM taken
individually is also higher here than in the other simulation study.
First, for completeness, we show the weights assigned to each kernel in the unsu-
pervised setting (Figure C.7). However, only the weights of Setting D differ from
the previous simulation study (Figure C.2), because in Settings A, B, and C the
response variable is not used. The weights assigned to each kernel matrix in the
outcome-guided case are shown in Figure C.8. These are of easier interpretation
compared to those presented above (Figure C.3): on average, kernels originated
































































































































































































FIGURE C.6: Simulation study where the response for each
observation is given by its true cluster label. ARI obtained by
summarising the PSMs one at a time using kernel k-means
(left), combining different subsets of three PSMs in an un-
supervised fashion using localised multiple kernel k-means
(centre), and combining the same subsets making use of a
response variable and multi-class SVMs to determine each
PSM’s weight and using kernel k-means for the final cluster-
ing (right).
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FIGURE C.7: Weights assigned to each PSM for each subset
of datasets by the unsupervised integration method for the
simulation study where the response for each observation is




















































































































FIGURE C.8: Weights assigned to each PSM for each subset
of datasets by the outcome-guided integration method for
the simulation study where the response for each observa-
tion is given by its true cluster label.
203
Appendix C. Appendix to Chapter 4
C.2 MULTIPLATFORM ANALYSIS OF TEN CANCER TYPES
We present here some additional figures and results for the multiplatform analy-
sis of ten cancer types of Section 4.4.
First, we give more details about the variable selection step performed using the
methodology developed in Chapter 2. Then, we assess the convergence of the
MCMC chains on the full and reduced datasets. In the last part of this section, we
present additional figures for the unsupervised and outcome-guided integration
of four PSMs described in Chapter 4 and repeat the entire analysis for each of the
reduced datasets obtained via variable selection.
C.2.1 Variable selection
In Table C.1 are reported the number of variables measured in each layer and
the number of selected variables using separate EN on each layer as described in
Chapter 2.
Dataset Full dataset α = 0.1 α = 0.5 α = 1
Protein expression 131 131 131 124
mRNA expression 6000 1893 568 258
Methylation 2043 1439 623 322
DNA copy number 84 84 84 84
miRNA expression 51 51 51 50
TABLE C.1: Number of selected variables in each dataset for
different values of the EN parameter α.
The full mRNA dataset is too large to be used as input to MDI and for this reason
it is only used for the integration of the reduced datasets obtained via variable
selection with values of α of 0.5 and 1.
C.2.2 MCMC convergence assessment
We run five MCMC chains for 50,000 iterations, with a burn-in period of 25,000 it-
erations and thinning of 5. For each set of five chains, we check the Vats-Knudson
R̂ (Vats and Knudson, 2018) with parameters ε = 0.1 and α = 0.1 to assess the
convergence of the mass parameter. The PSMs obtained for the five chains are
summarised into one by taking the average.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.87 0.80 0.76 0.69
Chain 2 1 0.91 0.87 0.73
Chain 3 1 0.82 0.68
Chain 4 1 0.83
TABLE C.2: ARI between the clusterings found on the PSMs
















































































FIGURE C.9: Five PSMs of the protein expression data and
their average (bottom right). λ = 0, α = 0.1, 0.5. On the right
of each PSM is indicated the tissue of origin of each tumour
sample.
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FIGURE C.10: MCMC convergence assessment, protein ex-
pression data. λ = 0, α = 0.1, 0.5.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.75 0.72 0.89 0.79
Chain 2 1 0.82 0.80 0.92
Chain 3 1 0.76 0.81
Chain 4 1 0.80
TABLE C.3: ARI between the clusterings found on the PSMs
















































































FIGURE C.11: Five PSMs of the protein expression data and
their average (bottom right). α = 1. On the right of each
PSM is indicated the tissue of origin of each tumour sample.
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FIGURE C.12: MCMC convergence assessment, protein ex-
pression data. α = 1.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.46 0.43 0.48 0.42
Chain 2 1 0.42 0.52 0.42
Chain 3 1 0.43 0.41
Chain 4 1 0.49
TABLE C.4: ARI between the clusterings found on the PSMs
















































































FIGURE C.13: Five PSMs of the mRNA expression data and
their average (bottom right). α = 0.5. On the left of each
PSM is indicated the tissue of origin of each tumour sample.
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FIGURE C.14: MCMC convergence assessment, mRNA ex-
pression data. α = 0.5.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.63 0.55 0.61 0.52
Chain 2 1 0.58 0.64 0.63
Chain 3 1 0.59 0.58
Chain 4 1 0.57
TABLE C.5: ARI between the clusterings found on the PSMs
















































































FIGURE C.15: Five PSMs of the mRNA expression data and
their average (bottom right). α = 1. On the left of each PSM
is indicated the tissue of origin of each tumour sample.
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FIGURE C.16: MCMC convergence assessment, mRNA ex-
pression data. α = 1.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.60 0.57 0.53 0.79
Chain 2 1 0.67 0.63 0.64
Chain 3 1 0.59 0.66
Chain 4 1 0.54
TABLE C.6: ARI between the clusterings found on the PSMs
















































































FIGURE C.17: Five PSMs of the methylation data and their
average (bottom right). λ = 0. On the left of each PSM is
indicated the tissue of origin of each tumour sample.
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FIGURE C.18: MCMC convergence assessment, methylation
data. λ = 0.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.55 0.53 0.61 0.64
Chain 2 1 0.48 0.57 0.49
Chain 3 1 0.71 0.55
Chain 4 1 0.57
TABLE C.7: ARI between the clusterings found on the PSMs
















































































FIGURE C.19: Five PSMs of the methylation data and their
average (bottom right). α = 0.1. On the left of each PSM is
indicated the tissue of origin of each tumour sample.
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FIGURE C.20: MCMC convergence assessment, methylation
data. α = 0.1
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.79 0.74 0.74 0.78
Chain 2 1 0.81 0.73 0.82
Chain 3 1 0.70 0.77
Chain 4 1 0.75
TABLE C.8: ARI between the clusterings found on the PSMs
















































































FIGURE C.21: Five PSMs of the methylation data and their
average (bottom right). α = 0.5. On the left of each PSM is
indicated the tissue of origin of each tumour sample.
217
Appendix C. Appendix to Chapter 4




































































































































FIGURE C.22: MCMC convergence assessment, methylation
data.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.81 0.70 0.83 0.78
Chain 2 1 0.61 0.76 0.67
Chain 3 1 0.67 0.60
Chain 4 1 0.76
TABLE C.9: ARI between the clusterings found on the PSMs
















































































FIGURE C.23: Five PSMs of the methylation data and their
average (bottom right). α = 1. On the left of each PSM is
indicated the tissue of origin of each tumour sample.
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FIGURE C.24: MCMC convergence assessment, methylation
data.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.39 0.45 0.35 0.35
Chain 2 1 0.58 0.60 0.62
Chain 3 1 0.59 0.57
Chain 4 1 0.54
TABLE C.10: ARI between the clusterings found on the
















































































FIGURE C.25: Five PSMs of the DNA copy number data and
their average (bottom right).
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FIGURE C.26: MCMC convergence assessment, DNA copy
number data.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.63 0.75 0.59 0.64
Chain 2 1 0.74 0.82 0.82
Chain 3 1 0.68 0.69
Chain 4 1 0.75
TABLE C.11: ARI between the clusterings found on the
















































































FIGURE C.27: Five PSMs of the miRNA data and their aver-
age (bottom right). λ = 0, α = 0.1, 0.5. On the left of each
PSM is indicated the tissue of origin of each tumour sample.
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FIGURE C.28: MCMC convergence assessment, miRNA.
λ = 0, α = 0.1, 0.5.
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Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.66 0.72 0.70 0.57
Chain 2 1 0.59 0.76 0.69
Chain 3 1 0.55 0.56
Chain 4 1 0.72
TABLE C.12: ARI between the clusterings found on the
















































































FIGURE C.29: Five PSMs of the miRNA data and their av-
erage (bottom right). α = 1. On the left of each PSM is
indicated the tissue of origin of each tumour sample.
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FIGURE C.30: MCMC convergence assessment, miRNA
data. α = 1.
226
C.2. Multiplatform analysis of ten cancer types
C.2.3 Unsupervised integration: additional figures and results
First, we report some additional figures for the unsupervised integration of Sec-
tion 4.4, then we repeat the analysis with the reduced datasets obtained as de-
scribed in Section C.2.1.
Comparison with the clusters identified by Hoadley et al. (2014)
In Figure C.31 are shown the correspondences between the clusters found in the
main paper and the clusters identified by Hoadley et al. (2014) using Cluster-Of-
Clusters Analysis (COCA).
371 0 2 19 3 19 6 0 0
0 330 0 2 1 78 138 0 0
0 0 0 0 257 24 0 0 1
0 0 192141 2 28 1 1 0
0 0 188 47 3 19 0 0 0
0 0 0 3 0 9 2 0 184
0 0 0 5 0 4 1 157 0
0 0 3 4 0 78 16 0 3
0 0 0 1 0 65 1 1 0
0 0 1 2 0 2 0 0 0
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FIGURE C.31: Comparison between the clusters found com-
bining the PSMs of each layer using multiple kernel learning
and those identified by Hoadley et al. (2014) using COCA.
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Clustering structure in the data
Figures C.32, C.33, C.33, and C.35 show the four data layers where the rows have













FIGURE C.32: Left: copy number data (each row is a tumour
sample). Right: final clusters, tissues of origin of each sam-













FIGURE C.33: Left: miRNA expression data (each row is a
tumour sample). Right: final clusters, tissues of origin of
each sample, and COCA clusters.
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FIGURE C.34: Left: methylation data (each row is a tumour
sample). Right: final clusters, tissues of origin of each sam-













FIGURE C.35: Left: protein expression data (each row is a
tumour sample). Right: final clusters, tissues of origin of
each sample, and COCA clusters.
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(A) Weighted kernel and clusters.
FIGURE C.36: Unsupervised multiplatform analysis of ten
cancer types. Weighted kernel, final clusters, tissues of ori-
gin, and COCA clusters.
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(A) Comparison to tissue of origin.
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(B) Comparison to COCA clusters.
FIGURE C.37: Unsupervised multiplatform analysis of ten
cancer types. (A) Coincidence matrix comparing the tissue
of origin of the tumour samples to the new clusters. (B) Co-
incidence matrix comparing the COCA clusters of Hoadley
et al. to the new clusters.
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FIGURE C.38: Average silhouette for number of clusters go-
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FIGURE C.39: Weights assigned by the multiple kernel k-
means algorithm to each observations in each layer, where
“CN” stands for copy number and “RPPA” for reverse phase
protein array. The weights assigned on average to the tu-
mour samples in each layer are: copy number 7.9%, methy-
lation 4.6%, miRNA 3.2%, protein 84.3%.
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(A) Weighted kernel and clusters.
0 330158158 0 1 7 3 0
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(B) Comparison to tissue of origin.
371 0 2 20 3 18 6 0 0
0 330 0 2 0 79 138 0 0
0 0 0 0 257 24 0 0 1
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(C) Comparison to COCA clusters.
FIGURE C.40: Unsupervised multiplatform analysis of ten
cancer types. (A) Weighted kernel, final clusters, tissues of
origin, and COCA clusters. (B) Coincidence matrix compar-
ing the tissue of origin of the tumour samples to the new
clusters. (c) Coincidence matrix comparing the COCA clus-
ters of Hoadley et al. to the new clusters.
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FIGURE C.41: Average silhouette for number of clusters go-
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FIGURE C.42: Weights assigned by the multiple kernel k-
means algorithm to each observations in each layer, where
“CN” stands for copy number and “RPPA” for reverse phase
protein array. The weights assigned on average to the tu-
mour samples in each layer are: copy number 5.8%, methy-
lation 6%, miRNA 5.9%, mRNA 5.9%, protein 76.4%.
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(A) Weighted kernel and clusters.
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(B) Comparison to tissue of origin.
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(C) Comparison to COCA clusters.
FIGURE C.43: Unsupervised multiplatform analysis of ten
cancer types. (A) Weighted kernel, final clusters, tissues of
origin, and COCA clusters. (B) Coincidence matrix compar-
ing the tissue of origin of the tumour samples to the new
clusters. (c) Coincidence matrix comparing the COCA clus-
ters of Hoadley et al. to the new clusters.
235
















































FIGURE C.44: Average silhouette for number of clusters go-
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FIGURE C.45: Weights assigned by the multiple kernel k-
means algorithm to each observations in each layer, where
“CN” stands for copy number and “RPPA” for reverse phase
protein array. The weights assigned on average to the tu-
mour samples in each layer are: copy number 8.1%, methy-
lation 3.8%, miRNA 3.6%, mRNA 3.7%, protein 80.8%.
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C.2.4 Outcome-guided integration: additional figures and results
First, we report some additional figures for the outcome-guided integration of
Section 4.4, then we repeat the analysis with the reduced datasets obtained as
described in Section C.2.1.
Comparison with the clusters identified by Hoadley et al. (2014)
In Figure C.46 are shown the correspondences between the clusters found in the
main paper in the outcome-guided case and the clusters identified by Hoadley
et al. (2014) using Cluster-Of-Clusters Analysis (COCA).
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FIGURE C.46: Comparison between the clusters found com-
bining the PSMs of each layer using the outcome-guided ap-
proach and those identified by Hoadley et al. (2014) using
COCA.
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Clustering structure in the data
Figures C.47, C.48, C.49, and C.50 show the four data layers where the rows have













FIGURE C.47: Left: copy number data (each row is a tumour
sample). Right: final clusters, tissues of origin of each sam-













FIGURE C.48: Left: miRNA expression data (each row is a
tumour sample). Right: final clusters, tissues of origin of
each sample, and COCA clusters.
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FIGURE C.49: Left: methylation data (each row is a tumour
sample). Right: final clusters, tissues of origin of each sam-













FIGURE C.50: Left: protein expression data (each row is a
tumour sample). Right: final clusters, tissues of origin of
each sample, and COCA clusters.
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Outcome-guided integration after variable selection, α = 0.1
The weights assigned on average to the tumour samples in each layer are: copy




































































(A) Clusters and weighted kernel.
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FIGURE C.51: Outcome-guided multiplatform analysis of
ten cancer types. (A) Weighted kernel, final clusters, tissues
of origin, and COCA clusters. (B) Coincidence matrix com-
paring the tissue of origin of the tumour samples with the
clusters.
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FIGURE C.52: Average silhouette for number of clusters go-
ing from 2 to 50.
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FIGURE C.53: Comparison between the clusters found com-
bining the PSMs of each layer using the outcome-guided ap-
proach and those identified by Hoadley et al. (2014) using
COCA.
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Appendix C. Appendix to Chapter 4
Outcome-guided integration after variable selection, α = 0.5
The weights assigned on average to the tumour samples in each layer are: copy






















































(A) Clusters and weighted kernel.
0 0 0 0 1 9 0 201101138120 87 0 0
2 0 0 1 0 23 0 0 2 1 0 12 210169
208 0 3 0 8 0 1 0 4 0 0 5 0 0
0 0 0 0 0 122137 0 17 0 1 8 0 0
0 0 177 0 19 6 0 0 2 0 0 1 0 0
10 0 6 0 126 2 0 0 5 0 0 1 0 0
0 0 14 1 1 2 0 0 89 0 0 2 0 0
0 0 0 105 0 5 0 0 1 1 0 4 0 0
0 0 0 50 0 0 0 0 0 0 0 0 0 0



































































































FIGURE C.54: Outcome-guided multiplatform analysis of
ten cancer types. (A) Weighted kernel, final clusters, tissues
of origin, and COCA clusters. (B) Coincidence matrix com-
paring the tissue of origin of the tumour samples with the
clusters.
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FIGURE C.55: Average silhouette for number of clusters go-
ing from 2 to 50.
0 0 0 0 0 0 15 8 0 0 201128111 86
0 209169 0 0 0 0 25 0 1 0 4 0 12
3 0 0 0 194136 19 8 0 0 0 1 0 4
213 0 0 1 2 16 18 0 2 0 0 0 0 5
0 0 0 198 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 17 121135 0 0 0 1 8
0 0 0 0 0 0 1 5 1 155 0 1 0 4
1 0 0 0 0 2 84 1 0 0 0 6 9 1
0 0 0 0 3 0 64 1 0 0 0 0 0 0
3 0 0 0 0 1 0 0 0 1 0 0 0 0
0 1 0 0 1 0 2 0 0 0 0 0 0 0




































































































FIGURE C.56: Comparison between the clusters found com-
bining the PSMs of each layer using the outcome-guided ap-
proach and those identified by Hoadley et al. (2014) using
COCA.
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Outcome-guided integration after variable selection, α = 1
The weights assigned on average to the tumour samples in each layer are: copy






























































(A) Clusters and weighted kernel.
0 0 1 0 0 0 0 1 0 0 0 0 0 0 99 96 91 89 87 78 67 48
2 0 0 0 0 0 110106103 97 0 0 1 1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 101100 83 1 0 0 0 0 0 0 0 0
0 0 0 0 122 83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
15 0 129 0 1 3 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0
1 0 2 0 1 4 0 2 0 0 0 0 0 99 0 0 0 0 0 0 0 0
0 0 1 114 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 191 0 0 0 0 0 1 0 0 0 0 8 0 0 0 0 0 0 0 0 0



















































































































































FIGURE C.57: Outcome-guided multiplatform analysis of
ten cancer types. (A) Weighted kernel, final clusters, tissues
of origin, and COCA clusters. (B) Coincidence matrix com-
paring the tissue of origin of the tumour samples with the
clusters.
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FIGURE C.58: Average silhouette for number of clusters go-
ing from 2 to 50.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 99 91 88 87 78 59 47
0 0 0 0 0 0 110106103 97 0 0 1 0 0 0 3 0 0 0 0 0
6 0 0 121124 88 0 1 0 0 0 0 0 24 0 0 0 0 0 0 1 0
0 190 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 101 98 83 0 0 0 0 0 0 0 0 0
2 0 0 1 0 0 0 1 0 0 0 0 0 0 89 0 2 1 0 0 7 1
1 0 0 1 0 0 0 0 0 0 0 0 0 65 1 0 0 0 0 0 0 0
3 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
0 0 0 1 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0
0 0 164 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0




















































































































































FIGURE C.59: Comparison between the clusters found com-
bining the PSMs of each layer using the outcome-guided ap-
proach and those identified by Hoadley et al. (2014) using
COCA.
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C.3 TRANSCRIPTIONAL MODULE DISCOVERY
We present here some additional figures for the transcriptional module discovery
application of Section 4.5.
Figures C.60 and C.61 show the initial data, the clusterings obtained on each
dataset individually and the PSMs. The cophenetic correlation coefficients are
0.953685 for the expression data and 0.9841434 for the ChIP data. 3.5% of the
weight is assigned on average to the ChIP data, and the remaining 96.5% to the
expression data.
(A) Expression data. (B) ChIP-chip data.
FIGURE C.60: Clusters obtained on each dataset separately.
The ordering of the rows is different in the two figures. (A)
Left: expression data. Each row corresponds to a gene and
each column to a different time point. Right: clusters ob-
tained using the expression data only. (B) Left: ChIP-chip
data. Each row corresponds to a gene and each column to a
transcriptional regulator. Right: clusters obtained using the
ChIP-chip data only.
In Figure C.62 are reported the values of the average silhouette for different val-
ues of the number of clusters K. We choose K = 25, which gives the highest value
of the silhouette.
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C.3. Transcriptional module discovery
(A) Expression data. (B) ChIP-chip data.
FIGURE C.61: PSMs and clusterings obtained via kernel k-
means on each dataset separately. The ordering of the ob-
servations is different in the two figures. (A) Left: weights
assigned to the expression data by KLIC. Centre: PSM of the
expression data. Right: clusters obtained using the expres-
sion data only. (B) Right: weights assigned to the ChIP-chip
data by KLIC. Centre: PSM of the ChIP-chip data. Right:
clusters obtained using the ChIP-chip data only.
FIGURE C.62: Plot of silhouette for different numbers of
clusters for the integration of the datasets of Harbison et al.





APPENDIX TO CHAPTER 5
This appendix contains additional figures and results for the cluster analysis of
the CMS data presented in Chapter 5.
D.1 APPLYING KLIC TO THE CARDIOMETABOLIC DISEASE DATA
Sections D.1.1 and D.1.2 contain some figures and tables summarising the output
of the MCMC algorithms run on the full and reduced CMS data layers respec-
tively. Sections D.1.3 and D.1.4 contain additional figures for the unsupervised
and outcome-guided analyses of the CMS data respectively.
D.1.1 MCMC convergence assessment: full dataset
As for the pan-cancer data analysis (Appendix C), we run five MCMC chains
for 50,000 iterations, with a burn-in period of 25,000 iterations and thinning of
5. For each set of five chains, we check the Vats-Knudson R̂ (Vats and Knudson,
2018) with parameters ε = 0.1 and α = 0.1 to assess the convergence of the mass
parameter. The PSMs obtained for the five chains are summarised into one by
taking the average.
249












































FIGURE D.1: Five PSMs of the ChIP-seq data (monocytes)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.22 0.31 0.27 0.26
Chain 2 1 0.24 0.56 0.35
Chain 3 1 0.30 0.26
Chain 4 1 0.33
TABLE D.1: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.






































































































































FIGURE D.2: MCMC convergence assessment, ChIP-seq
data (monocytes).
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FIGURE D.3: Five PSMs of the ChIP-seq data (neutrophils)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.20 0.20 0.10 0.80
Chain 2 1 0.18 0.16 0.18
Chain 3 1 0.12 0.12
Chain 4 1 0.17
TABLE D.2: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.








































































































































FIGURE D.4: MCMC convergence assessment, ChIP-seq
data (neutrophils).
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FIGURE D.5: Five PSMs of the RNA-seq (monocytes) and
their average (bottom right). On the right of each PSM is
indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.08 0.20 0.14 0.07
Chain 2 1 0.04 0.21 0.10
Chain 3 1 0.09 0.07
Chain 4 1 0.07
TABLE D.3: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.








































































































































FIGURE D.6: MCMC convergence assessment, RNA-seq
data (monocytes).
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FIGURE D.7: Five PSMs of the RNA-seq (neutrophils) and
their average (bottom right). On the right of each PSM is
indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.11 0.13 0.04 0.16
Chain 2 1 0.06 0.25 0.03
Chain 3 1 0.05 0.06
Chain 4 1 0.04
TABLE D.4: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.








































































































































FIGURE D.8: MCMC convergence assessment, RNA-seq
data (neutrophils).
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FIGURE D.9: Five PSMs of the methylation (monocytes) and
their average (bottom right). On the right of each PSM is
indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.13 0.23 0.25 0.18
Chain 2 1 0.10 0.20 0.06
Chain 3 1 0.26 0.18
Chain 4 1 0.20
TABLE D.5: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.






































































































































FIGURE D.10: MCMC convergence assessment, methylation
data (monocytes).
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FIGURE D.11: Five PSMs of the methylation (neutrophils)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.17 0.11 0.12 0.09
Chain 2 1 0.17 0.33 0.06
Chain 3 1 0.14 0.08
Chain 4 1 0.05
TABLE D.6: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.








































































































































FIGURE D.12: MCMC convergence assessment, methylation
data (neutrophils).
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FIGURE D.13: Five PSMs of the metabolites and their aver-
age (bottom right). On the right of each PSM is indicated the
cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.42 0.25 0.22 0.20
Chain 2 1 0.20 0.46 0.18
Chain 3 1 0.13 0.14
Chain 4 1 0.14
TABLE D.7: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.






































































































































FIGURE D.14: MCMC convergence assessment, metabolite
data.
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FIGURE D.15: Five PSMs of the lipids and their average (bot-
tom right). On the right of each PSM is indicated the cohort
to which each individual belongs.
264
D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.82 0.38 0.83 0.80
Chain 2 1 0.42 0.95 0.90
Chain 3 1 0.42 0.40
Chain 4 1 0.93
TABLE D.8: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.







































































































































FIGURE D.16: MCMC convergence assessment, lipids data.
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Appendix D. Appendix to Chapter 5
D.1.2 MCMC convergence assessment: reduced dataset
Again, we assess the convergence of the MCMC chains first, and then combine











































FIGURE D.17: Five PSMs of the ChIP-seq data (monocytes)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.33 0.27 0.26 0.51
Chain 2 1 0.24 0.21 0.32
Chain 3 1 0.45 0.34
Chain 4 1 0.33
TABLE D.9: ARI between the clusterings found on the PSMs
of different chains with the number of clusters that max-
imises the silhouette.




































































































































FIGURE D.18: MCMC convergence assessment, ChIP-seq
data (monocytes).
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FIGURE D.19: Five PSMs of the ChIP-seq data (neutrophils)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.43 0.65 0.43 0.20
Chain 2 1 0.32 0.51 0.36
Chain 3 1 0.37 0.20
Chain 4 1 0.27
TABLE D.10: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.







































































































































FIGURE D.20: MCMC convergence assessment, ChIP-seq
data (neutrophils).
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FIGURE D.21: Five PSMs of the RNA-seq (monocytes) and
their average (bottom right). On the right of each PSM is
indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.21 0.47 0.38 0.34
Chain 2 1 0.33 0.25 0.42
Chain 3 1 0.35 0.45
Chain 4 1 0.49
TABLE D.11: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.






































































































































FIGURE D.22: MCMC convergence assessment, RNA-seq
data (monocytes).
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FIGURE D.23: Five PSMs of the RNA-seq (neutrophils) and
their average (bottom right). On the right of each PSM is
indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.71 0.39 0.37 0.45
Chain 2 1 0.36 0.36 0.48
Chain 3 1 0.42 0.23
Chain 4 1 0.31
TABLE D.12: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.







































































































































FIGURE D.24: MCMC convergence assessment, RNA-seq
data (neutrophils).
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FIGURE D.25: Five PSMs of the methylation (monocytes)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.75 0.88 0.88 0.79
Chain 2 1 0.71 0.72 0.90
Chain 3 1 0.89 0.76
Chain 4 1 0.77
TABLE D.13: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.










































































































































FIGURE D.26: MCMC convergence assessment, methylation
data (monocytes).
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FIGURE D.27: Five PSMs of the methylation (neutrophils)
and their average (bottom right). On the right of each PSM
is indicated the cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.84 0.80 0.90 0.80
Chain 2 1 0.85 0.84 0.83
Chain 3 1 0.80 0.75
Chain 4 1 0.79
TABLE D.14: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.


































































































































FIGURE D.28: MCMC convergence assessment, methylation
data (neutrophils).
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FIGURE D.29: Five PSMs of the metabolites and their aver-
age (bottom right). On the right of each PSM is indicated the
cohort to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.71 0.80 0.80 0.79
Chain 2 1 0.73 0.70 0.65
Chain 3 1 0.75 0.76
Chain 4 1 0.80
TABLE D.15: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.


































































































































FIGURE D.30: MCMC convergence assessment, metabolite
data.
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FIGURE D.31: Five PSMs of the lipids and their average (bot-
tom right). On the right of each PSM is indicated the cohort
to which each individual belongs.
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D.1. Applying KLIC to the cardiometabolic disease data
Chain 2 Chain 3 Chain 4 Chain 5
Chain 1 0.97 1.00 0.73 0.97
Chain 2 1 0.97 0.72 0.99
Chain 3 1 0.73 0.97
Chain 4 1 0.71
TABLE D.16: ARI between the clusterings found on the
PSMs of different chains with the number of clusters that
maximises the silhouette.












































































































































FIGURE D.32: MCMC convergence assessment, lipid data.
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Appendix D. Appendix to Chapter 5
D.1.3 Unsupervised integration: additional figures
Clustering structure in the data
Figures D.33 to D.40 show how the eight data layers where the rows have been

























FIGURE D.33: Left: ChIP-seq data, monocytes (each row is

























FIGURE D.34: Left: ChIP-seq data, monocytes (each row is
an individual). Right: cohorts and final clusters.
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FIGURE D.35: Left: RNA-seq data, monocytes (each row is

























FIGURE D.36: Left: RNA-seq data, neutrophils (each row is
an individual). Right: cohorts and final clusters.
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FIGURE D.37: Left: methylation data, monocytes (each row

























FIGURE D.38: Left: methylation data, neutrophils (each row
is an individual). Right: cohorts and final clusters.
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FIGURE D.39: Left: metabolite data (each row is an individ-

























FIGURE D.40: Left: lipid data (each row is an individual).
Right: cohorts and final clusters.
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Appendix D. Appendix to Chapter 5
D.1.4 Outcome-guided integration: additional figures
Figures D.41 to D.48 show how the eight data layers where the rows have been


























FIGURE D.41: Left: ChIP-seq data, monocytes (each row is


























FIGURE D.42: Left: ChIP-seq data, monocytes (each row is
an individual). Right: cohorts and final clusters.
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FIGURE D.43: Left: RNA-seq data, monocytes (each row is


























FIGURE D.44: Left: RNA-seq data, neutrophils (each row is
an individual). Right: cohorts and final clusters.
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FIGURE D.45: Left: methylation data, monocytes (each row


























FIGURE D.46: Left: methylation data, neutrophils (each row
is an individual). Right: cohorts and final clusters.
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FIGURE D.47: Left: metabolite data (each row is an individ-


























FIGURE D.48: Left: lipid data (each row is an individual).
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Kieć-Klimczak, Małgorzata, Małgorzata Malczewska-Malec, and Bohdan Huszno
(2008). “Leptin to adiponectin ratio, as an index of insulin resistance and ather-
osclerosis development”. In: Przeglad Lekarski 65.12, pp. 844–849.
Kim, Seyoung, Eric P Xing, et al. (2012). “Tree-guided group lasso for multi-
response regression with structured sparsity, with an application to eQTL map-
ping”. In: The Annals of Applied Statistics 6.3, pp. 1095–1117.
DOI: 10.1214/12-AOAS549.
Kim, Sinae, Mahlet G Tadesse, and Marina Vannucci (2006). “Variable selection in
clustering via Dirichlet process mixture models”. In: Biometrika 93.4, pp. 877–
893.
DOI: 10.1093/biomet/93.4.877.
Kim, SungHwan et al. (2015). “Integrative phenotyping framework (iPF): integra-
tive clustering of multiple omics data identifies novel lung disease subpheno-
types”. In: BMC Genomics 16.1, p. 924.
DOI: 10.1186/s12864-015-2170-4.
Kim, Sunghwan et al. (2017). “Integrative clustering of multi-level omics data
for disease subtype discovery using sequential double regularization”. In: Bio-
statistics 18.1, pp. 165–179.
DOI: 10.1093/biostatistics/kxw039.
Kirk, Erik P and Samuel Klein (2009). “Pathogenesis and pathophysiology of
the cardiometabolic syndrome”. In: The Journal of Clinical Hypertension 11.12,
pp. 761–765.
DOI: 10.1111/j.1559-4572.2009.00054.x.
Kirk, Paul DW et al. (2012). “Bayesian correlated clustering to integrate multiple
datasets”. In: Bioinformatics 28.24, pp. 3290–3297.
DOI: 10.1093/bioinformatics/bts595.
Klein, Robert J et al. (2005). “Complement factor H polymorphism in age-related
macular degeneration”. In: Science 308.5720, pp. 385–389.
DOI: 10.1126/science.1109557.
Knerr, Stefan, Léon Personnaz, and Gérard Dreyfus (1990). “Single-layer learning
revisited: a stepwise procedure for building and training a neural network”. In:
Neurocomputing: Algorithms, Architectures and Applications 68.41-50, p. 71.
DOI: 10.1007/978-3-642-76153-9_5.
Koestler, Devin C et al. (2010). “Semi-supervised recursively partitioned mixture
models for identifying cancer subtypes”. In: Bioinformatics 26.20, pp. 2578–2585.
DOI: 10.1093/bioinformatics/btq470.
Kohavi, Ron (1995). “A study of cross-validation and bootstrap for accuracy esti-
mation and model selection”. In: International Joint Conference of Artificial Intel-
ligence. Vol. 14. 2, pp. 1137–1145.
Kolde, Raivo et al. (2012). “Robust rank aggregation for gene list integration and




Koning, AP Jason de et al. (2011). “Repetitive elements may comprise over two-
thirds of the human genome”. In: PLoS Genetics 7.12, e1002384.
DOI: 10.1371/journal.pgen.1002384.
Kristensen, Vessela N et al. (2012). “Integrated molecular profiles of invasive breast
tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and in-
terleukin signaling”. In: Proceedings of the National Academy of Sciences 109.8,
pp. 2802–2807.
DOI: 10.1073/pnas.1108781108.
Kristensen, Vessela N et al. (2014). “Principles and methods of integrative ge-
nomic analyses in cancer.” In: Nature Reviews Cancer 14.5, pp. 299–313.
DOI: 10.1038/nrc3721.
Kulis, Brian et al. (2013). “Metric learning: A survey”. In: Foundations and Trends R©
in Machine Learning 5.4, pp. 287–364.
DOI: 10.1561/2200000019.
Kuo, Min-Hao and C David Allis (1998). “Roles of histone acetyltransferases and
deacetylases in gene regulation”. In: Bioessays 20.8, pp. 615–626.
DOI: 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H.
Lala, Vasimahmed and David A Minter (2018). “Liver function tests”. In: Stat-
Pearls. StatPearls Publishing.
URL: http://europepmc.org/books/NBK482489.
Lanckriet, Gert RG et al. (2004a). “A statistical framework for genomic data fu-
sion”. In: Bioinformatics 20.16, pp. 2626–2635.
DOI: 10.1093/bioinformatics/bth294.
– (2004b). “Learning the kernel matrix with semidefinite programming”. In: Jour-
nal of Machine Learning Research 5.Jan, pp. 27–72.
URL: https://www.jmlr.org/papers/v5/lanckriet04a.html.
Latchman, David S (1997). “Transcription factors: an overview”. In: The interna-
tional journal of biochemistry & cell biology 29.12, pp. 1305–1312.
DOI: 10.1016/S1357-2725(97)00085-X.
Lavit, Christine et al. (1994). “The ACT (STATIS method)”. In: Computational Statis-
tics & Data Analysis 18.1, pp. 97–119.
DOI: 10.1016/0167-9473(94)90134-1.
Lee, James C et al. (2011). “Gene expression profiling of CD8+ T cells predicts
prognosis in patients with Crohn disease and ulcerative colitis”. In: The Journal
of clinical investigation 121.10, pp. 4170–4179.
DOI: 10.1172/JCI59255.
Leek, Jeffrey T et al. (2010). “Tackling the widespread and critical impact of batch
effects in high-throughput data”. In: Nature Reviews Genetics 11.10, pp. 733–739.
DOI: 10.1038/nrg2825.





Lemsara, Amina, Salima Ouadfel, and Holger Fröhlich (2020). “PathME: pathway
based multi-modal sparse autoencoders for clustering of patient-level multi-
omics data”. In: BMC Bioinformatics 21.1, pp. 1–20.
DOI: 10.1186/s12859-020-3465-2.
Levine, Adrian B et al. (2019). “Rise of the machines: Advances in deep learning
for cancer diagnosis”. In: Trends in Cancer.
DOI: 10.1016/j.trecan.2019.02.002.
Li, Xue, Xinlei Wang, and Guanghua Xiao (2019). “A comparative study of rank
aggregation methods for partial and top ranked lists in genomic applications”.
In: Briefings in Bioinformatics 20.1, pp. 178–189.
DOI: 10.1093/bib/bbx101.
Li, Yifeng, Fang-Xiang Wu, and Alioune Ngom (2018). “A review on machine
learning principles for multi-view biological data integration”. In: Briefings in
Bioinformatics 19.2, pp. 325–340.
DOI: 10.1093/bib/bbw113.
Liang, Muxuan et al. (2014). “Integrative data analysis of multi-platform cancer
data with a multimodal deep learning approach”. In: IEEE/ACM Transactions
on Computational Biology and Bioinformatics 12.4, pp. 928–937.
DOI: 10.1109/TCBB.2014.2377729.
Lin, Shili (2010). “Rank aggregation methods”. In: Wiley Interdisciplinary Reviews:
Computational Statistics 2.5, pp. 555–570.
DOI: 10.1002/wics.111.
Lin, Shili and Jie Ding (2009). “Integration of ranked lists via cross entropy Monte
Carlo with applications to mRNA and microRNA studies”. In: Biometrics 65.1,
pp. 9–18.
DOI: 10.1111/j.1541-0420.2008.01044.x.
Lindsay, Tim et al. (2019). “Descriptive epidemiology of physical activity energy
expenditure in UK adults (The Fenland study)”. In: International Journal of Be-
havioral Nutrition and Physical Activity 16.1, p. 126.
DOI: 10.1186/s12966-019-0882-6.
Liu, Jie et al. (2018). “Data integration by multi-tuning parameter elastic net re-
gression”. In: BMC Bioinformatics 19.1, pp. 1–9.
DOI: 10.1186/s12859-018-2401-1.
Liu, Xiangdong et al. (2007). “Bayesian hierarchical model for transcriptional mod-
ule discovery by jointly modeling gene expression and ChIP-chip data”. In:
BMC Bioinformatics 8.1, p. 283.
DOI: 10.1186/1471-2105-8-283.
Liverani, Silvia et al. (2015). “PReMiuM: An R package for profile regression mix-





Lock, Eric F and David B Dunson (2013). “Bayesian consensus clustering”. In:
Bioinformatics, btt425.
DOI: 10.1093/bioinformatics/btt425.
Lock, Eric F et al. (2013). “Joint and individual variation explained (JIVE) for in-
tegrated analysis of multiple data types”. In: The annals of applied statistics 7.1,
p. 523.
Luenberger, David G and Yinyu Ye (1984). Linear and nonlinear programming. Springer.
DOI: 10.1007/978-3-319-18842-3.
Lunn, David et al. (2012). The BUGS book: A practical introduction to Bayesian anal-
ysis. CRC press.
Ma, Tianle and Aidong Zhang (2018). “Affinity network fusion and semi-supervised
learning for cancer patient clustering”. In: Methods 145, pp. 16–24.
DOI: 10.1016/j.ymeth.2018.05.020.
Mann, Henry B and Donald R Whitney (1947). “On a test of whether one of two
random variables is stochastically larger than the other”. In: The Annals of Math-
ematical Statistics, pp. 50–60.
DOI: 10.1214/aoms/1177730491.
Mariette, Jérôme and Nathalie Villa-Vialaneix (2018). “Unsupervised multiple ker-
nel learning for heterogeneous data integration”. In: Bioinformatics 34.6, pp. 1009–
1015.
DOI: 10.1093/bioinformatics/btx682.




Mason, Samuel A et al. (2016). “MDI-GPU: accelerating integrative modelling for
genomic-scale data using GP-GPU computing.” In: Statistical Applications in Ge-
netics and Molecular Biology 15.1, pp. 83–86.
DOI: 10.1515/sagmb-2015-0055.
McCarroll, Steven A and David M Altshuler (2007). “Copy-number variation and
association studies of human disease”. In: Nature genetics 39.7, S37–S42.
DOI: 10.1038/ng2080.
McIntyre, Lauren M et al. (2000). “Circumventing multiple testing: a multilocus
Monte Carlo approach to testing for association”. In: Genetic Epidemiology: The
Official Publication of the International Genetic Epidemiology Society 19.1, pp. 18–
29.
DOI: 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y.
McKay, Michael D, Richard J Beckman, and William J Conover (1979). “Compar-
ison of three methods for selecting values of input variables in the analysis of




McLachlan, Geoffrey J and David Peel (2004). Finite mixture models. John Wiley &
Sons.
Medvedovic, Mario and Siva Sivaganesan (2002). “Bayesian infinite mixture model
based clustering of gene expression profiles”. In: Bioinformatics 18.9, pp. 1194–
1206.
DOI: 10.1093/bioinformatics/18.9.1194.
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